Evaluation Of Anaerobic Biodegradability Characteristics Of Antibiotics And Toxic/inhibitory Effect On Mixed Microbial Culture by Çetecioğlu, Zeynep
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISTANBUL TECHNICAL UNIVERSITY  INSTITUTE OF SCIENCE AND TECHNOLOGY 
Ph.D. Thesis by 
Zeynep ÇETECĠOĞLU 
 
Department : Environmental Engineering 
Programme : Environmental Biotechnology 
 
OCTOBER 2011  
EVALUATION OF ANAEROBIC BIODEGRADABILITY 
CHARACTERISTICS OF ANTIBIOTICS AND  
TOXIC/INHIBITORY EFFECT ON MIXED MICROBIAL CULTURE 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISTANBUL TECHNICAL UNIVERSITY  INSTITUTE OF SCIENCE AND TECHNOLOGY 
 
Ph.D. Thesis by 
Zeynep ÇETECĠOĞLU 
(501062804) 
 
 Date of submission : 08 July 2011 
Date of defence examination: 04 October 2011 
 
Supervisor (Chairman) : Prof. Orhan ĠNCE (ITU) 
Co-Supervisor : Prof. Derin ORHON (ITU) 
   Members of the Examining Committee : Prof. Candan TAMERLER (ITU) 
Assoc. Prof. Süleyman ÖVEZ (ITU) 
Prof. Emine UBAY ÇOKGÖR (ITU) 
Prof. Orhan YENĠGÜN (BOUN) 
Prof. Bülent KESKĠNLER (GYTE) 
  
  
 
OCTOBER 2011 
 
EVALUATION OF ANAEROBIC BIODEGRADABILITY 
CHARACTERISTICS OF ANTIBIOTICS AND  
TOXIC/INHIBITORY EFFECT ON MIXED MICROBIAL CULTURE 
 
  
 
 
 
 
 
 EKĠM 2011 
 
ĠSTANBUL TEKNĠK ÜNĠVERSĠTESĠ  FEN BĠLĠMLERĠ ENSTĠTÜSÜ 
 
DOKTORA TEZĠ 
Zeynep ÇETECĠOĞLU 
(501062804) 
 
Tezin Enstitüye Verildiği Tarih : 08 Temmuz 2011 
Tezin Savunulduğu Tarih : 04 Ekim 2011 
 
 Tez DanıĢmanı : Prof. Dr. Orhan ĠNCE (ĠTÜ) 
EĢ-DanıĢman : Prof. Dr. Derin ORHON (ĠTÜ) 
                                    Diğer Jüri Üyeleri: Prof. Dr. Candan TAMERLER (ĠTÜ) 
Doç. Dr. Süleyman ÖVEZ (ĠTÜ) 
Prof. Dr. Emine UBAY ÇOKGÖR (ĠTÜ) 
Prof. Dr. Orhan YENĠGÜN (BOUN) 
Prof. Dr. Bülent KESKĠNLER (GYTE) 
 
 
 
ANTĠBĠYOTĠKLERĠN ANAEROBĠK BĠYOLOJĠK AYRIġABĠLĠRLĠK 
ÖZELLĠKLERĠNĠN VE KARIġIK MĠKROBĠYAL KÜLTÜR ÜZERĠNE 
TOKSĠSĠTE/ĠNHĠBĠSYON ETKĠLERĠNĠN DEĞERLENDĠRĠLMESĠ 
  v 
 
 
 
              To the memory of my father, Cahit Çetecioğlu... 
 
 
 
 
 vi 
 
 
 
 
 
 
 
 
  vii 
 
FOREWORD 
I would like to express my deep appreciation and thanks for my supervisor, Prof. 
Orhan İnce for his guidance and encouragement during not only this study but in 
every step of my life. I will always appreciate to him for having me chance on the 
academic life and giving a life-time experience. He has always supported me both in 
the academic and personal life.  
I would also like to thank my co-supervisor, Prof. Derin Orhon, who has supported 
me during this study. He has shared with me his all deep experience and my vision 
has expanded with his valuable approaches. I appreciate his many useful comments 
on this work, but even more so, I appreciate his advice and willingness to discuss any 
questions or ideas that I have had. 
I would also like to express my deep and sincere gratitude to Prof. Bahar İnce. She 
has presented all facilities in Bogazici University and I could not complete this study 
without her support. However I express my heartiest thanks to her because she 
always makes me feel that I am not alone and I have a second family. I must say that 
I feel lucky to know her. 
I would also thanks to Assis. Prof. Nilgün Ayman Öz who shared all experimental 
experience with me. 
Many thanks go in particular to Samet Azman, Neşe Coşkun and Nazlı Gökçek for 
their support during the work and helping me run the experiments.  
I would like to thank to the Microbial Ecology Group (MEG) as well as the all 
academic personal of Environmental Engineering Department of Istanbul Technical 
University.  
I would also like to thank to all members of Water Quality Group of Catalan Institute 
for Water Research (ICRA) for not only their scientific helps but also their 
friendship. They made me fell in my home during my stay in Girona.  
This study was supported by Joint Doctoral Programme of The Turkish Academy of 
Sciences (TUBA). The financial support partly provided by the Istanbul Technical 
University Research Fund to the project I type is greatly acknowledged.  
I express my heartiest thanks to my dear friends Bilge Baş, Senem Teksoy Başaran 
and Sinem Karaman for their friendship and helps. Also I would like to thank Gözde 
Özbayram and Sevcan Aydın for their support.  
 
 
 
 
 
 
 viii 
The most special thanks go to my dear father Cahit Çetecioğlu, who lost his life in 
the beginnig of my PhD, for his endless love, support, patience and understanding 
during my life. Words fail me to express my feeling to my father. The life without 
him and his encouragement has been difficult for me, but I feel happy to achieve his 
dream: ‗Babiş yaptım‘.  
 
July 2011 
 
Zeynep Çetecioğlu 
Environmental Engineer and 
Molecular Biologist 
 
 
 
 
  ix 
TABLE OF CONTENTS 
                                                                                                                                                 Page 
   
FOREWORD ............................................................................................................ vii 
TABLE OF CONTENTS .......................................................................................... ix 
ABBREVIATIONS ................................................................................................. xiii 
LIST OF TABLES ................................................................................................... xv 
LIST OF FIGURES ............................................................................................... xvii 
SUMMARY ........................................................................................................... xxiii 
ÖZET ....................................................................................................................... xxv 
1. INTRODUCTION ............................................................................................... 1 
1.1 Aim and Scope ............................................................................................... 2 
2. LITERATURE BACKGROUND ...................................................................... 5 
2.1 Pharmaceuticals ............................................................................................. 5 
2.1.1 Parent compounds, metabolites and transformation products................. 6 
2.2 Antibiotics ...................................................................................................... 8 
2.2.1 Sulfamethoxazole .................................................................................... 9 
2.2.2 Erythromycin......................................................................................... 10 
2.2.3 Tetracycline ........................................................................................... 11 
2.2.4 Consumption and occurrence ................................................................ 12 
2.2.5 Production and manufacturing .............................................................. 15 
2.2.6 Elimination and treatment ..................................................................... 15 
2.2.6.1 Sorption .......................................................................................... 15 
2.2.6.2 Photolysis ....................................................................................... 16 
2.2.6.3 Hydrolysis and thermolysis ............................................................ 17 
2.2.6.4 Oxidation ........................................................................................ 17 
2.2.6.5 Biodegradation ............................................................................... 18 
2.3 Inhibition and Toxicity ................................................................................. 19 
2.3.1. Types of inhibition ............................................................................... 19 
2.4 Fundamentals of Anaerobic Treatment ........................................................ 20 
2.4.2 Acidogenesis ......................................................................................... 23 
2.4.3 Acetogenesis ......................................................................................... 24 
2.4.4 Methanogenesis ..................................................................................... 25 
2.4.5 Characterization of microbial communities in anaerobic reactors ........ 29 
2.4.5.1 Molecular tools............................................................................... 32 
2.5 Environmental and Operational Factors Effecting Anaerobic Treatment.... 36 
2.5.1 Temperature .......................................................................................... 36 
2.5.2 Alkalinity and pH .................................................................................. 37 
2.5.3 Nutrients ................................................................................................ 37 
2.5.4 Mixing ................................................................................................... 38 
2.5.5 Retention Time ...................................................................................... 38 
2.5.6 Toxicants ............................................................................................... 38 
 x 
2.5.6.1 Volatile Fatty Acids (VFA) inhibition ........................................... 38 
2.5.6.2 Alkali and alkaline salts inhibition ................................................. 39 
2.5.6.3 Ammonia-Nitrogen inhibition ........................................................ 39 
2.5.6.5 Heavy metal inhibition ................................................................... 40 
2.6 Anaerobic Bioreactor Configurations .......................................................... 41 
2.6.1 Anaerobic contact reactors .................................................................... 41 
2.6.2 Upflow anaerobic sludge blanket (UASB) reactors .............................. 42 
2.6.3 Anaerobic sequencing batch reactors (ASBR) ...................................... 42 
2.6.4 Fixed bed processes ............................................................................... 44 
2.6.5 Anaerobic expanded/fluidized bed processes ....................................... 44 
2.6.6 Anaerobic membrane bioreactor ........................................................... 45 
3. MATERIALS AND METHODS...................................................................... 46 
3.1 Experimental Approach................................................................................ 46 
3.2 Bioreactor Operations .................................................................................. 47 
3.2.1 Laboratory scale anaerobic sequencing batch reactor (stock reactor) ... 47 
3.2.2 Laboratory scale anaerobic batch reactors (acute tests) ........................ 48 
3.2.3 Laboratory scale anaerobic sequencing batch reactors (chronic tests) . 48 
3.3 Seed Sludge .................................................................................................. 50 
3.4 Analytical Methods ...................................................................................... 50 
3.5 Specific Activity Test ................................................................................... 50 
3.6 Antibiotic Measurement ............................................................................... 51 
3.6.1 Sludge .................................................................................................... 51 
3.6.1.1 Method optimization ...................................................................... 51 
3.6.1.2 Extraction ....................................................................................... 52 
3.6.1.3 Clean-up ......................................................................................... 52 
3.6.2 Wastewater ............................................................................................ 52 
3.6.3 Instrumental analysis ............................................................................. 52 
3.7 Microbial Characterization and Enzyme Expression Level ......................... 53 
3.7.1. Genomic DNA (GDNA) extraction ..................................................... 53 
3.7.2 Total RNA isolation and cDNA synthesis ............................................ 54 
3.7.3 PCR amplification of 16S rDNA .......................................................... 54 
3.7.4 Cloning, sequencing and phylogenetic analysis .................................... 55 
3.7.5 Denaturing gradient gel electrophoresis (DGGE) ................................. 56 
3.7.6 Quantitative real time polymerase chain reaction (Q-PCR) .................. 57 
3.7.7 Fluorescence in situ hybridization (FISH) ............................................ 58 
3.8 Statistical Analysis ....................................................................................... 60 
4. RESULTS AND DISCUSSION ........................................................................ 62 
4.1 Stock Anaerobic Sequencing Batch Reactor ................................................ 62 
4.1.1 Performance of the reactor .................................................................... 62 
4.2 Characterization of Seed Sludge .................................................................. 64 
4.2.1 Specific methanogenic activity (SMA) test .......................................... 64 
4.2.2 Bacterial and archaeal 16S rDNA clone libraries ................................. 65 
4.2.3 Quantification by Q-PCR and FISH...................................................... 75 
4.3 Acute Tests ................................................................................................... 76 
4.3.1 Acute effects on acetoclastic methanogenic activity ............................. 77 
4.3.1.1 Cumulative biogas production ....................................................... 77 
4.3.1.2 Chemical oxygen demand (COD) and acetate removal ................. 81 
4.3.2 Acute effects on methanogenic activity ................................................ 84 
4.3.2.1 Cumulative biogas production ....................................................... 84 
  xi 
4.3.2.2 Chemical oxygen demand (COD) and volatile fatty acid (VFA) 
removal ....................................................................................................... 88 
4.4 Chronic Tests ............................................................................................... 92 
4.4.1 Sulfamethoxazole .................................................................................. 92 
4.4.1.1 Performance of the Sulfamethoxazole (SMX) reactor ................... 92 
4.4.1.2 Volatile fatty acids ......................................................................... 95 
4.4.1.3 Antibiotic measurement ................................................................. 96 
4.4.1.4 Specific methanogenic activity tests .............................................. 97 
4.4.2 Erythromycin....................................................................................... 121 
4.4.2.1 Performance of the Erythromycin (ERY) reactor ........................ 121 
4.4.2.2 Volatile fatty acids ....................................................................... 124 
4.4.2.3 Antibiotic measurement ............................................................... 125 
4.4.2.4 Specific methanogenic activity tests ............................................ 126 
4.4.2.5 Microbiological Approach ........................................................... 129 
4.4.3 Tetracycline ......................................................................................... 150 
4.4.3.1 Performance of the Tetracycline (TET) reactor ........................... 150 
4.4.3.2 Volatile fatty acids ....................................................................... 154 
4.4.3.3 Antibiotic measurement ............................................................... 155 
4.4.3.4 Specific methanogenic activity tests ............................................ 155 
4.4.3.5 Microbiological approach ............................................................ 158 
5. CONCLUSION AND RECOMMENDATIONS .......................................... 179 
REFERENCES ....................................................................................................... 181 
CURRICULUM VITAE ........................................................................................ 207 
 
 xii 
  xiii 
ABBREVIATIONS 
ACP : Anaerobic Contact Reactor 
AnMBR : Anaerobic Membrane Bioreactor 
API : Active Pharmaceutical Ingredients 
ASBR : Anaerobic Sequencing Batch Reactor 
BOD : Biochemical Oxygen Demand 
CBP : Cumulative Biogas Production 
CMP : Cumulative Methane Production 
COD : Chemical Oxygen Demand 
CSTR : Continuous Stirred Tank Reactor 
DGGE : Denaturing Gradient Gel Electrophoresis 
EGSB : Expanded Granular Sludge Bed Reactor 
ERY : Erytromycin 
FISH : Fluoresence in situ Hybridization 
HRT : Hydraulic Retention Time 
MOA : Mode of Action 
OHPA : Obligate Hydrogen Producing Acetogens 
PCR : Polymerase Chain Reaction 
PMP : Potential Methane Production Rate 
Q-PCR : Quantitative Real-Time PCR 
RFLP : Restriction Fragment Length Polymorphism 
RT-PCR : Reverse Transcription PCR  
SCFA : Short Chain Fatty Acid 
SMA : Specific Methanogenic Activity 
SMX : Sulfamethoxazole 
SRT : Solid Retention Time 
SS : Suspended Solid 
SSCP : Single-Strand Conformation Polymorphism 
TET : Tetracycline 
TGGE : Temperature Gradient Gel Electrophoresis 
TOC : Total Organic Compound 
TS : Total Solid 
TVS : Total Volatile Solid 
UASB : Upflow Anaerobic Sludge Blanket Reactor 
VFA : Volatile Fatty Acid 
VSS : Volatile Suspended Solid 
 xiv 
  xv 
LIST OF TABLES 
                                                                                                                                                 Page 
Table 2.1: Pharmacology and eco-pharmacology (Kummerer, 2008) ........................ 6 
Table 2.2: Country specific antibiotics consumption and occurrence data. .............. 14 
Table 2.3: Exoenzymens and substrates (Gerardi, 2003). ......................................... 22 
Table 2.4: Substrates converted to methane by various methanogenic Archaea 
(Madigan et al., 2009). ............................................................................ 27 
Table 3.1: Organic components and concentrations of model wastewater. .............. 48 
Table 3.2: Organic components and concentrations of model wastewater. .............. 49 
Table 3.3: Extraction protocoles and recoveries. ...................................................... 51 
Table 3.4: Target Compounds and Their Optimized QqLIT-MS/MS Parameters by 
SRM Negative and Positive Ionization Mode ......................................... 53 
Table 3.5: Primers using in PCR amplification and their annealing temperatures. .. 55 
Table 3.6: Q-PCR primers ......................................................................................... 58 
Table 3.7: Oligonucleotide probes ............................................................................ 60 
Table 4.1: Affiliation of bacterial clones and their abundance within the seed 
sludges. .................................................................................................... 68 
Table 4.2: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of the seed 
sludges. .................................................................................................... 70 
Table 4.3: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of the seed 
sludges ..................................................................................................... 72 
Table 4.4: Affiliation of archaeal clones and their abundance within the seed 
sludges. .................................................................................................... 74 
Table 4.5: Affiliation of bacterial clones and their abundance at the different phases 
of the SMX reactor. ............................................................................... 102 
Table 4.6: Affiliation of archaeal clones and their abundance at the different phases 
of the SMX reactor. ............................................................................... 104 
Table 4.7: Affiliation of bacterial clones and their abundance within the active 
community at the different phases of the SMX reactor. ....................... 108 
Table 4.8: Affiliation of archaeal clones and their abundance within the active 
community at the different phases of the SMX reactor. ....................... 110 
Table 4.9: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the SMX reactor. .................................. 113 
Table 4.10: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the SMX reactor. .................................. 113 
Table 4.11: Affiliation of bacterial clones and their abundance at the different phases 
of the ERY reactor................................................................................. 132 
Table 4.12: Affiliation of archaeal clones and their abundance at the different phases 
of the ERY reactor................................................................................. 134 
 xvi 
Table 4.13: Affiliation of bacterial clones and their abundance within the active 
community at the different phases of the ERY reactor. ........................ 137 
Table 4.14: Affiliation of archaeal clones and their abundance within the active 
community at the different phases of the ERY reactor. ........................ 139 
Table 4.15: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the ERY reactor. ................................... 142 
Table 4.16: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the ERY reactor. ................................... 142 
Table 4.17: Affiliation of bacterial clones and their abundance at the different phases 
of the TET reactor. ................................................................................ 160 
Table 4.18: Affiliation of archaeal clones and their abundance at the different phases 
of the TET reactor. ................................................................................ 162 
Table 4.19: Affiliation of bacterial clones and their abundance within the active 
community at the different phases of the TET reactor. ......................... 165 
Table 4.20: Affiliation of archaeal clones and their abundance within the active 
community at the different phases of the TET reactor. ......................... 167 
Table 4.21: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the TET reactor. ................................... 170 
Table 4.22: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the TET reactor. ................................... 170 
 
 
  
  xvii 
 
LIST OF FIGURES 
                                                                                                                                                 Page 
Figure 2.1: Metabolites and transformation products (Kummerer, 2008). ................. 7 
Figure 2.2: Chemical structure of Sulfamethoxazole (Url-1, 2011). .......................... 9 
Figure 2.3: Chemical structure of Erythromycin (Url-2, 2011). ............................... 10 
Figure 2.4: Chemical structure of Tetracycline (Url-3, 2011). ................................. 11 
Figure 2.5: Substrate conversion patterns associated with the anaerobic digestion 
(Harper and Pohland, 1986). ................................................................. 21 
Figure 2.6: Phylogeny of methanogens, domain Archaea. (Non-methanogens are 
indicated by their group names, large triangles) (Garcia et al., 2000). 26 
Figure 2.7: Secondary structure of the 16S rRNA of E. coli, showing conserved and 
variable regions (van de Peer et al., 1996). .......................................... 31 
Figure 2.8: The rRNA tree of life (Madigan et al., 2009)......................................... 31 
Figure 2.9: Strategies based on rRNA sequence analysis for characterization of 
microbial communities without cultivation (arrows indicate the 
interconnected use of methods, experimental materials, and information 
in the study of microbial ecosystems. RT-PCR: reverse transcription to 
produce DNA from RNA, followed by PCR. DGGE: denaturing 
gradient gel electrophoresis. RFLP: restriction fragment length 
polymorphism (Hofman-Bang et al., 2003). ......................................... 32 
Figure 2.10: Outline of the cloning procedure for studying a microbial community 
(Sanz and Kochling, 2007). .................................................................. 34 
Figure 2.11: Classification of anaerobic reactors. (Khanal 2008). ........................... 41 
Figure 2.12: Operating steps for the anaerobic-sequencing batch reactor (Dague et 
al., 1992). .............................................................................................. 44 
Figure 4.1: Stock ASBR performance in terms of influent and and effluent soluble 
COD concentration. .............................................................................. 63 
Figure 4.2: Stock ASBR performance in terms of biogas production and COD 
removal efficiency. ............................................................................... 64 
Figure 4.3: Distribution of phylogentic phylums from clone sequences of bacterial 
16S rDNA clone library. ....................................................................... 66 
Figure 4.4: Neighbor-joining full-length 16S rDNA trees showing the genetic 
distances among individual clones from bacterial 16S rDNA clone 
library. Tha bar scale represents 2 nucleotide substitutions per 100 
nucleotides. ........................................................................................... 69 
Figure 4.5: Distribution of phylogentic phylums from clone sequences of archaeal 
16S rDNA clone library. ....................................................................... 70 
Figure 4.6: Neighbor-joining full-length 16S rDNA trees showing the genetic 
distances among individual clones from archaeal 16S rDNA clone 
library. Tha bar scale represents 10 nucleotide substitutions per 100 
nucleotides. ........................................................................................... 73 
 xviii 
Figure 4.7: Quantitative changes in bacterial, archaeal, and methanogenic 16S rDNA 
concentrations determined by Q-PCR. ................................................. 75 
Figure 4.8: Relative abundance of methanogenic genus in seed sludge of acute and 
chronic tests. ......................................................................................... 76 
Figure 4.9: Inhibition effect of SMX dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 78 
Figure 4.10: Inhibition effect of ERY dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 79 
Figure 4.11: Inhibition effect of TET dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 80 
Figure 4.12: Inhibition of CMP levels and EC50 values associated with SMX, ERY 
and TET. ............................................................................................... 81 
Figure 4.13: Initial and final COD concentrations in SMX experiments. ................ 82 
Figure 4.14: Initial and final COD concentrations in ERY experiments. ................. 82 
Figure 4.15: Initial and final COD concentrations in TET experiments. .................. 83 
Figure 4.16: Inhibition effect of SMX dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 85 
Figure 4.17: Inhibition effect of ERY dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 86 
Figure 4.18: Inhibition effect of TET dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production.................................. 87 
Figure 4.19: Inhibition of CMP levels and EC50 values associated with SMX, ERY 
and TET. ............................................................................................... 88 
Figure 4.20: Initial and final COD concentrations in SMX experiments. ................ 89 
Figure 4.21: VFA concentration in effluents of SMX experiments. ......................... 89 
Figure 4.22: ERY initial and final COD concentrations in ERY experiments. ........ 90 
Figure 4.23: VFA concentration in effluents of ERY experiments. ......................... 90 
Figure 4.24: Initial and final COD concentrations in TET experiments. .................. 91 
Figure 4.25: VFA concentration in effluents of TET experiments. .......................... 91 
Figure 4.26: Performance of Control and SMX reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L SMX, Phase b: 1 
mg/L SMX, Phase c: 10 mg/L SMX, Phase d: 25 mg/L SMX, Phase e: 
30 mg/L SMX, Phase f: 35 mg/L SMX, Phase g: 40 mg/L SMX, Phase 
h: 45 mg/L SMX). ................................................................................. 93 
Figure 4.27: Performance of Control and SMX reactors in terms of biogas 
production and COD removal efficiency (Phase a: 0 mg/L SMX, Phase 
b: 1 mg/L SMX, Phase c: 10 mg/L SMX, Phase d: 25 mg/L SMX, 
Phase e: 30 mg/L SMX, Phase f: 35 mg/L SMX, Phase g: 40 mg/L 
SMX, Phase h: 45 mg/L SMX). ............................................................ 94 
Figure 4.28: Antibiotic measurement results of SMX reactor. ................................. 96 
Figure 4.29: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production. ............................................................................................ 98 
Figure 4.30: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane 
production. ............................................................................................ 99 
Figure 4.31: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 114 
  xix 
Figure 4.32: Cluster analysis and similarity matrix of archaeal 16S rDNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 114 
Figure 4.33: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 115 
Figure 4.34: Cluster analysis and similarity matrix of archaeal 16S rRNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 116 
Figure 4.35: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the SMX reactor. ................................................................. 117 
Figure 4.36: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the SMX reactor. ................................................................. 117 
Figure 4.37: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the SMX reactor. .................................................. 117 
Figure 4.38: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the SMX reactor. ................................................................. 118 
Figure 4.39: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the SMX reactor. ................................................................. 118 
Figure 4.40: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the SMX reactor. .................................................. 119 
Figure 4.41: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the SMX reactor. .............................................. 120 
Figure 4.42: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the SMX reactor. .................................................. 121 
Figure 4.43: Performance of Control and ERY reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L ERY, Phase b: 1 
mg/L ERY, Phase c: 2 mg/L ERY, Phase d: 3 mg/L ERY, Phase e: 0 
mg/L ERY). ........................................................................................ 122 
Figure 4.44: Performance of Control and ERY reactors in terms of biogas 
production and COD removal efficiency (Phase a: 0 mg/L ERY, Phase 
b: 1 mg/L ERY, Phase c: 2 mg/L ERY, Phase d: 3 mg/L ERY, Phase e: 
0 mg/L ERY). ..................................................................................... 123 
Figure 4.45: Antibiotic measurement results of ERY reactor. ................................ 126 
Figure 4.46: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production. .......................................................................................... 127 
Figure 4.47: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane 
production. .......................................................................................... 128 
Figure 4.48: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 143 
Figure 4.49: Cluster analysis and similarity matrix of archaeal 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 144 
Figure 4.50: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 144 
 xx 
Figure 4.51: Cluster analysis and similarity matrix of archaeal 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 145 
Figure 4.52: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the ERY reactor. .................................................................. 146 
Figure 4.53: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the ERY reactor. .................................................................. 146 
Figure 4.54: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the ERY reactor. ................................................... 147 
Figure 4.55: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the ERY reactor. .................................................................. 147 
Figure 4.56: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the ERY reactor. .................................................................. 148 
Figure 4.57: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the ERY reactor. ................................................... 148 
Figure 4.58: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the ERY reactor. ............................................... 150 
Figure 4.59: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the ERY reactor. ................................................... 150 
Figure 4.60: Performance of Control and TET reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L TET, Phase b: 1 
mg/L TET, Phase c: 2 mg/L TET, Phase d: 3 mg/L TET, Phase e: 0 
mg/L TET). ......................................................................................... 151 
Figure 4.61: Performance of Control and TET reactors in terms of biogas production 
and COD removal efficiency (Phase a: 0 mg/L TET, Phase b: 1 mg/L 
TET, Phase c: 2 mg/L TET. ................................................................ 152 
Figure 4.62: Antibiotic measurement results of TET reactor ................................. 155 
Figure 4.63: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production. .......................................................................................... 156 
Figure 4.64: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane 
production. .......................................................................................... 158 
Figure 4.65: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 171 
Figure 4.66: Cluster analysis and similarity matrix of archaeal 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 172 
Figure 4.67: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 172 
Figure 4.68: Cluster analysis and similarity matrix of archaeal 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. ................................................................... 173 
Figure 4.69: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the TET reactor. .................................................................. 174 
Figure 4.70: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the TET reactor. .................................................................. 175 
  xxi 
Figure 4.71: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the TET reactor. ................................................... 175 
Figure 4.72: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the TET reactor. .................................................................. 176 
Figure 4.73: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the TET reactor. .................................................................. 176 
Figure 4.74: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the TET reactor. ................................................... 177 
Figure 4.75: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the TET reactor. ............................................... 178 
Figure 4.76: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the TET reactor. ................................................... 178 
 
 
 
 
 
 
 xxii 
  xxiii 
EVALUATION OF ANAEROBIC BIODEGRADABILITY 
CHARACTERISTICS OF ANTIBIOTICS AND TOXIC/INHIBITORY 
EFFECT ON MIXED MICROBIAL CULTURE 
SUMMARY 
In last decades, pharmaceuticals production and consumption have been increased. 
Occurrence and fate of these compounds are one of the main issues because of their 
unknown potential risks and their effects on the environment. Antibiotics are one of 
these compounds and approximately 500 tonnes of them are produced and consumed 
every year in the worldwide. Antibiotics are resistant to conventional biological 
treatment process and the wastewaters including these compounds are directly 
discharged to the receiving waterbodies without efficient treatment. Also 
pharmaceutical industries need to use physico-chemical treatment approaches to 
remove these compounds from their high-strength wastewater. The occurrence of the 
antibiotics in the ecosystem increases from day to day and it causes to spread 
antibiotic-resistant pathogens which are important threat aganst to public health. 
Anaerobic treatment is one alternative for high-strength wastewater including 
inhibitory compounds such as pharmaceutical industry wastewater. In the literature, 
there are a few studies reported information about the anaerobic treatment of 
antibiotic containing wastewater. Also these reported studies have presented limited 
information about anaerobic systems. A comprehensive study including inhibitory 
effects and biodegradability characteristics of these compounds with microbial 
community definition is a lack in the literature. 
The focusing items in this dissertation are acute and chronic effects of the three 
selected antibiotics; Sulfamethoxazole, Erythromycin, Tetracycline; on anaerobic 
systems were examined. Also the microbial community in terms of bacterial and 
archaeal species were defined in the system under different operation conditions. The 
presence and active microbial diversity changes were monitored and quantified. 
Addition of them, chronic effects of these selected antibiotics on homoacetogenic 
and methanogenic pathways were investigated on mRNA level studies. 
In the scope of this dissertation, significant chronic effects of the selected antibiotics 
were started from lower levels compared to short-terms tests. While the significant 
acute effects were observed after 50 mg/L for the three compounds, in the chronic 
tests, the reactors collapsed at 45 mg/L of SMX addition and 3 mg/L of ERY and 
TET additions. Also long-term effects of these compounds on the microbial diversity 
reflected that Clostridium species were generally abundant within the systems, they 
could be got the resistance against the antibiotics. While acetoclastic and 
hydrogenotrophic species were abundant in the ERY added system, 
hydrogenotrophic methanogens were dominant in the SMX and TET reactors. Also 
the effects on these compounds on the metabolic pathways were determined. 
According to expression level of the selected enzymes on mRNA based approache, 
the inhibition was also observed on methanogenic step within all reactors, however 
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specific methanogenic activity of SMX fed sludge increased even performance of the 
reactor ceased. At the ERY and TET fed reactors, after the reactors collapsed, 
antibiotic addition was stopped and the reactors were operated for a while to recover 
the performance again. While the performances of the reactors couldn‘t be recovered, 
the specific methanogenic activity of ERY fed sludge and the expression level of the 
selected enzymes from methanogenic pathway increased. 
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ANTĠBĠYOTĠKLERĠN ANAEROBĠK BĠYOLOJĠK AYRIġABĠLĠRLĠK 
ÖZELLĠKLERĠNĠN VE KARIġIK MĠKROBĠYAL KÜLTÜR ÜZERĠNE 
TOKSĠSĠTE/ĠNHĠBĠSYON ETKĠLERĠNĠN DEĞERLENDĠRĠLMESĠ 
ÖZET 
İlaç etken maddelerinin üretimi ve tüketimi son yıllarda oldukça artmıştır. Henüz 
çevre üzerindeki riskleri ve etkileri tam olarak bilinemediği için, bu maddelerin 
varlıkları ve giderimleri en önemli araştırma konularından biri olmuştur. 
Antibiyotikler bu maddelerden biridir ve yıllık üretim ve tüketimleri tüm dünyada 
yaklaşık 500 tondur. Antibiyotikler konvansiyonel biyolojik arıtma proseslerine 
dirençli oldukları için alıcı su kaynaklarına tam olarak arıtılamadan deşarj 
edilmektedirler. Bu maddeleri içeren ilaç endüstrisi atıksuların arıtımı için fiziko-
kimyasal arıtıma ihtiyaç duyulmaktadır. Miktarları her geçen gün ekosistemde artan 
bu ilaç etken maddeleri, doğada antibiyotiğe dirençli patojen organizamların artışına 
sebep olmakta ve bu durum halk sağlığı için büyük bir tehdit oluşturmaktadır. 
Anaerobik arıtım ilaç endüstrisi gibi organik ve inhibitör madde içeriği yüksek olan 
atıksuların arıtımı için alternatif oluşturmaktadırlar. Literatürde antibiyotik içeren 
atıksuların anaerobik arıtımı ile ilgili az sayıda çalışma bulunmaktadır. Bu çalışmalar 
da anaerobik sistemlerle ilgili oldukça sınırlı bir bilgi sunmaktadır. Bu tip 
maddelerin, inhibisyon etkisi, biyolojik olarak arıtılabilirliği ve bu proseste rol alan 
mikrobiyal komünitenin tanımlanması ile ilgili kapsamlı bir çalışma henüz literatürde 
rastlanmaıştır. 
Bu tezde seçilen 3 farklı antibiyotiğin (Sülfometaksazol, Eritromisin ve Tetrasiklin) 
anaerobik sistemler üzerindeki akut ve kronik etkileri çalışılmıştır. Ayrıca farklı 
işletme koşullarında bakteriyel ve arkeyal kömünite tanımlanmıştır. Mikrobiyal 
çeşitlilik ve aktif kömünitedeki değişimler izlenmiş ve kantifikasyonu yapılmıştır. 
Bunlara ilaveten seçilen antibiyotiklerin homoasetojenik ve metanojenik yolizleri 
üzerindeki kronik etkisi mRNA bazlı çalışmalar ile tespit edilmiştir. 
Bu kapsamda elde edilen sonuçlar, seçilmiş antibiyotiklerin anaerobik sistemlerde 
kronik inhibisyon etkilerinin kısa dönem testlerine göre daha düşük 
konsantrasyonlarda başladığını göstermiştir. Akut testlerde her 3 antibiyotik için 
biyolojik aktvitedeki belirgin düşüş 50 mg/L‘den sonra başlarken, kronik testlerde bu 
etki SMX reaktörü için 45 mg/L, ERY ve TET reaktörleri için 3 mg/L antibiyotik 
konsantrasyonunda gözlemlenmiştir. Uzun dönemli işletmede bütün reaktörlerde 
baskın bakteriyel grup Clostridium olarak tespit edilmiştir, bu gruptaki bakteriler her 
3 antibiyotiğe karşı direnç kazanmış olabilirler. ERY reaktöründe hem asetoklastik 
hem de hidrogenotrofik metanojenler baskın durumdayken, SMX ve TET 
reaktörlerinde hidrogenotrofik türler baskındır. Ayrıca bu maddelerin metabolik 
yolizleri üzerindeki etkileri de belirlenmiştir. Seçilmiş enzimlerin mRNA düzeyinde 
incelenmiş olan ekspresyon seviyeleri, inhibisyonun metanojenik yolizleri üzerindeki 
etkisini ortaya koyarken, SMX reaktör çamurunun aktivitesi, reaktör performansının 
tersine antibiyotik konsantrasyonu ile orantılı olarak artmıştır. ERY ve TET 
reaktörleri çöktükten sonra bir süre antibiyotik beslemesi kesilerek sistemin kendini 
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toparlaması için işletilmeye devam edilmiştir. Reaktörlerin performansında herhangi 
bir düzelme olmazken, ERY çamurunun aktivitesinde ve seçilen enzimlerin 
ekspresyonunda artış tespit edilmiştir. 
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1. INTRODUCTION 
Xenobiotics called as unfamiliar to existing enzyme systems and persistent in the 
environment and resistant biodegradation like heavy metals, metalloids and man-
made organic compounds are of rising concern in the urban water cycle. The major 
reason is that these chemicals persist in the environment, bioaccumulate through food 
chain, and pose a risk of adverse effects to human health and the environment (van 
der Meer, 1992). There are numerous sources of xenobiotics in urban water systems 
because of the excess usage of these compounds with the increasing life standarts. 
Increased focus on use of rainwater and reuse of wastewater for industrial as well as 
domestic non-potable purposes further increase the exposure to xenobiotics, but the 
conventional urban water cycle approaches are not designed to deal with xenobiotics. 
The main problems for environmental engineers are that these compounds cannot be 
detected by conventional parameters like chemical oxygen demand (COD), 
biochemcial oxygen demand (BOD) or total organic carbon (TOC) etc. and treated by 
a classical sewage treatment plants. The presence of these micro pollutants and 
persistent organics that come out of various industrial processes has increased the 
necessity in the removal and the determination of the effect on the treatment systems 
of these compounds. Therefore, detection of existing and fate of these compounds and 
developing innovation technologies to treat them are the main purpose of the scientist 
and engineers. 
The medicines that are accepted as one of these xenobiotics are produced 
approximately 100,000 tons every year in worldwide. While the worldwide average 
yearly consumption of medicine per person is 15 g (Kummerer, 2004), this value is 
accepted to be 50-150 g a year in advanced countries (Sedlak et al., 2005; Stockholm 
County Council, 2005). The yearly consumption of antibiotics, which are aimed to 
use in this study, is 500 tons throughout the world according to the data of 2001. 
Approximately 90% of the consumed antibiotics after being partially metabolized or 
not being metabolized are excreted by the help of urea or feces from the body and 
transferred to the domestic sewage plants. These antibiotics are discharged into the 
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receiving environment with no or low elimination after being treated in 
conventionally operated domestic sewage plants. While the concentration of these 
materials in domestic wastewaters and surface waters are in µg/l level, in 
pharmaceutical wastewater they are in 100-1000 mg/L level (Daughton and Ternes, 
1999; Stuer-Lauridsen, 2000; Chelliapan et al., 2006; Amin et al., 2006). As this low 
concentration in the surface wastewaters cause important problems in the ecosystem, 
it necessitates the removal of high antibiotic amount that are found in the 
pharmaceutical wastewaters. However, because the chemical removals of these 
materials are costly, biological treatment is essential. Antibiotics are the one of these 
compounds and the most often discussed pharmaceuticals because of their potential 
role in the spread and maintenance of (multi)resistance of bacterial pathogens. There 
are lots of studies that have been done in Europe and North America on the detection 
and removal of antibiotics in the receiving environment and the treatment plant 
(Hartig et al., 1999; Hirsch et al., 1999; Alder et al., 2001; Golet et al., 2001; Lindsey 
et al., 2001; Golet et al., 2002; Kolpin et al., 2002; Golet et al., 2003; McArdell et al., 
2003; Miao et al., 2004; Göbel et al., 2005). However, the studies on the treatability 
of these antibiotics biologically are quite few (Drilla et al., 2005; Kim et al., 2005). 
Also the scope of the studies done on the biodegradability potential of these materials 
is limited (Gartiser et al., 2007a and b; Alexy et al., 2004; Matamaros et al., 2008). In 
these studies, the biodegradability of these chosen antibiotics under aerobic and 
anaerobic conditions has been tried to determine by only chemical analysis. Studies 
on the microbial groups and species that are responsible for degradation have not been 
done yet. 
1.1 Aim and Scope 
Xenobiotics, including both inorganic elements like the heavy metals, metalloids and 
organic compounds such as pesticides, surfactants, preservatives, solvents, fragrances, 
flavours, endocrine disrupters and pharmaceuticals are of rising concern in the urban 
water cycle. There are more than 100,000 xenobiotic compounds on the market in the 
European Union and approximately 30,000 of these are ―everyday‖ chemicals i.e. 
estimated to be used in volumes over 1 ton each year. It has been estimated that 
70,000 xenobiotics may potentially be hazardous for humans and/or ecosystems. In 
order to assess the role of the xenobiotics information is needed with respect to the 
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sources, flow paths, fate (transport, treatment, natural attenuation) and impact on 
humans, livestock and the environment. Furthermore, it is necessary to have suitable 
tools like chemical analytical methods or eco-toxicological test methods for collecting 
the information that is needed and determining the potential risk.  
Antibiotics are among these compounds and every year approximately 500 ton of 
them are produced and consumed. Nearly the 90% of the consumed antibiotics are 
excreted out of the body with no or little metabolization via the urea or the fecal 
matter and end up in domestic sewage plants. These antibiotics are discharged into 
receiving environment with no removal or low removal rate from the conventionally 
operated treatment plants. 
Even though there are studies present in the literature considering the detection and 
the behavior in the receiving environment about these antibiotics that are resistant to 
degrade biologically, the literature information about the biodegradation and the 
active microbial groups in the degradation of this type of xenobiotics is very limited. 
In this scope, determination of biodegradation characteristics of the refractory 
compounds and their toxic/inhibition effects on microbial community is substantial 
for environmental engineering. Four sub-topics will be investigated during the study.  
 
These sub-topics are: 
 Acute and chronic effect of compound on microbial community 
 Anaerobic biodegradability characteristics of the chosen xenobiotic compound 
 Profile of microbial community having role on biodegradation 
 Syntrophic relations and metabolisms of microbial community which responsible 
to fate of these compounds 
1.2 Problem Definition 
Antibiotic including wastewater generated from houses, hospitals, pharmaceutical 
industries, stock farms are one of the current environmental problems. This kind of 
the wastewaters cannot be treated in the conventional treatment plants and discharge 
directly to the receiving water bodies such as rivers, lakes, and seas. The 
concentration of these active compounds and their metabolites in the water bodies 
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increase gradually and it causes to gain the antibiotic resistance of the pathogen 
organisms. Also these water bodies are mostly used as drinking water sources. Up to 
this study, there are some studies in the literature focused on the biological treatability 
of this compound, especially under aerobic conditions. Most of the studies examined 
the fate of the antibiotics in full-scale sewage treatment plants and receiving water 
bodies. Different treatment strategies based on the lab-scale studies including the 
influent and effluent antibiotic concentration together with conventional parameter to 
analyze specific fate of these compounds and microbial community analysis not only 
to identify the species which have a role in degradation but also to monitor changes 
the groups depending on time and antibiotic concentration are the most important lack 
of the literature. This study aims to bridge the gaps between bioreactor operation and 
manipulation/change of microbial community during to treat the selected 
pharmaceuticals. 
In this scope, this thesis presented results obtained from: 
- Acute tests to determine the short-term effect of the antibiotics on the 
acclimated anaerobic biomass. 
- Chronic tests to observe the long-term effects and biodegradability 
characteristics of the selected compounds in the anaerobic systems. 
- Methanogenic activity test to  
- Molecular studies to identify bacterial and archaeal species in the systems and 
their behaviors during time and antibiotic concentration.
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2. LITERATURE BACKGROUND 
2.1 Pharmaceuticals 
Pharmaceuticals used in medicine and veterinary applications have been one of the 
main concerns for the environment in last decade. A vast amount of literature has 
been published about their occurrence, fate, and risk and these subjects are still hot 
topics in the environmental science (Daughton and Ternes, 1999; Kolpin et al., 2002; 
Boyd et al., 2003; Bendz et al., 2005; Clara et al., 2005; Glassmeyer et al., 2005; Kim 
and Aga, 2007; Avisar et al., 2009; Benotti and Brownawell, 2009; Segura et al., 
2009; Rodríguez-Rodríguez et al., 2011). 
These active compounds called as pharmaceutical (sometimes called as active 
pharmaceutical ingredients, APIs) are complex molecules with different 
physicochemical and biological properties and functionalities (Kummerer, 2009). 
Their more or less specific biological activity is the main reason to use and develop as 
API. Approximately 3000 different pharmaceutical compounds including painkillers, 
antibiotics, antidiabetics, beta-blockers, contraceptives, lipid regulators, 
antidepressants, impotence drugs and cytostatic agents are used in Europe (Ternes et 
al., 2006). Globally production and consumption of these compounds are considered 
around 100,000 ton/year (Kummerer, 2004). They are also most notably characterized 
by their ionic nature and classified as parent compounds and metabolites and /or 
transformation compounds: 
Classification of small molecule APIs according to chemical structure is used mainly 
for the active substances within subgroups of medicines, e.g.,within the group of 
antibiotics or the subgroups within the antibiotics such as β-lactams, cephalosporins, 
penicillins or quinolones. In this case, the compounds can be treated as groups with 
respect to chemical behavior. Other classifications refer to the mode of action (MOA) 
e.g., anti-metabolites or alkylating agents within the group of 
cytotoxics/antineoplastics, the targets or the effects. In the case of classification 
according to MOA, chemical structures of molecules within the same group can be 
very different and therefore their environmental fate can vary, too. In this case, 
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compounds cannot be handled as a group with respect to environmental issues. Their 
fate and effects on humans or on other target organisms such as bacteria or parasites 
and on non-target organisms in the environment can be classified according to not 
only different pharmaceuticals of special interest of the compounds, but also because 
of the differences in their occurrence, This can be illustrated by comparing 
pharmacology and eco-pharmacology as seen in Table 2.1. Eco-pharmacology deals 
with all aspects of a pharmaceutical within the environment and emphasizes that 
pharmaceuticals in the environment are an issue for doctors and pharmacists. This 
concept is much broader than pharmacoenvironmentology, a concept, which has only 
recently been derived from it (Rhaman et al. 2007). Their environmental relevance is 
not yet clear in spite of high consumption of them. 
Table 2.1: Pharmacology and eco-pharmacology (Kummerer, 2008). 
 Pharmacology (humans) 
Ecopharmacology 
(environment) 
Numbers of compounds 
administered 
One or only a few 
compounds at the same 
time 
An unknown cocktails of 
different compounds 
Desirable physicochemical 
properties 
Stable Readily (bio)degradable 
Administration 
Tarfeted on demand 
controlled 
Diffuse, i.e. emissions from 
medical care units and the 
community 
Wanted effects/side effects 
Active wanted effects, side 
effects 
Wanted effects in target 
organism are often most 
important, side effects in the 
environment 
Metabolism/ 
biotransformation/ affected 
organism 
One type of organism 
Various type organisms of 
different trophic levels 
2.1.1 Parent compounds, metabolites and transformation products 
The studies which were carried out in the recent years, not only these parent 
compounds but also metabolites and transformation products of these compounds are 
important for the environment and have a different role in the ecosystem (Golan et al. 
2007). The compounds can be changed due to biotic and abiotic processes in the 
environment. These structural changes start in the body of human and animals. It 
could be a microbial process occurred in the gut and/or enzymatic reaction such as 
cytochromes. The second structure of APIs derived from metabolism in the body is 
called as metabolites. After extraction of the body, these changes undergo in the 
effluent streams and also in the wastewater treatment plants by photochemically and 
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biologically (Qiting and Xiheng, 1988; Ravina et al., 2002; Schroder, 2002; Ternes et 
al., 2003; Zuhlke et al., 2004; Lee et al., 2007; Trautwein et al., 2008; Mendez-
Arriaga et al., 2008). The chemicals from differentiation of APIs by biotic and abiotic 
processes in the environments after excretion such as biodegradation by 
microorganisms or fungi, chemical oxidation, photochemical reaction are called as 
transformation products (Burhenne et al., 1997, Mendez-Arriaga et al., 2008). Figure 
2.1 shows the processes, which were explained above. 
 
Figure 2.1: Metabolites and transformation products (Kummerer, 2008). 
Both pharmacological and toxicological properties of the metabolites and 
transformation products differ from their parent drugs. Pharmaceuticals may be 
applied via oral or intravenous ways depending on the compound itself and the 
medical circumstances. This application way has an effect on their metabolism that is 
their structural change within the body of the target organism (e.g., within humans in 
the case of pharmaceuticals administered to humans). Metabolism may lower activity 
and/or enhance water solubility. However, metabolism is mostly incomplete. It is 
assumed that toxicity of APIs decreases after metabolized, however, sometimes 
metabolism causes to create more active compounds. 
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2.2 Antibiotics 
Antibiotics are among the most important groups of pharmaceuticals and 
chemotherapeutic agents that inhibit or terminate the growth of microorganisms, such 
as bacteria, fungi, or protozoa without affecting host (Korolkovas, 1976; Foye et al., 
1995). The term antibiotic used for drugs that block any of these microorganisms. 
Other terms as chemotherapeutics or antimicrobials are not synonymous because of 
their scopes; the terms of antimicrobial is used for the medicine which is also 
effective against viruses and the expression ‗‗chemotherapeutical‖ refers to 
compounds used for the treatment of disease which kill cells, specifically 
microorganisms or cancer cells. The term ‗‗chemotherapeutical‖ may also refer to 
antibiotics (antibacterial chemotherapy).  
The expression of antibiotic is originally used to describe any agent with biological 
activity against living organisms; however, ‗‗antibiotic‖ now refers to substances with 
antibacterial, anti-fungal, or anti-parasitical activity. During the years, this definition 
has been changed and now it includes also synthetic and semi-synthetic products. 
There are approximately 250 different compounds registered for use in medicine and 
veterinary application (Kummerer and Henninger, 2003).  
In this thesis the term ―antibiotic‖ refers only to drugs that kill or inhibit bacteria. 
Antibiotics that are sufficiently nontoxic to the host are used as chemotherapeutic 
agents in the treatment of infectious diseases of humans, animals and plants. They are 
extensively used for prevention and treatment of diseases caused by microorganisms 
in human and veterinary medicine as well as in aquaculture nowadays. Also, they are 
being still used as growth factor in livestock farming. Some compounds may be used 
for different purposes such as in growing fruit and in bee keeping other than human or 
veterinary medicine. The application purposes may vary from country to country.  
Antibiotics are classified as their chemical structures and the mechanism of inhibition 
of microorganisms and they can be divided into subgroups such as β-lactams, 
quinolones, tetracyclines, macrolides, sulfonamides and others. The active 
compounds of antibiotics are often complex molecules, which may have different 
functionalities. In the environment, these molecules could be found as neutral, 
cationic, anionic, or zwitterionic forms. Because of the different functionalities within 
one molecule, their physicochemical and biological properties may change with pH 
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levels (Cunningham, 2008). 
In this study, sulfamethoxazole (SMX), erytromycin (ERY) and tetracycline (TET) 
were selected as model compounds. 
2.2.1 Sulfamethoxazole 
The systematic name of this compound is 4-amino-N-(5-methylisoxazol-3-yl)-
benzenesulfonamide as seen in Figure 2.2.  
 
 
 
Figure 2.2: Chemical structure of Sulfamethoxazole (Url-1, 2011). 
Sulfamethoxazole and other sulfonamides have a similar structure to p-aminobenzoic 
acid and inhibit to the synthesis of nucleic acids in sensitive microorganisms by 
blocking the conversion of p-aminobenzoic acid to the coenzyme dihydrofolic acid, a 
reduced form of folic acid; dihydrofolic acid is obtained from dietary folic acid so 
sulfanomides do not have any influence on human cells. Their action is primarily 
bacteriostatic, although they may be bactericidal where concentrations of thymine are 
low in surrounding medium. The sulfonamides have a broad spectrum of action, but 
the development of widespread resistance has greatly reduced their usefulness, and 
susceptibility often varies widely even among nominally sensitive pathogens like 
Gram-positive and Gram-negative cocci. 
There are several mechanisms of resistance including alteration of dyhydropteroate 
synthetase, the enzyme inhibited by sulfonamides, to a less sensitive form, or an 
alteration in folate biosynthesis to an alternative pathway; increased production of  
p-aminobenzoic acid; or decreased uptake or enhanced metabolism of sulfonamides.  
Resistance may result from chromosomal alteration, or may be plasmid-mediated and 
transferable, as in many resistant strains of enterobacteria. High-level resistance is 
usually permanent and irreversible. There is complete cross-resistance between the 
different sulfonamides (Sweetman, 2009). 
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2.2.2 Erythromycin 
The systematic name of this antibiotic is (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-
{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-14-ethyl-
7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-
yl]oxy}-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione as seen in 
Figure 2.3. It is a macrolide groıup compound with a broad and essentially 
bacteriostatic action against many Gram-positive and to a lesser extent some Gram-
negative bacteria, as well as other organisms including some Mycoplasma spp., 
Chlamydiaceae, Rickettsia spp., and spirochaetes. 
 
Figure 2.3: Chemical structure of Erythromycin (Url-2, 2011). 
Erythromycin and other macrolide group antibiotics bind reversibly 50S subunit of 
the ribosome, resulting the blockage of the transpeptidation or translocation reactions, 
restriction of protein synthesis, and hence inhibition of cell growth. Its action is 
mainly bacteriostatic, but high concentrations are slowly bactericidal against the more 
sensitive strains. Because these compouns penetrate readily into white blood cells and 
macrophages there has been some interest in their potential synergy with the host 
defence mechanism in vivo. The actions of erythromycin are increased moderately 
alkaline pH (up to about 8.5), particularly in Gram-negative species, probably because 
of improved cellular penetration of the nonionised form of the drug.  
Several resistance mechanisms of it have been reported of which the most common is 
a plasmid-mediated ability to methylate ribosomal RNA, resulting in decreasing 
binding of the antimicrobial drug. This can result in cross-resistance between 
erythromycin and other macrolides, lincosamides, and streptogramin B, because they 
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share a common binding site on the ribosome and this pattern of resistance is referred 
to as the MLSB phenotype.  
Decreased binding of antimicrobial to the ribosome may also occur as a result of a 
chromosomal mutation, resulting in an alteration of the ribosomal proteins in the 50S 
subunit, which conveys one-step high-level erythromycin resistance. 
Other forms of erythromycin resistance may be due to the production of plasmid-
determined erythromycin esterase that can inactivate the drug, or to decreased drug 
penetration. The latter may be partly responsible for the intrinsic resistance of Gram-
negative bacteria like the Enterobacteriaceae, but has also been shown to be acquired 
as a plasmid-mediated determinant in some organisms; production of a protein which 
increase drug efflux from the cell is thought to explain the M phenotype resistance, in 
which organisms are resistant to 14-and 15-carbon ring macrolides, but retain 
sensitivity to 16-carbon ring macrolides, lincosamides, and streotogramins 
(Sweetman, 2009). 
2.2.3 Tetracycline 
The systematic names of this compound are 42-(amino-hydroxy-methylidene)-4-
dimethylamino-6,10,11,12a-tetrahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-
1,3,12-trione or 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro- 3,6,10,12,12a-
pentahydroxy-1,11-dioxo-naphthacene-2-carboxamide or (4S,6S,12aS)-4-
(dimethylamino)- 3,6,10,12,12a-pentahydroxy- 6-methyl-1,11-dioxo-
1,4,4a,5,5a,6,11,12a- octahydrotetracene-2-carboxamide as seen in Figure 2.4.  
 
 
 
 
 
Figure 2.4: Chemical structure of Tetracycline (Url-3, 2011). 
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Tetracyclines are mainly bacteriostatic, with a broad spectrum of antimicrobial 
activity including Chlamydiaceae, Mycoplasma spp., Rickettsia spp., spirochaetes, 
many aerobic and anaerobic Gram-positive and Gram-negative pathogenic bacteria, 
and some protozoa. 
This compound is transferred into sensitive bacterial cells by an active transport 
process. Once within the cell they bind reversibly to 30S subunit of ribosome, 
preventing the binding of aminoacyl transfer RNA and restricting protein synthesis, 
and hence cell growth. Although they also inhibit protein synthesis in mammalian 
cells they are not actively taken up, permitting selective activity against the infecting 
organisms. 
It affects mostly Gram-positive and Gram-negative cocci, other Gram-positive 
bacteria, Gram-negative anaerobes Bacteriodes fragilis may sometimes susceptible, 
although wild strains are often resistant, and Fusobacterium may also be sensitive. 
Resistance to the tetracyclines is usually plasmid-mediated and transferable. It is often 
inducible, and appears to be associated with the ability to prevent accumulation of 
antibacterial within the bacterial cells, both by decreasing active transport of the drug 
into the cell or by increasing tetracycline efflux. 
Unsurprisingly, given the widespread use of tetracyclines (including as components of 
animal feeds, although this is now banned in some countries), resistant strains of the 
majority of sensitive species have now been reported (Sweetman, 2009).  
2.2.4 Consumption and occurrence  
The yearly consumption of antibiotics worldwide is estimated between 500 tons 
(Wise, 2002). Approximately 90% of the consumed antibiotics are excreted via 
urinary or fecal pathways from the human body after partial or no metabolism and 
they are transferred to the domestic sewage plants or directly to the environment. 
Conventional biological treatment of domestic sewage provides very low or no 
reduction for these compounds, which usually by-pass treatment and accumulate in 
the receiving waters. 
Antibiotic consumption changes depending on the country and/or region however the 
situation is scarce and heterogenous. Country specific consumption for groups of 
antibiotics in DDDs can be found for Europe on the ESAC homepage 
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(http://www.esac.ua.ac.be/main.aspx?c=*ESAC2&n=1066l). Using patterns of 
different regions and countries are given Table 2.2. The relative importance of the 
different use patterns in different countries is still not known.  
An increasing number of studies have been done to determine the source, occurrence, 
fate, and effects on the ecosystem of antibiotics. However, there is still a lack of 
understanding and knowledge of these compounds. So studies maybe focus on the 
strategies about stream segregation and at-source treatment of the concentrated 
streams appears.  
 
 
 
 
 
 
 
 
 
 
 
 
 14 
 
Table 2.2: Country specific antibiotics consumption and occurrence data. 
Region/ 
Country 
Total volume 
used in human 
medicine 
(ton/year) 
Volume used in 
human medicine 
(gram per capita) 
Thereof in 
hospitals (%) 
Unuse 
medicaments 
Measured in 
sewage up to 
(µg/L) 
Measured in 
surface water 
up to (µg/L) 
Reference 
World wide 100000-200000 N.D. N.D. N.D. N.D. N.D. Wise, 2002 
EU 
+ 
Switzerland 
8367 22.4 N.D. N.D. N.D. N.D. FEDESA, 2001 
USA 4860 17 70 N.D. 1.9 0.73 
Union of Concerned 
Scientists, 2001; Kolpin et 
al., 2002 
Canada N.D. N.D. N.D. N.D. N.D. 0.87 Miao et al., 2004 
Switzerland 34.2 4.75 20-40 N.D. 0.57 0.2 Kummerer, 2004 
Germany 411 4.95 25 20-40 6 1.7 
Kummerer and 
Henninger, 2003; 
Rönnefahrt, 2005 
Denmark 40 7.4 N.D.b N.D. 5N.D. N.D. Kummerer, 2008 
Austria 38 4.7 N.D. 20-30 N.D. N.D. Sattelberger, 1999 
Netherlands 40.9 3.9 20 N.D. 4.4 0.11-0.85 
Verbrugh and de Neeling, 
2003 
Italy 283 4.88 N.D. N.D. 0.85- 0.25 
Calamar 
 Et al., 2003;  
Turkey N.D. 31.4 N.D. N.D. N.D. N.D. Karabay, 2009 
N.D.: not defined
  15 
2.2.5 Production and manufacturing 
Pharmaceutical industries have minor importance on the sewage treatment plants. 
Only in some Asian countries, wastewaters from this industry contributes to the 
sewage and cause an increase in the concentration of single compound up to mg/L 
level (Larsson et al., 2007; Li et al., 2008a,b). Also in developed countries, 
manufacturing plants increases the total antibiotic concentrations in the domestical 
wastewater (Thomas, 2008). 
The main problem for this industry, they still use the physicochemical treatment 
technologies in the plant to remove the compounds from their wastewater. However, 
this approach is expensive.  
2.2.6 Elimination and treatment 
In the literature, there are lots of studies focused on the fate of these compounds in 
conventional domestical wastewater treatment plants and also lab-scale applications 
in the innovative treatment methods. Elimination and/or treatment of these organic 
compounds are the results of biotic and abiotic processes. While biotic process is the 
biodegradation by microorganisms, abiotic processes are sorption, hydrolysis, 
oxidation-reduction, and photolysis. 
2.2.6.1 Sorption 
Before to assess the sorption characteristics of antibiotics, it is necessary to consider 
their physical and chemical parameters. Tolls (2002) investigated the sorption 
behavior of these compounds in soil and the results showed that sorption mechanism 
of antibiotics could be very complex and difficult. 
Additionally, binding to particles or the formation of complexes may prevent their 
detection. For example, tetracyclines are able to form complexes with double cations 
such as magnesiumor calcium (Christian et al., 2003). Also humic substances cause 
the change in the surface properties and sites available for sorption and reactions. Gu 
and Karthikeyan (2008) reported that there is a strong interaction between humic 
acids, hydrous Al oxide and tetracycline. Some studies showed that antibiotics used in 
medicine such as fluoroquinolones and macrolides can reach the terresrial 
environment by sewage sludge (Trivedi and Vasuden, 2007; Gu and Karthikeyan, 
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2008). Also Golet et al. (2002) and Giger et al. (2003) also confirmed that 
fluoroquinolone concentration is high in the sewage sludges.  
Also sorption mechanism is a significant process for sulphonamides (Tolls, 2001; 
Kreuzig and Holtge, 2005; Heise et al., 2006; Schmidt et al., 2008). However, 
knowledge about the interaction of antibiotics with sludge and of sediments with 
sludge in activated sludge plants as well as the subsequent potential for their release 
back into the environment is still too sparse. 
2.2.6.2 Photolysis 
Photochemical process can be important in the surface waters and treatment plant 
effluents as another elimination process (Viola et al., 2004; Edhlund et al., 2006; Paul 
et al., 2007; Werner et al., 2007; Hu and Coats, 2007; Hu et al., 2008; Lorenzo et al., 
2008). In the environment, photolysis process is not effective in turbid water or river 
and lakes, which are shadowed. So, the in the lab-scale experiments cannot reflect the 
photochemical process in the nature. Also, effectiveness of depletion process can 
differ under different environmental conditions such as pH, temperature, water 
hardness (Werner et al., 2006) and depends on type of matrix, location, season, 
latitude (Kallenborn et al., 2008). 
One of the problems about this type of process is that incomplete photo-transformation 
and photo-degradation can cause to more or less stable or toxic compounds although 
this does not necessarily have to happen (Cokgor et al., 2006; Arslan-Alaton and 
Caglayan, 2006; Gonzalez et al., 2007; Iskender et al., 2007; Paul et al., 2007). 
The significance and extent of direct and indirect photolysis of antibiotics in the 
aquatic environment are different for each compound because some of them are light 
sensitive (e.g. quinolones, tetracyclines, sulphonamides, tylosin, nitrofuran 
antibiotics). However, not all compounds are photo-degradable (Turiel et al., 2005). 
Tetracyclines are senstive to photo-degradation. Samuelsen (1989) investigated the 
sensitivity of oxytetracycline towards light in seawater as well as in sediments. The 
antibiotics proved to be stable in sediments rather than in seawater. As no mechanism 
of decomposition other than photolysis is known for them (Oka et al., 1989), the 
substance remains in the sediment for a long period, as shown by Lunestad and 
Goksøyr (1990). Boree et al. (2004) showed that sulphanilic acid was found as a 
degradation product common to most of the sulpha drugs. 
  17 
2.2.6.3 Hydrolysis and thermolysis 
Another important pathway for the non-biotic decomposition of organic substances in 
the environment is hydrolysis. Some instability in water could be demonstrated for 
some tetracycylines (Halling-Sørensen, 2000). In general, the hydrolysis rates for 
oxytetracycline increase with reascept to temperature at pH 7. The half-lives of 
oxytetracycline under investigation changed by differences in temperature, light 
intensity and flow rate from one test tank to another. However sulphonamides and 
quinolones are known as resistant antibiotic to hydrolysis. 
2.2.6.4 Oxidation 
Pharmaceutical industry wastewaters including antibiotic are well known for the 
difficulty of their elimination by conventional biological treatment methods and their 
important contribution to environmental pollution is due to their fluctuating and 
recalcitrant nature. For this reason, oxidation processes are usually applied.  
The presence of carbon–carbon double bonds, aromatic bonds or nitrogen is a 
necessary essential for this application. However, the presence of these structural 
elements does not provided the fast and full degradation or even the complete 
degradation.  
The effect of ozonation on the degradation of oxytetracycline in aqueous solution at 
different pH values (3, 7 and 11) was reported by Li et al. (2008c). The study was 
designed that ozonation as a partial step in a combined treatment concept is a 
potential technique for biodegradability enhancement. It has been shown that COD 
removal rates increase with increasing pH as a consequence of enhanced ozone 
decomposition rates at elevated pH values. The results of bioluminescence data 
indicate that the initial by-products after partial ozonation (5–30 min) of 
oxytetracycline were more toxic than the parent compound (Li et al., 2008c). 
Sulfamethoxazole was also efficiently degraded by ozonation (Dantas et al., 2007). 
An improvement in biodegradability by the increasing of BOD5/COD ratio from 0 to 
0.28 was observed by the authors after 60 min of ozonation. The acute toxicity of the 
intermediates was checked and a slight acute toxicity increment in the first stage of 
ozonation was found. pH variation was found as important parameter on TOC and 
COD removal efficiencies. The complete sulfamethoxazole removal was achieved for 
an in photo-Fenton process (Gonzalez et al., 2007). Toxicity and inhibition tests 
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pointed in the same direction: no toxic effect of oxidized intermediates was 
determined and also no inhibition was detected on activated sludge activity.  
2.2.6.5 Biodegradation 
Biodegradability of most antibiotics has been checked and it was found that they are 
not biodegradable under aerobic conditions until today. (Richardson and Bowron, 
1985; Al-Ahmad et al., 1999; Wiethan et al., 2000; Kummerer et al., 2000; Ingerslev 
et al., 2001; Ingerslev and Halling-Sørensen, 2001; Thiele-Bruhn, 2003; Alexy et al., 
2003, 2004; Gartiser et al., 2007a; Li et al., 2008c). Biodegradability characteristics 
have been weak for most of the compounds investigated in laboratory tests such as the 
OECD test series (301–303, 308) – even for some of the ß-lactams (Alexy et al., 
2004). Out of 16 antibiotics tested, only benzyl penicillin (penicillin G) was 
completely mineralized in a combination test (combination of the OECD 302 B and 
OECD 301 B tests; Gartiser et al., 2007a).  
Biodegradation for tetracycline was not observed during a biodegradability test 
(sequence batch reactor), and sorption was found to be the principal removal 
mechanism for tetracycline in activated sludge (Kim et al., 2005). 
Some antibiotics occurring in soil and sediment proved to be quite persistent in 
laboratory testing as well as in field studies. Some of them were not biodegradable 
also under anaerobic conditions (Gartiser et al., 2007b) others did (Maki et al., 2006). 
Substances extensively applied in fish farming had long half-lives in soil and 
sediment, as reported in several investigations (Jacobsen and Berglind, 1988; Hansen 
et al., 1992; Samuelsen et al., 1992, 1994; Hektoen et al., 1995; Capone et al., 1996; 
Marengo et al., 1997; Lai et al., 2008). However, some substances were at least partly 
degradable (Donoho, 1984; Gilbertson et al., 1990; Samuelsen et al., 1991, 1994; 
Capone et al., 1996; Thiele-Bruhn, 2003). Maki et al. (2006) found that ampicillin, 
doxycycline, oxytetracycline, and thiamphenicol were significantly degraded, while 
josamycin remained at initial levels. Tylosin was biodegraded (Hu and Coats, 2007). 
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2.3 Inhibition and Toxicity 
Inhibitors which cause slowing and/or halting enzymatic reactions are molecular 
agents. They are most important pharmaceutical agents nowadays (Lehninger et al., 
2005).  
Toxicity is  is the degree to which a substance can damage an organism. Toxicity can 
mention to the effect on a whole organism, such as an animal, bacterium, or plant, as 
well as the effect on a substructure of the organism.  
2.3.1. Types of inhibition 
Inhibition types are divided into two main classes as reversible and irreversible 
inhibition. 
Inhibition effect can be recovered in the reversible inhibition type. One common type 
of reversible inhibition is called competitive. Inhibitors competes with the substrate 
for the active site of enzyme in the competitive one. While the inhibitor fills up the 
active site it prevents binding of the substrate to the enzyme. Many competitive 
inhibitors are compounds that resemble the substrate and combine with the enzyme to 
form an enzyme-inhibitor complex, but without leading to catalysis. Even fleeting 
combinations of this type will reduce the efficiency of the enzyme.  
The other types of reversible inhibition is uncompetitive. An uncompetitive inhibitor 
binds at a site distinct from the substrate active site and, unlike a competitive 
inhibitor, binds only to the enzyme-substrate complex.  
The last type of reversible inhibition is mixed inhibition also binds at a site distinct 
from the substrate active site, but it binds to either enzyme or enzyme-substrate 
complex.  
Also there is a special case of mixed inhibition which is defined as noncompetitive 
inhibition. In this inhibition, the inhibitor reduces the activity of the enzyme. In 
practice, uncompetitive and mixed inhibition are observed only for enzymes with two 
or more substrates and are very important in the experimental analysis of such 
enzymes.  
In the irreversible inhibition, the inhibitory effect cannot be recovered. The 
irreversible inhibitors are those that bind covalently with or destroy a functional group 
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on an enzyme that is essential for the enzyme‘s activity, or those that form a 
particularly stable noncovalent association. Formation of a covalent link between an 
irreversible inhibitor and an enzyme is common. Irreversible inhibitors are another 
useful tool for studying reaction mechanisms. Amino acids with key catalytic 
functions in the active site can sometimes be identified by determining which residue 
is covalently linked to an inhibitor after the enzyme is inactivated.  
A special class of irreversible inhibitors is the suicide inactivators. These compounds 
are relatively unreactive until they bind to the active site of a specific enzyme. A 
suicide inactivator undergoes the first few chemical steps of the normal enzymatic 
reaction, but instead of being transformed into the normal product, the inactivator is 
converted to a very reactive compound that combines irreversibly with the enzyme. 
These compounds are also called mechanism-based inactivators, because they hijack 
the normal enzyme reaction mechanism to inactivate the enzyme. Suicide inactivators 
play a significant role in rational drug design, a modern approach to obtaining new 
pharmaceutical agents in which chemists synthesize novel substrates based on 
knowledge of substrates and reaction mechanisms. A well-designed suicide 
inactivator is specific for a single enzyme and is unreactive until within that enzyme‘s 
active site, so drugs based on this approach can offer the important advantage of few 
side effects (Lehninger et al., 2005).  
2.4 Fundamentals of Anaerobic Treatment 
Anaerobic degradation is a complex process that the organic compounds are 
mineralized to CH4 and CO2 in the absence of oxygen. Different microbial groups 
have role on this process. Anaerobic degradation of the organic matters is occurred 
with a multi step and parallel reactions which different microbial groups have role. 
These steps are generally classified, namely: 
- hydrolysis 
- acidogenesis 
- acetogenesis 
- methanogenesis 
Various models have been suggested to explain these biochemical stages such as 
nine-stage model (Harper and Pohland, 1986), six-stage model (Lester et al., 1986) 
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and three-stage model (Gerardi, 2003). Biochemical reactions in the nine-stage model 
of anaerobic digestion are listed below (Harper and Pohland, 1986) and shown 
diagrammatically in Figure 2.5. The biochemistry and microbiology of anaerobic 
digestion is a complex biogenic process involving a number of microbial populations, 
linked by their individual substrate and product specifities (Hutnan et al., 1999). 
 
 
Figure 2.5: Substrate conversion patterns associated with the anaerobic digestion 
(Harper and Pohland, 1986). 
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2.4.1 Hydrolysis 
Hydrolysis, which is the first step of the anaerobic degradation, consists the 
extracellular enzymatic reactions to serve the particulate organic matters for bacteria. 
This process is only surface phenomena where the complex polymeric particles such 
as carbohydrates, proteins, and lipids are degraded through the action of exo-
enzymes, which are produced in the cell but are released through the ―slime‖ coating 
the cell to the insoluble substrate attached to the slime (Gerardi, 2003), to monomers, 
which can transport to the cell barriers. While all bacteria produce endoenzymes, it is 
not the same for exoenzymes. Also there is no bacterium can prıduce all type of 
exoenzymes that are needed to degrade the large variety of particulate and colloidal 
substrates that are found in sludges and wastewaters. The substrate types and the 
spesific exoenzymes are given in Table 2.3. Each enzyme has role on degradation of 
only a specific substrate or group of substrates. Therefore, a large and diverse 
community of bacteria is needed to ensure that the proper types of exoenzymes and 
endoenzymes are available for degradation of the substrates present. 
Table 2.3: Exoenzymens and substrates (Gerardi, 2003). 
Substrate Exoenzyme Example Bacterium Product 
Polysaccharides Saccharolytic Cellulase Cellulomonas Monosaccharides 
Proteins Proteolytic Protease Bacillus Amino acids 
Lipids Lipolytic Lipase Mycobacterium Fatty acids 
Hydrolysis can be a rate limiting steps for all treatment of the waste and/or 
wastewater because the hydrolytic bacteria, their enzymes, the availability of free 
accessible surface area of the organic compounds and the overall structure of the solid 
substrate are of paramount importance for the succeeding steps in the anaerobic 
degradation sequence (Stronach et al., 1986, Pavlostathis and Giraldo-Gomez, 1991, 
Zeeman et al., 1996). Furthermore, this step is very sensitive to temperature. Also pH, 
cell residence time and the waste constituents in the reactor directly influence to the 
reaction rate. 
In the hydrolysis step, a wide range of bacteria takes the role. Bacillus play role in the 
degradation of proteins and fats, while The strictly anaerobic genus Clostridium 
includes many species that are highly active in the production of extracellular 
hydrolytic enzymes and is responsible for degradation of compounds containing 
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cellulose and starch. The types of hydrolytic microorganisms are classified namely as, 
the cellulytic (Clostridium thermocellum), proteoytic (Clostridium bifermentas, 
Peptococcus), lipolytic (genera of clostridia and micrococci) and aminolytic 
(Clostridium butyricum, Bacillus subtilis) bacteria (Hungate, 1982; Payton and 
Haddock, 1986). The hydrolytic bacteria may also break down the some intermediate 
products to simple volatile fatty acids, carbon dioxide, hydrogen, ethanol (Eastman 
and Ferguson, 1981). 
As seen in Table 2.3, the spesific exoenzymes carries out the hydrolysis. Lipases 
convert lipids to long-chain fatty acids. The produced long-chain fatty acids are 
degraded by β-oxidation to produce acetyl-CoA. Proteins are generally hydrolyzed to 
amino acids by proteases, secreted by Bacteroides, Butyrivibrio, Clostridium, 
Fusobacterium, Selenomonas, and Streptococcus. The amino acids produced are then 
degraded to fatty acids such as acetate, propionate, and butyrate, and to ammonia as 
found in Clostridium, Peptococcus, Selenomonas, Campylobacter, and Bacteroides. 
Polysaccharides such as cellulose, starch, and pectin are hydrolyzed by cellulases, 
amylases, and pectinases.  
2.4.2 Acidogenesis 
Acidogenesis is the second step of the anaerobic degradation in which the hydrolysis 
products are transferred to bacterial cells and subsequently fermented or anaerobically 
oxidized. In this phase, ammonia acids, simple sugars and long chain fatty acids are 
converted to carbon dioxide, hydrogen, alcohols, ammonia and short-chain fatty acids 
such as acetic, butyric, propionic, valeric acid. Acidogenesis is carried out by a large 
group of hydrolytc and non-hydrolytic microorganisms. The products of this step 
differ with not only type of bacteria but also temperature, pH, and the composition of 
the influent feed. The catabolism of these organic compounds is carried out by a large 
number of both obligatory and facultatively anaerobic microorganisms. While single 
amino acids are degraded under anaerobic conditions by Clostridia, Mycoplasmas and 
Streptococci, butanol, butyric acid, acetone and iso-propanol are generally converted 
by the bacteria of the genera Clostridium and Butyribacterium, for example 
Clostridium butyricum, Clostridium acetobutylicum, and Clostridium butylicum 
produce butyrate, acetone and butanol and only butanol in addition to hydrogen, 
carbondioxide and iso-proponol. The genera Clostridium and Butyribacterium are 
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involved in the production of butyrate, buthanol, butyric acid, acetone and iso-
propanol. 
2.4.3 Acetogenesis 
The third stage of the anaerobic degradation is acetogenesis in which the short chain 
fatty acids (SCFA), other than acetate, are further converted to acetate, hydrogen and 
carbon dioxide by two groups of bacteria, which have a sytrophic relationship 
between methanogenic archaea. The process in which a molecule is removed from 
fatty acids having more than two carbons at each reaction step until all fatty acids are 
converted to acetate molecules is generally called as -oxidation. The activity of the 
organisms playing role in the step is of paramount importance, since methanogens 
cannot utilize the fatty acids other than acetic acid.  
The first group bacteria taking the role in acetogenesis, the obligate hydrogen 
producing acetogens (OHPA), also called proton-reducing acetogens, produce acetic 
acid, carbon dioxide and hydrogen from the major fatty acid intermediates 
(propionate and butyrate), alcohols and other higher fatty acids (valerate, isovalerate 
stearate, palmitate and myristate via -oxidation). These species are capable of 
growth only in environments that maintain a low concentration of the metabolic 
product hydrogen. Only a limited number of OHPA species have been isolated and 
identified, namely Syntrophomonas wolfei and Syntrophobacter wolinii, which 
oxidize butyrate and propionate, respectively (Malina and Pohland, 1992; Gujer et al., 
1983). 
The second group in acetogenesis is homoacetogens which are strictly anaerobic 
microorganisms catalyzing the formation of acetate from hydrogen and carbon 
dioxide. Homoacetogens are known in the genera Acetobacterium, Acetoanaerobium, 
Acetogenium, Butribacterium, Clostridium and Pelobacter. Homoacetogenic bacteria 
are also syntrophs like OHPA because they participate in the interspecies hydrogen 
transfer process, which maintains the low hydrogen concentrations required by the 
OHPA. Acetogenic bacteria reproduce very slowly. Generation time for these 
organisms is usually greater than 3 days (Anderson et al., 2003). 
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2.4.4 Methanogenesis 
In the final step of the anaerobic degradation, the products of the previous step are 
mineralized to methane and carbon dioxide by methanogens via two conversion 
mechanisms including decarboxylation of acetic acid and reduction of carbon 
dioxide in the absence of other electron acceptors such as oxygen, nitrate, and 
sulfate except bicarbonate and protons as terminal electron acceptors (Garcia et al., 
2000; De Bok et al., 2004; Stams et al., 2006). This stage is considered as the rate-
limiting step in the anaerobic process because of the slow growth rate of the 
methanogens (Malina et al., 1992). Methanogens is a phylogenetic member of 
Archaea domain that are distinguished from Eubacteria by a number of 
characteristics, including the possesxion of membrane lipids composed of 
isoprenoids ether-linked to glycerol or other carbohydrates, a lack of peptidoglycan 
containing muramic acid, a distinctive ribosomal RNA sequences (Woese, 1987). 
Some extreme halophiles and some extremely thermophilic, sulfur-dependent 
microbes (Woese, 1987) are also included in this grup and they are 
phylogenetically distinct from eukaryotes and bacteria. 
Methanogens, which have orders and sub-groups, are strictly anaerobic organisms and 
gain their energy by producing CH4 and CO2 from simple substrates such as H2, CO, 
acetate, formate, and a few alcohols (Figure 2.6). Alternatively, methanogens produce 
CH4 by the reduction of the methyl groups in acetate, methanol, trimethylamine, and 
dimethylsulfide, part of which are oxidized to CO2 to generate the electrons necessary 
for reduction of the methyl group to CH4. Some methanogens are able to use H2 as 
second substrate to reduce the methyl, for example in methanol. The substrates 
including CO2-type, methyl substrates and acetate converted to methane by various 
methanogenic Archaea are listed in Table 2.4. All reactions are thermodynamically 
exergonic at standard conditions allowing occur in nature, if substrate concentrations 
are sufficiently high.  
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Figure 2.6: Phylogeny of methanogens, domain Archaea. (Non-methanogens are 
indicated by their group names, large triangles) (Garcia et al., 2000). 
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Table 2.4: Substrates converted to methane by various methanogenic Archaea 
(Madigan et al., 2009). 
Substrates and Reactions Organisms 
I. CO2-type substrates (Carbon dioxide with electrons derived from H2, certain alcohols, or pyruvate; 
Formate, Carbon monoxide) 
4 H2 + CO2 →CH4 + 2 H2O  
 4 HCOOH→CH4 + 3 CO2 + 2 H2O   
CO2+4isopropanol→CH4 + 4acetone + 2H2O  
4 CO+ 2H2O→CH4 + 3 CO2 
Most methanogens 
Many hydrogenotrophic methanogens 
Some hydrogenotrophic methanogens 
Methanothermobacter and Methanosarcina 
II. Methylated C1 compounds (Methanol, Methylamine, Dimethylamine, Trimethylamine, 
Methylmercaptan, Dimethylsulfide) 
4 CH3OH→3 CH4 + CO2 + 2 H2O  
 
CH3OH + H2 →CH4 + H2O  
 
2 (CH3)2-S + 2 H2O→3 CH4 + CO2 + 2 H2S  
4 CH3-NH2 + 2 H2O→3 CH4 + CO2 + 4 NH3  
2(CH3)2-NH + 2 H2O→3 CH4 + CO2 + 2 NH3  
4 (CH3)3-N+ 6 H2O→9 CH4 + 3 CO2 + 4 NH3  
4CH3NH3Cl + 2H2O→3CH4 +CO2 + 4 NH4Cl 
Methanosarcina and other methylotrophic 
methanogens 
Methanomicrococcus blatticola and 
Methanosphaera 
Some methylotrophic methanogens 
Some methylotrophic methanogens 
Some methylotrophic methanogens 
Some methylotrophic methanogens 
Some methylotrophic methanogens 
III. Acetate 
CH3COOH→CH4 + CO2 Methanosarcina and Methanosaeta 
As seen in Table 2.4, CO2, formate and CO are called as CO2-type substrates and 
reduced to methane in accordance with Eq 3.1. Hydrogenotrohic methanogens such as 
Methanobacteriales, Methanomicrobiales, Methanococcales and 
Methanosarcinaceae are responsible in this process. Most hydrogenotrophic 
methanogens that can reduce CO2 to methane use H2 as the primary electron donor. 
Many hydrogenotrophic methanogens are also able to use formate and secondary 
alcohols, such as 2-propanol, 2-butanol, and cyclopentanol as electron donors. A 
small number of methanogens can also use ethanol.  
CO2+4H2 CH4+2H2O               G =-131kJ/mol (Batstone et al., 2002) (2.1) 
The methyl groups, which are the second class substrate of methanogenesis, are 
converted to methane via two conversion mechanisms. First of them is the formation 
of methane by reducing methyl group substances using an external electron donor 
such as H2. In the conversion equations methanol (CH3OH) is used as a model methyl 
 28 
substrate, as given in Eq. 3.2. In the second mechanism, the methane is produced via 
reducing methyl group substances using an external electron donor such as H2. In the 
conversion equations, methanol (CH3OH) is used as a model methyl substrate, as 
given in Eq. 3.3. Methanogens that are able to use methylated compounds, or 
methylotrophicmethanogens, are limited to the order Methanosarcinales, except for 
Methanosphaera species, which belong to the order Methanobacteriales. 
CH3OH+H2 CH4+H2O          G =-113kJ/mol (Batstone et al., 2002) (2.2) 
 
4CH3OH 3CH4+CO2+2H2     G =-319kJ/mol(Batstone et al., 2002) (2.3) 
The last type of substrate that is used by methanogens is acetate. Acetate is a major 
product of the fermentation and accounts for 70% of the methane production in 
anaerobic bioreactors. Acetate is degraded by cleavage, with the carboxyl group being 
oxidized to CO2 and the methyl group being reduced to CH4. The CH4-producing 
reaction is generated by the activity of methyl-CoM reductase, which converts 
methyl-CoM (methyl-coenzymeM) and HS-HTP (N-7-mercaptoheptanoyl-O-
phospho-L-threonine) to CH4 and a heterodisulfide consisting of HS-HTP and CoM-
SH. This reaction is occurred by all methanogens, independent of primary substrate. 
The subsequent reduction of the heterodisulfide to CoM-SH and HS-HTP is coupled 
to the generation of a proton motive force. This reaction is the most important one for 
energy conservation and is universal for all methanogens. In the first step, acetate has 
to be converted to acetylcoenzyme A (acetyl-CoA), which requires the expenditure of 
energy. Formation of acetyl-CoA occurs by two different reactions (Zinder, 1993). In 
Methanosarcina spp., acetate is first phosphorylated with ATP by an acetate kinase 
producing acetyl-P and ADP. Subsequently, the acetyl-P is converted by a 
phosphotransacetylase with CoA-SH to acetyl-CoA and phosphate. In summary, 
conversion of acetate to acetyl-CoA requires one energy-rich phosphate bond of ATP 
in Methanosarcina spp. In Methanosaeta spp., on the other hand, acetate is activated 
using an acetyl-CoA synthetase, which converts acetate, CoA-SH, and ATP to acetyl-
CoA, AMP, and pyrophosphate. In summary, this reaction requires two energy-rich 
phosphate bonds of ATP. This means that Methanosaeta spp. use more energy for 
acetate activation than Methanosarcina spp. Acetate is catabolized by the members of 
only two genera of methanogens, that is Methanosarcina and Methanosaeta, which 
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belong to the families of Methanosarcinaceae and Methanosaetaceae, respectively. 
Methanosarcina has a low affinity for acetate and dominate when acetate 
concentrations are high. On the other hand, Methanosaeta has a high affinity for 
acetate and dominate when acetate concentrations are as low. Methanosaeta, which 
uses only acetate as substrate, is a superior acetate utilizer in that it can use acetate at 
concentrations as low as 5–20 μM, while Methanosarcina requires a minimum 
concentration of about 1 mM. Members of the family Methanosarcinaceae, including 
Methanosarcina spp. are also able to utilize H2/CO2, methanol, metyl amines and 
pyruvate besides acetate as energy substrate for CH4 production. The difference 
between the organisms in terms of acetate affinity depends probably on the 
differences in the first step of acetate metabolism. Methanosarcina uses the low-
affinity acetate kinase (AK)-phosphotransacetylase (PTA) system to activate acetate 
to acetyl-CoA. On the other hand, Methanosaeta uses the high-affinity adenosine 
monophosphate (AMP)–forming acetyl-CoA synthetase.  
2.4.5 Characterization of microbial communities in anaerobic reactors 
Anaerobic bioreactors are used for waste(water) treatment and much is known about 
the pathways occurred in the system. However, only little part of the microbial 
ecology within these systems has been revealed, yet. This small fraction cannot reflect 
the composition and diversity of the ecosystems. So, in the full-scale application, the 
black-box model is still acceptable for design and operation. Despite, culture 
dependent techniques are being developed day to day, a few percent of Bacteria and 
Archaea have been isolated. Also their dynamic in the system and relations between 
each other are still unknown.  
To overcome this unpredictable and unexplainable lack, molecular tools have been 
used in last decades (Amann et al., 1995; Muyzer et al., 1996; Head et al., 1998). 
Using the molecular tools in the anaerobic treatment systems, we can find the answers 
of the questions such as ‗which species do exist?‘, ‗which species are active?‘, ‗how 
many microorganisms are there?‘, which species do utilize the specific compounds?‘.  
Microbial ecology studies need identification of species based on a comprehensive 
classification system that perfectly reflect the evolutionary relations between the 
microorganisms (Pace, 1996). Numerous authors pointed out that traditional 
classification systems based on phenotypic characteristics such as morphology, 
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physiology, and structure of cell components) offer a few information on evolutionary 
relations and the cultivation was necessary for identification (Pace, 1996 and 1997).  
Zuckerkandl and Pauling (1965) indicated that nucleic acids could document 
evolutionary history. Due to the pioneering studies, nucleic acids, especially 16S 
rRNA, are the ultimate biomarkers and hereditary molecules probably because of 
their essential role in protein synthesis, making them one of the earliest evolutionary 
functions in all cellular life-forms (Olsen et al., 1986; Pace et al., 1986; Woese, 1987; 
Stahl et al., 1988). In particular, 16S rRNA and 16S rDNA have been used in 
phylogenetic analysis and accepted as ideal evolutionary chronometers because: 
i) They are a key element for all prokaryotic organisms, and evolutionary 
homologous, 
ii) They are very conserved against to mutations. 
iii) Their conserved and variable regions reflect the differences between 
species and provided to analyze phylogenetically as seen in Figure 2.7 
(Woese, 1987, Amann et al., 1995; Head et al., 1998). Therefore to design 
primers and probes are possible. 
iv) They are sufficiently large molecules (≈1500 nucleotides) to provide the 
information species and strain level (Woese, 1987). 
v) They have enough copy in most of the cells (103 to 105 copies), which 
provide easy detection (Amann et al., 1995). 
vi) There is no evidence about transfer of this gene between the organisms. 
Using 16S rRNA, Woese and his colleagues developed the first phylogenetic trees, 
which show the evolutionary relations of all organisms as seen Figure 2.8. 
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Figure 2.7: Secondary structure of the 16S rRNA of E. coli, showing conserved and 
variable regions (van de Peer et al., 1996). 
 
Figure 2.8: The rRNA tree of life (Madigan et al., 2009). 
In the last decade, metabolically functional genes such as methyl coenzyme M 
reductase subunit A gene (mcrA) in methanogenesis, nitrite reductases (nirK), nitrate 
reductase (narG), nitrous oxide reductase (nosZ) genes in nitrification process, 
ammonia monooxygenase genes in nitrification process have been used to investigate 
diversities in the ecosystems (Gray and Head, 1999; Kowalchuk et al., 1999; Nogales 
et al., 2002; Nunoura et al., 2008).  
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2.4.5.1 Molecular tools 
The microbiological analysis based on 16S rRNA and rDNA sequences for 
characterization are given in Figure 2.9. 
 
Figure 2.9: Strategies based on rRNA sequence analysis for characterization of 
microbial communities without cultivation (arrows indicate the 
interconnected use of methods, experimental materials, and 
information in the study of microbial ecosystems. RT-PCR: reverse 
transcription to produce DNA from RNA, followed by PCR. DGGE: 
denaturing gradient gel electrophoresis. RFLP: restriction fragment 
length polymorphism (Hofman-Bang et al., 2003). 
Nucleic Acid Isolation 
DNA and RNA isolation are the first step of PCR-based methods. The important point 
in this step is to obtain representative and bias-free samples. Also adequate nucleic 
acid should be retrieved. After the sampling, DNA samples can be stored at -20 ºC 
until extraction. However, RNAs should be isolated quickly and under appropriate 
conditions.  
Several methods have been used for the isolation from different kind of samples such 
as sludge, water, manure, soil, and sediment (Moran et al., 1993; Ibrahim and Ahring, 
1999; Frischer et al., 2000; Cetecioglu et al., 2009). Obtaining RNA or DNA 
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quantitatively from all cells in a complex community without bias can be difficult. In 
general, mechanical lysis methods have shown less bias than enzymatic lysis 
methods, leading to the recovery of intact high molecular weight nucleic acids (Yu 
and Mohr, 2001). 
Polymerase Chain Reaction (PCR) 
PCR are used to amplify a selective, small part of DNA, which is extracted from 
environmental samples. Nowadays, it is generally the first step of the phylogenetic 
analysis. The products of the PCR are analyzed by further techniques such as cloning-
sequencing, DGGE or TGGE which have the potential to separate the PCR products 
originating from different DNA sequences representing populations in the original 
samples (Hofman-Bang, 2003).  
Reverse-Transcription PCR (RT-PCR) 
RT-PCR is used to synthesis complementary DNAs (cDNAs) from RNA (rRNA or 
mRNA) to analyze active community based on 16S rRNA or expression level of 
enzymes via mRNAs (Felske et al., 1998; Miskin et al., 1999). In 16S rRNA 
approach, positive relationship between growth rate and cellular rRNA content. So, it 
seems to allow a better analysis of active communities. Still, this approach needs to be 
improved because it is known that inactive but viable microorganisms will contain 
ribosomes, in order to be able to react to changing environmental conditions. 
The amount of ribosomes in starved microorganisms can be considerable, when 
compared to the ribosome content during growth at maximal growth rates, and high 
levels can be maintained over long periods of time (Fukui et al., 1996) and it has been 
shown that autotropic ammonia-oxidizing bacteria maintain very high levels of rRNA 
even in the absence of detectable ammonia oxidation activity (Wagner et al., 1995). 
Quantitative Real-Time PCR (Q-PCR) 
Q-PCR is applied for exact quantification of the microbial groups as kingdom, family 
or genus level (Conklin et al., 2006; Siggins et al., 2011) and for determination of 
expression level of specific enzymes on mRNA level (Lopez-Gutierrez et al., 2004; 
Nunoura et al., 2008; Ince et al., 2011). It is a technique based on the continuous 
monitoring of changes of fluorescence in the PCR tube during amplification. In 
contrast to traditional PCR, in which end-point detection is occurred, quantification is 
done based on the exponential phase of amplification in Q-PCR (Malinen et al. 2003). 
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Thus, the bias often observed in the PCR template-to-product ratios can be largely 
avoided (Suzuki & Giovannoni 1996).  
Cloning and Sequencing 
Construction of clone libraries is the most common molecular analysis for 
environmental samples. This technique allows identifying the species on strain level. 
After amplicons obtained from PCR, the single sequences are retrieved for 
sequencing via cloning (Madigan et al., 2009). Analysis of 16S rRNA clone library to 
assess microbial diversity and populations in ecosystems is an important approach 
(Giovanni et al., 1990). The steps of this technique are given in Figure 2.10: (A) 
direct nucleic acid extraction, without the need for previous isolation of 
microorganisms; (B) amplification of the genes that code for 16S rRNA by 
polymerase chain reaction (PCR), commonly using universal primers for bacteria or 
archaea, resulting in a mixture of rDNA copies corresponding to the microorganisms 
present in the sample; (C) cloning of the PCR products obtained into a suitable high 
copy number plasmid and transformation of competent E. coli cells with this vector; 
(D) selection of transformed clones with an indicator contained in the plasmid (the 
white colonies in the figure); (E) extraction of plasmid DNA; (F) sequencing of the 
cloned gene, creating a clone library; (G) determination of the phylogenetic affiliation 
of the cloned sequence with the help of dedicated computer programs (ARB, Seqlab, 
PAUP, PHYLIP). 
 
Figure 2.10: Outline of the cloning procedure for studying a microbial community 
(Sanz and Kochling, 2007). 
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Fingerprinting Techniques 
A lot of fingerprinting techniques such as DGGE, TGGE, RFLP, T-RFLP, and SSCP, 
have been developed for estimation of diversity in ecosystems, screening clone 
libraries, following the diversity changes with respect to time and location (Hofman-
Bang, 2003). 
The DGGE (denaturing gradient gel electrophoresis) technique has been used to 
characterize the microbial diversity in different environments such as activated sludge 
(Curtis and Craine, 1998), sediments (Muyzer and De Wall, 1993), lake water 
(Ovreas et al., 1997), hot springs (Santegoeds et al., 1996), biofilm (Santegoeds et al., 
1998). It provides a fast, less labor-intensive approach to comparing community 
composition in many different samples than sequencing of clone libraries but little 
direct information on population identity (Muyzer and Smalla, 1998). The method can 
be used to as both qualitative and semi-quantitative approaches for biodiversity 
estimations. 
TGGE (temperature gradient gel electrophoresis) is also similar technique. The only 
differences between DGGE and TGGE, while chemical denaturing polyacrylamide 
gel is used to separate equal-length DNA fragments in DGGE, temperature gradient is 
applied for the same target in TGGE. 
Another fingerprinting method is RFLP (restriction fragment length polymorphism) in 
which rDNA can be digested with restriction enzymes and the banding pattern 
obtained from previous step has been used to identify different genotypes of 
microorganisms (Ingianni et al., 1997) and to monitor population changes in 
environmental samples (Smit et al., 1997; Vachee et al., 1997). 
SSCP (single-strand conformation polymorphism) is used for separation of DNAs 
based on their secondary structures product by NaOH prior to non-denaturing 
polyacrylamide gel electrophoresis. The advantage of the technique is that even point 
mutations can be detected as a change of conformation in the secondary structure of 
the single stranded DNA. In this method, each SSCP peak reflects to a distinct 
microbial sequence, indicating the presence of a microbial strain or species retrieved 
from the sample (Leclerc et al., 2001; 2004). 
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Fluoresence in situ Hybridization (FISH) 
This technique is commonly applied investigate the overall taxonomic composition of 
bacterial communities or assemblages in environmental samples. Fluoresence probes 
can be designed to be complementary to species-, group-, or kingdom-specific target 
sites. Cells are fixed to make them permeable to the probe, which then hybridizes its 
specific target site. There are a lot of studies which FISH was used to explore 
microbail communities in activated sludge, anaerobic reactors, marine and freshwater 
environments, and in both pristine and contaminated aquifers (Wagner et al., 1993; 
Borneman et al., 1996; Snaidr et al., 1997; Shi et al., 1999; Cottrell and Kirchman, 
2000; Ince et al., 2007 and 2009). 
2.5 Environmental and Operational Factors Effecting Anaerobic Treatment  
Methanogenesis is assumed that the rate limiting step of the anaerobic degradation. 
However, all metabolic products play a regulative role in maintaining the overall 
process because of syntrophic relation. Low growth rate of methanogens can make the 
anaerobic system sensitive to environmental changes (Xing et al., 1997) and 
disturbances in populations from one trophic level may affect the entire community 
(Raskin et al., 1996). The most important environmental and operational factors in the 
anaerobic systems are listed below. 
2.5.1 Temperature 
Oscillation in temperature of even a few degrees affects almost all biological 
activities as the inhibition of some anaerobic microorganisms, especially 
methanogens. The main reason of this, ionization equilibrium, solubility of substrates, 
substrate removal rate and other constants such as specific growth rate, decay biomass 
yield, and half- saturation constant are depends on the temperature. Three different 
temperature conditions are used for the operation of the anaerobic systems; 
psycrophilic, mesophilic and thermophilic. However the most common application is 
mesophilic conditions t temperatures from 25°C to up to 40°C with the optimum at 
approximately 35°C. Psycrophilic bacteria function between 0-20°C. Thermophilic 
digestion operates at temperature ranges of 50-65°C. Temperature fluctuations 
become more important in high loading rates. Also methane production in the 
thermophilic range is usually performed at industrial wastewater treatment plants that 
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are able to heat wastewaters or sludges (Gerardi, 2003). Because of the impact of 
temperature on enzymatic activity, SRT in the system should increase with decreasing 
temperatures. Although anaerobic microorgansism can be acclimated to operating 
temperatures out of their optimum range, biomass activity and reactor performance 
may be adversely affected. Because methanogens grow slowly and are very sensitive 
to small changes in temperature, acclimation must proceed very slowly. 
2.5.2 Alkalinity and pH 
Sufficient alkalinity is essential for proper pH control. Alkalinity serves as a buffer 
that prevents oscillation in pH. pH influences on enzymatic activity and reactor 
performance. Acceptable enzymatic activity of bacteria occurs above pH 5.0, but 
acceptable range for methanogens are changed between pH 6.2. and 8.0. However, ph 
range of 6.8 to 7.2 is optimum for the single-stage reactors (Pohland, 1987; Malina et 
al., 1992). The pH in the anaerobic reactors initially decreases with the production of 
volatile acids if the adequate alkalinity is not provided. A decrease in alkalinity can be 
caused by:  
1) an accumulation of organic acids due to the failure of methanogens to convert the 
organic acids to methane,  
2) a slug discharge of organic acids to the anaerobic reactor, or  
3) the presence of wastes that inhibit the activity of methanogens.  
2.5.3 Nutrients 
All microorganisms need to macro and micro-nutrient for basal metabolism and 
growing under both aerobic and anaerobic conditions. Macro nutrient requirement of 
anaerobic systems is lower than aerobic systems. Methanogens need trace amounts of 
elements called as micronutrients besides nitrogen and phosphorus for their 
fundamental requirements of microbial metabolism (Speece, 1996). Methanogens are 
needed iron, nickel, magnesium, calcium, sodium, barium, tungstate, molybdate, 
selenium and cobalt (Henze et al., 1983). Some of the elements such as selenium, 
tungsten and nickel are important in the enzyme systems of acetogenic and 
methanogenic microorganisms (Stronach et al., 1986).  
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2.5.4 Mixing 
Anaerobic reactors should be mixed for appropriate conditions. Mixing enhances the 
process efficiency by distributing microorganisms, substrate, and nutrients throughout 
the reactor as well as equalizing temperature. Mixing could be energy consuming 
process but it is applied most of treatment systems. 
2.5.5 Retention Time 
According to wastewater characteristics, the adequate hydraulic retention time (HRT) 
should be provided to allow the mineralization of organic compound by 
microorganisms. 
2.5.6 Toxicants 
Anaerobic digestion is known as a favourable process for inhibitory or toxic materials 
that cause disturbances in biological systems. There are many compounds, both 
organic and inorganic, which may be toxic or inhibitory to the anaerobic process, 
although the general effect which results from the addition of most substances may 
vary from stimulation to toxicity. The effective concentration of an inhibitory or toxic 
substance may vary.  
Inhibition of methanogenesis is generally indicated by reduced methane production 
and increased concentration of volatile acids.  Methanogenesis is generally the most 
sensitive step to inhibitory or toxic material although all groups involved in process 
can be affected. Bacteria are affected by increasing undesirable environmental 
conditions. However; methanogens can be acclimatized to these compounds (Speece 
and Parkin, 1983). 
A wide range of toxicants is responsible for the occasional failure of anaerobic 
reactors such as volatile acids, alkali and alkaline earth salts, ammonia nitrogen, 
sulfide and heavy metals.  
2.5.6.1 Volatile Fatty Acids (VFA) inhibition 
The most common inhibition, which restricts the stability of an anaerobic reactor, is 
known as the accumulation of volatile fatty acids produced by the acidogenic culture. 
Acetic acid is identified as the least toxic volatile acid in literature whereas propionic 
acid has often been defined as the major source of system failure in anaerobic 
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digesters. The maintenance of a balance between the rate of volatile acids production 
and their conversion to methane is essential factor on the effectiveness of anaerobic 
digestion.  
2.5.6.2 Alkali and alkaline salts inhibition 
Salt toxicity is normally associated with the cation rather than the anion of the salt. 
Excess concentrations of alkali and alkaline earth-metal salts such as Na, K, Ca, or 
Mg particularly in industrial wastewaters can cause instabilities in the system and are 
defined as inhibitory.  
2.5.6.3 Ammonia-Nitrogen inhibition 
Normally, the presence of ammonium bicarbonate resulting from digestion of heavily 
proteinaceous or urea wastes is beneficial to the digester as a source of nitrogen and 
as a buffer to changing values of pH.  
However, both the ammonium ion (NH4
+
) and dissolved ammonia gas (NH3) may 
become inhibitory at high concentrations. These two forms are in equilibrium with 
each other, the relative concentration of each depending upon the pH as indicated in 
the Eq. 3.4 below: 
NH4
+
              NH3 + H
+
  (2.4) 
At high hydrogen ion concentration (pH 7.2 or lower), the equilibrium is shifted to the 
left so the inhibition is related to the ammonium ion concentration. At higher pH 
levels, the equilibrium shifts to the right and the ammonia gas may become inhibitory. 
2.5.6.4 Sulfide inhibition 
Sulfide inhibition is a potential problem in anaerobic treatment primarily due to 
biological production of sulfates and other sulfur-containing inorganic compounds, as 
well as from anaerobic protein degradation.  
Sulfate in the influent of an anaerobic digester particularly inhibits methanogenesis 
due to both the competition for acetate and production of sulfide from sulfate 
reduction.  As sulfate reduction to produce hydrogen sulfide (H2S) is energetically 
favored over methane production, excessive amounts of sulfide are produced by 
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anaerobic digestion of industrial wastewaters containing high concentrations of 
sulfates.  
Sulfides in anaerobic digesters may distribute between a soluble and insoluble form, 
and also as gaseous hydrogen sulfide depending upon the digester pH and the quantity 
of the gas produced per volume of waste. The higher the gas production per unit 
volume of waste, the higher will be the amount of sulfides driven from solution as a 
gas.  
Heavy metal sulfides are insoluble and precipitate from solution, so they are not 
harmful to the microorganisms. 
2.5.6.5 Heavy metal inhibition 
Heavy metals are known as the most common source of inhibition or toxicity in 
anaerobic systems. They have been a great deal of interest on the inhibition of 
anaerobic biodegradation since their accumulation in the sludge or solids fraction 
during the treatment may be detrimental on the enzyme systems of biomass. 
The most important feature, which distinguishes them from other toxicants is that they 
are not biodegradable.  
Toxic elements and compounds such as chromium, chromates, nickel, zinc copper, 
arsenic and cyanides are classified as highly toxic inorganic toxins. 
Particularly, the presence of low but soluble concentrations of copper, zinc and nickel 
is known to be quite toxic and these salts are associated with most of the problems of 
heavy metal toxicity in anaerobic treatment. The inhibitory levels of these metals have 
been reports as being 170 mg/L (copper), 163 mg/L (zinc) and 180 mg/L (cadmium). 
However, trace stimulatory quantities of most of these heavy metals are required for 
enzymatic activation.  
Concentration of more toxic heavy metals which can be tolerated are related to the 
concentrations of sulfides available to combine with the heavy metals to form the very 
insoluble sulfide salt.  
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2.6 Anaerobic Bioreactor Configurations 
One of the most critical point in design of the anaerobic systems is selection of the 
appropriate bioreactor type and configuration to maximize metabolic, nonoxidative 
bioenergy production. Anaerobic reactors can be classified as low rate or high rate as 
shown in Figure 2.11. 
Low-rate anaerobic reactors are unmixed and temperature, SRT, and other 
environmental conditions are not regulated. The organic loading rate is low ranges 
varied between 1 and 2 kg COD/m
3
day. These reactor configurations are not suitable 
for methane production. However, to enhance biogas production some of the anaerobic 
ponds and lagoons are covered. 
High-rate anaerobic systems maintain a very high biomass level in the reactor. 
Environmental conditions are well regulated to optimize performance of the reactor. 
The organic loading rates change from 5 to 30 kg COD/m
3
day or even higher. High-
rate anaerobic reactors are more appropriate for methane production. 
 
Figure 2.11: Classification of anaerobic reactors. (Khanal 2008). 
2.6.1 Anaerobic contact reactors 
The anaerobic contact process (ACP), which is essentially a CSTR with an external 
settling tank to settle biomass with recycling to provide long SRT, is improved to 
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overcome the disadvantage of the completely mixed digesters, which are among the 
earliest configurations of anaerobic digestion. Waste streams with high concentrations 
of particulates and very high concentrations of soluble biodegradable organic 
materials are suitable for these systems. 
Typical reactor biomass concentrations change between 4 and 6 g/L, with maximum 
concentrations as high as 25–30 g/L, depending on the settleability of sludge. Organic 
loading rates of 0.5 to 10 kg COD/m
3
.day can be applied to the reactor with HRTs of 
range between 0.5 and 5 days. The required SRT can be maintained by controlling the 
recycle rate similarly to an activated sludge process. 
2.6.2 Upflow anaerobic sludge blanket (UASB) reactors 
The upflow anaerobic sludge blanket reactor (UASB) reactor developed to treat 
sugar-rich soluble wastewater (Lettinga et al., 1991) is characterized by an anaerobic 
granular sludge with a notably high metabolic activity and good biosolids 
settleability. This reactor is essentially a suspended growth system in which proper 
hydraulic and organic loading conditions are maintained 
UASB reactors are operated at a superficial upflow velocity less than 2 m/h. Under 
this condition, an extremely long SRT of 200 days can be achieved at HRT as low as 
6 h (Hulshoff Pol et al., 2004). Due to its ability to absorb extremely high VOLR (up 
to kg COD/m
3
.day), UASB is ideal for methane production applications from high-
strength wastewaters including soluble compounds (Hulshoff Pol et al., 2004). 
In this system, the influent wastewater is uniformly distributed through a specially 
designed distributor at the bottom of the reactor. The active anaerobic granules in the 
reaction zone mineralize the organic matter to biogas. Large and dense granules 
remain suspended within the sludge bed due to superficial upflow velocity and rising 
biogas bubbles. A gas collection system is used for produced biogas. The effluent is 
collected in a series of weirs placed at the top of the reactor. 
2.6.3 Anaerobic sequencing batch reactors (ASBR) 
The anaerobic sequential batch reactor (ASBR) was developed by Dague and 
coworkers in the early 1990s (Dague et al., 1992). The ASBR system was developed 
for treatment of high-strength and medium solids content feeds (TS: 1–4%) with high 
loading rate. Because of sequential operation, a single reactor can be used as a 
  43 
reaction vessel and as a settling tank, achieving high biomass levels in the reactor 
regardless of HRT. The ASBR process retains biomass due to bioflocculation 
followed by biogranulation similar to a UASB reactor.  
ASBRs are run by four operational steps: settle, decant, feed, and react as seen in 
Figure 2.12. The sequencing frequency and the feed volume processed with each 
sequence determine the hydraulic loading (HRT) and the strength of the wastewater. 
One of the most variable is also biomass concentration and it directly affects biomass 
settleability. Initial food-to-microorganism (F/M) ratio has an impact on 
bioflocculation and biochemical reactions. The optimization and well-operation 
provide a decrease in the cycle time. Reaction time depends on the intrinsic kinetics 
of substrate consumption by the biomass and on the mass-transfer rates that must be 
enhanced by mixing (Bosma et al., 1997). Factors affecting performance of ASBRs 
have been reported as geometric reactor characteristics (Sung and Dague, 1995), 
mixing (Brito et al., 1997), F/M ratio (Sung and Dague, 1995; Timur and Ozturk, 
1999), and wastewater loading strategy (Ratusznei et al., 2003). Mixing is one of the 
most important factors affecting ASBR performance and is applied during the 
reaction step in order to improve the mass transfer rates, increasing the overall 
organic matter uptake rates. It can be supplied by recirculating the biogas produced 
during the anaerobic digestion (Sung and Dague, 1995) and liquid recycle or 
mechanical agitation (Brito et al., 1997). Wastewater loading strategy has also been 
reported as an important factor in ASBRs. Longer fill cycles has more advantages 
because of rapidly acidified substrates (Bagley and Brodkorb, 1999). However, the 
approach should be improved for the treatment of complex wastewaters in the 
reactors. The variable substrate concentration in the reactor during the sequencing 
operation results in a variable food-to-microorganism (F/M) ratio in the reactor: high 
substrate concentrations during and immediately after feeding (high F/M ratio) and 
low substrate concentrations at the end of the react step (low F/M ratio). The feast and 
famine conditions can be considered as an advantage for obtaining high removal 
efficiency. High F/M ratio verifies high substrate utilization rate providing high 
driving forces for metabolic activity, in accordance with Monod kinetics (Dague et 
al., 1998). The low F/M ratio occurring at the end of the react step through the end of 
the decant step is known to stimulate bioflocculation, granulation, efficient biomass 
settling (Sung and Dague, 1995) and a long SRT. 
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Figure 2.12: Operating steps for the anaerobic-sequencing batch reactor (Dague et 
al., 1992). 
2.6.4 Fixed bed processes 
Fixed bed processes include a flooded bed of inert filter medium, which is used for 
the increase of biomass concentrations required for efficient anaerobic treatment of 
wastewaters. While wastewater is passing through the medium, soluble organic 
compounds diffuse in surfaces of the attached biomass where the organics are 
mineralized to methane and carbondioxide. Fixed bed processes can be used for 
almost all types of industrial wastewaters with low (COD<1000 mg/L) to 
intermediate (COD>20000 mg/L) concentrations. 
2.6.5 Anaerobic expanded/fluidized bed processes 
An expanded granular sludge bed (EGSB) reactor is derived from UASB concept 
(Kato, 1994). It was designed according to a faster rate of upward-flow velocity for 
the wastewater passing through the sludge bed. The use of effluent recirculation in a 
UASB (or a high height/diameter ratio) results in the EGSB reactor (Seghezzo et al., 
1998). The higher upflow liquid velocity keeps in the granular sludge bed under an 
expanded condition (Zoutberg and Frankin, 1996). The increased flux permits partial 
expansion (fluidization) of the granular sludge bed to enhance wastewater-
microorganism contact as well as improving segregation of small inactive suspended 
particle from the sludge bed. The increased flow velocity is either accomplished by 
utilizing tall reactors, or by incorporating an effluent recycle (or both). The EGSB 
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design is appropriate for low strength soluble wastewaters (less than 1 to 2 g soluble 
COD/L) or for wastewaters that contain inert or poorly biodegradable suspended 
particles, which should not be allowed to accumulate in the sludge bed. 
2.6.6 Anaerobic membrane bioreactor 
The anaerobic membrane bioreactor (AnMBR) includes a membrane unit integrated 
to the reactor or in an external loop to aid in solid–liquid separation. An AnMBR is 
capable of keeping biomass and thus can be operated at an extremely long SRT 
regardless of HRT. The most noticeable advantage of this technology is the reductions 
in costs in recent years (Visvanathan et al. 2000), membranes have great potential in 
anaerobic biotechnology for renewable energy generation. 
This system provides an advantage to treatment of the wastewater with high 
particulate matter (such as stillage from biofuel plants, sludge, and food waste), which 
traditionally has been digested in a CSTR. Integration of a membrane may overcome 
the drawbacks of CSTR such as increasing SRT. 
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3. MATERIALS AND METHODS 
3.1 Experimental Approach 
This thesis involved acute and chronic anaerobic tests with microbiological analysis 
to evaluate the inhibitory effect of antibiotics in terms of conventional parameters and 
cellular activities. For this aim, firstly a stock anaerobic sequencing batch (ASBR) 
reactor was operated to acclimate the biomass.  
In the second step, a series of batch reactors seeded with acclimated microbial culture 
were set-up to determine the short-term effect of the antibiotics. Each batch reactor 
was also inoculated with a different concentration of the selected antibiotics in the 
range of 1 – 1000 mg/L tested in the experiments. Batch reactors were kept running 
for an observation period of six days for assessing short-term inhibitory impact. COD 
removal was monitored using both soluble COD and VFA measurements at the 
beginning and at the end of the observation period. Biogas production and methane 
generation were monitored daily throughout the experiment. 
In the third step, four different ASBRs were set-up and operated to evaluate the long-
term effects of the antibiotics. The reactors were operated at the 50-day SRT and 2.8-
day HRT. Influent and effluent COD, VFA, biogas production and composition, pH, 
temperature, SS and VSS were monitored daily. Biomass was taken in different 
antibiotic feeding phases to determine the methanogenic activity of the sludge. 
Additionally microbial characterization of the seed by cloning-sequencing was done 
and the bacterial and archaeal clone libraries were compared to the sludges which 
were collected from different antibiotic feeding regimes. All samples including seed 
sludge were quantified by Q-PCR. Also methanogenic sub-groups was determined by 
FISH. DNA and RNA based approaches were applied to monitor the microbial 
community changes during long-term inhibition experiment by DGGE. 
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Finally, mRNA level expression of selected enzymes was determined to evaluate the 
long-term effects of selected antibiotic within the cells.  
3.2 Bioreactor Operations 
In the scope of this study, a variety of reactor was operated. The characteristics of the 
reactors and related information are explained in detail below. 
3.2.1 Laboratory scale anaerobic sequencing batch reactor (stock reactor) 
An anaerobic sequencing batch reactor (ASBR) that has 8 L total volume was set-up 
and operated at 35 
0
C. The reactor was operated with a 24-hour cycle consisting of fill 
(10 min), react (23 h), settle (45 min) and decant (5 min). The rector was mixed using 
a magnetic stirrer at 90 rpm. The system was inoculated by an anaerobic sludge taken 
from a mesophilic anaerobic contact reactor treating the wastewater of raki (alcohol) 
and fresh grape alcohol. The MLVSS concentration of the reactor was 7000 mg/L. 
The reactor was fed by 4500 mg/L of COD equivalent substrate mixture. The organic 
compounds and concentration of model wastewater was given in Table 3.1. Trace 
element solution as mg/L (FeCl2.4H2O, 2; CoCl2.6H2O, 2; MnCl2, 0.32; CuCl2, 0.024; 
ZnCl2, 0.05; H3BO3, 0.05; (NH4)Mo7O24.4H2O, 0.09; Na2SeO3, 0.068; NiCl2.6H2O, 
0.05; EDTA, 1; resazurine, 0.5; HCl (36%) 0.001 mL), vitamin as mg/L (4-
aminobenzoic acid, 0.04; D(+)-biotin, 0.01; nicotinic acid, 0.1; calcium D(+)-
pantothenate 0.05; pyroxidine dihydrochloride, 0.15; thiamine, 0.1 in NaP buffer (10 
mM, pH 7.1) and 0.05 mg/L B12 solution were added to the wastewater. The pH of 
the model wastewater was adjusted 7 and the pH in the reactor varied from 6.8 to 7.2. 
The reactor was operated with an organic loading rate (OLR) 1400 mg/L*d for the 
first 10 days of operation and then increased to 4500 mg/L*d in a stepwise manner. 
The solid retention time was approximately 15 days throughout the study and was 
calculated based on VSS loss in the effluent and removed during sampling with 
excess sludge. The hydraulic retention time was 2.8 days. 
Temperature, pH and gas production were monitored daily in situ. Duplicate samples 
were collected from the reactor for chemical and microbiological analysis.  
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Table 3.1: Organic components and concentrations of model wastewater. 
Components COD (mg/L) 
Starch 2090 
Glucose 1350 
NaAcetate 240 
NaButyrate 330 
NaPropionate 490 
Total COD 4500 
3.2.2 Laboratory scale anaerobic batch reactors (acute tests) 
Acute tests were constructed as batch studies based on specific methanogenic activity 
(SMA) principles in anaerobic cabinet. Laboratory bottles (total volume 120 mL) 
sealed with butyl rubber septa were used as reactors. The liquid volume as well as the 
headspace volume was 60 mL. Biomass was taken from acclimated anaerobic sludge 
of lab scale ASBR. 2000 mg/L VSS were added to the serum bottles. Acute effects of 
antimicrobials on the biomass were tested in two different substrate sets as acetate and 
volatile fatty acid (VFA) mixture. Acetate and VFA concentrations in a range (range: 
1000-5000 mg/L) were initially tested in order to reach maximum potential methane 
production (PMP) rate during the batch tests. Among those 4000 mg/L of acetate 
concentration and 3000 mg/L of each VFA concentration (acetate, butyrate and 
propionate) were found to be optimum. Antibiotic concentrations (Sulfamethoxazole-
SMX, Tetracycline-TET, Erythromycin-ERY; range: 1, 10, 25, 50, 100, 250, 500, 750 
and 1000 mg/L) were maintained within the batch reactors for acute studies in 
duplicate bottles. In addition to these test tubes, two control bottles, which only 
included acetate or VFA mixture, were prepared. During 6 days (test duration), the 
bottles were stored at 35±2 0C and shaken daily by hand. Headspace pressure was 
measured every day by hand-held pressure transducer (Lutron PM-9107, U.S.A.). The 
percentage inhibition of biogas production was calculated from the amount produced 
in the respective test and control bottles.  
3.2.3 Laboratory scale anaerobic sequencing batch reactors (chronic tests) 
An anaerobic sequencing batch reactor (ASBR) that has 1 L total volume was set-up 
and operated at 35 
0
C. The reactor was operated with a 24-hour cycle consisting of fill 
(10 min), react (23 h), settle (45 min) and decant (5 min). The rector was mixed using 
a magnetic stirrer at 90 rpm. The system was inoculated by an anaerobic sludge taken 
from the stock reactor treating model wastewater given the components in Table 3.2. 
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The MLVSS concentration of the reactor was 5000 mg/L. The reactor was fed by 
2250 mg/L COD equivalent substrate mixture. The organic compounds and 
concentration of model wastewater was given in Table 3.2. Trace element solution 
which is adapted from a previous study (Amin et al., 2006) as mg/L (FeCl2.4H2O, 2; 
CoCl2.6H2O, 2; MnCl2, 0.32; CuCl2, 0.024; ZnCl2, 0.05; H3BO3, 0.05; 
(NH4)Mo7O24.4H2O, 0.09; Na2SeO3, 0.068; NiCl2.6H2O, 0.05; EDTA, 1; resazurine, 
0.5; HCl (36%) 0.001 mL), vitamin as mg/L (4-aminobenzoic acid, 0.04; D(+)-biotin, 
0.01; nicotinic acid, 0.1; calcium D(+)-pantothenate 0.05; pyroxidine dihydrochloride, 
0.15; thiamine, 0.1 in NaP buffer (10 mM, pH 7.1) and 0.05 mg/L B12 solution were 
added to the wastewater. The pH of the model wastewater was adjusted 7 and the pH 
in the reactor varied from 6.8 to 7.2. 
The reactor was operated with an organic loading rate (OLR) 1.4 g/L*d for the first 
10 days of operation and then increased to 2.25 g/L*d in a stepwise manner.  After 
78
th
 day, 1 mg/L of antibiotic addition was started. While SMX concnetration was 
increased up to 45 mg/L in a stepwisemanner, ERY and TET was fed up to 3 mg/L 
during the operation. The solid retention time was approximately 50 days throughout 
the study and was calculated based on VSS loss in the effluent and removed during 
sampling with excess sludge. The hydraulic retention time of the reactors was 2.8 
days. 
Temperature, pH and gas production were monitored daily in situ. Duplicate samples 
were collected from the reactor for chemical and microbiological analysis.  
Table 3.2: Organic components and concentrations of model wastewater. 
Components COD (mg/L) 
Starch 1045 
Glucose 675 
NaAcetate 120 
NaButyrate 165 
NaPropionate 245 
Total COD 2250 
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3.3 Seed Sludge 
Seed was obtained from a full-scale UASB reactor (with a volume of 490 m
3
) being 
the first stage of a two-stage anaerobic-aerobic biological treatment plant at a local 
alcohol distillery. The temperature and pH in the UASB reactor were maintained 
within the ranges of 32-35°C and 7.2-7.7, respectively. Total solid (TS) and total 
volatile solid (TVS) concentrations of the granular sludge was 58000 mg/L and 44000 
mg/L, respectively.  
3.4 Analytical Methods 
Biogas production by the ASBRs was monitored using Milligas Counter (Ritter 
Digital Counter, U.S.A.). The methane content of the in the biogas and VFA 
concentrations were measured using gas chromatograph (Perichrom, France and 
Agilent Technologies 6890N, USA, respectively). Suspended solids (SS), volatile 
suspended solids (VSS), total suspended solids (TS), total volatile suspended solids 
(TVS) and soluble COD were determined according to Standard Methods  
(APHA, 2005). 
3.5 Specific Activity Test 
Methanogenic activity tests were performed using the pressure transducer technique 
(Colleran et al., 1992). The pressure increase in sealed vials fed with non-gaseous 
substrates such as acetate, proponate, butyrate was monitored. The hand-held pressure 
transducer (Lutron PM-9107, U.S.A.) was capable of measuring a pressure in a range 
of 5 to 7000 mbar, corresponding to 0.01 mol biogas in 60 mL headspace. The liquid 
volume as well as the headspace volume was 60 mL. 2000 mg/L VSS were added to 
the serum bottles. Acetate and VFA mixture (acetate, butyrate, propionate) 
concentrations in a range of 1000-5000 mg/L were initially tested in order to reach 
maximum potential methane production (PMP) rate during the batch tests. Among 
those 4000 mg/L of acetate concentration and 3000 mg/L of VFA concentration were 
found to be optimum. The basal medium in the batch experiments was prepared based 
on OECD311 protocol under strict anaerobic conditions (2006). During the 6-day test 
duration, the bottles were stored at 35±2 °C and shaken daily by hand. Headspace 
pressure was measured every day by hand-held pressure transducer.  
  51 
3.6 Antibiotic Measurement 
3.6.1 Sludge 
3.6.1.1 Method optimization 
The extraction procedure of the sludge samples consists of two steps:  
1- extraction of the antibiotics by sonication 
2- clean-up of the extracts by SPE. 
For the method development, three different methods were examined to obtain the 
highest recovery as given in Table 3.3. 
Table 3.3: Extraction protocoles and recoveries. 
    Recoveries % 
Method 
No 
Extraction SPE Reference SMX ERY TET 
1 
5% (w/v) 
sodium acetate, 
100 mM EDTA 
in a 50:50 
solution with 
methanol, 
adjusted to pH 
8 with sodium 
hydroxide 
OASIS 
HLB, 
6mL, 200 
mg 
cartridge 
was used. 
O‘Connor 
et al., 
2007 
107.8±25.7 133.7±40.0 188.1±63.8 
2 
5% (w/v) 
sodium acetate, 
100 mM EDTA 
in a 50:50 
solution with 
methanol, 
adjusted to pH 
8 with sodium 
hydroxide 
Prior to 
SPE, all 
extracts 
were 
acidified 
by HCl. 
OASIS 
HLB, 
6mL, 200 
mg 
cartridge 
was used. 
O‘Connor 
et al., 
2007 and 
this study 
63.8±29.2 N.D. 117.2±29.0 
3 
0.2 M citric 
acid buffer 
pH4:acetonitrile 
Prior to 
SPE, 0.2 g 
of 
Na2EDTA 
was added 
into each 
sample. 
OASIS 
HLB, 
6mL, 200 
mg 
cartridge 
was used. 
Yang et 
al., 2010 
89.5±11.3 89.0±20.4 202.8±45.9 
 
According to the recovery results, Method 1 was selected for SMX and ERY samples 
and Method 2 was selected for TET samples. 
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3.6.1.2 Extraction 
20 mg of freeze-dried sludge samples were weighted in 15 mL centrifuge tubes and 
10 mL of the extraction buffer was added to each tube. The tubes were sonicated for 
15 min and then they were centrifuged at 1370Xg at 25ºC during 10 min.  The 
supernatants were transffered to 60 mL glass tubes. The extraction protocol was 
performed 3 times in each sample and obtained supernatants were evaporated at 25ºC 
under nitrogen stream to remove the organic solvent before clean-up step. 
3.6.1.3 Clean-up 
Before clean-up step, evaporated samples were diluted by MilliQ water to 500 mL 
and filtered. For the clean-up, OASIS HLB cartridges (6mL, 200 mg, Waters, USA) 
were used. The cartridges were conditioned by 5 mL methanol followed by 5 mL 
HPLC grade water. The samples were loaded to cartridges at a rate of approximately 
1 mL/min. The cartridges were washed by 10 mL HPLC grade water and then dried 
by vacuum during 30 min. The samples were eluted by 6 mL of methanol. The 
extracts were exaporated less than 50 µL under nitrogen streams and then 
reconstituted to 1 mL with 50:50 methanol:water mixture. Before analysis, 10 ppb of 
a internal standard mixture (sulfamethoxazole D6, roxithromycin and 
chlorotetracycline) was added. The concentratin of antibiotics in the samples was 
quantified by internal standard calibration curve, in order to correct for possible 
matrix effects.  
3.6.2 Wastewater 
Wastewater samples were filtered and diluted by 50:50 methanol:water mixture  
according to their concentration in the reactors. Antibiotics were quantified by 
external standard calibration.  
3.6.3 Instrumental analysis 
Chromatographic separation was achieved using a Waters Acquity Ultra-
Performance
TM
 liquid chromatograph system, equipped with two binary pumps 
system (Milford, MA, USA) using an Acquity BEH T3 colum (50mm x 2.1mm i.d., 
1.7 μm particle size). Compounds were analyzed under positiove ionization mode.  
The optimized separation conditions were as follows: solvent (A) acetonitrile, solvent 
(B) water with 0.1% formic acid at a flow rate of 0.5mL/min. The gradient elution 
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was:  initial conditions 5% A; 0–3 min, 70%A; 3.0–3.5 min, 100% A; 3.5–5.0 min, 
100% A; from 5.0 to 5.1 return to initial conditions; 5.1 to 6, equilibration of the 
column.  
The sample volume injected was 5μL. The UPLC instrument was coupled to a 5500 
QTRAP hybrid triple quadrupole-linear ion trap mass spectrometer (Applied 
Biosystems, Foster City, CA, USA) with a turbo Ion Spray source. Target antibiotics 
were quantified from the samples by MRM mode. MRM transitions for antibiotics 
and internal standards used in the quantification of sludge samples are indicated in 
Table 3.4. 
Settings for source-dependent parameters were as follows: curtain gas (CUR), 30V; 
nitrogen collision gas (CAD) medium; source temperature (TEM) was 650ºC; ion 
spray voltage was 5500 V; ion source gases GS1 and GS2 were set 60 and 50V, 
respectively.  
Table 3.4: Target Compounds and Their Optimized QqLIT-MS/MS Parameters by 
SRM Negative and Positive Ionization Mode. 
Compound SRM 1 
DP-CE-
CXP 
SRM2 
DP-CE-
CXP 
Sulfamethoxazole 253.992>156.100 81-23-12 253.992>92 81-37-12 
Sulfamethoxazole D6 
(IS) 
257.943>160.000 
101-23-
18 
  
Erithromycin 734.299>158.100 
116-39-
14 
734.299>576.400 
116-27-
22 
Roxithromycin (IS) 837.377>679.4 91-31-26   
Tetracycline 445.000>410.000 
101-27-
14 
445.000>154.000 76-37-18 
Chlorotetracycline (IS) 479.043>444.100 51-31-18   
     
3.7 Microbial Characterization and Enzyme Expression Level 
Triplicate samples were collected from seed and reactor sludges and then GDNA and 
total RNA isolation were applied for further molecular analysis.  
3.7.1. Genomic DNA (GDNA) extraction 
Genomic DNAs were extracted from 1-mL sludge samples using FastDNA Spin Kit 
for Soil (Qbiogene Inc., U.K.) following
 
the manufacturer's instructions. Extracted 
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GDNA concentrations were determined Qubit 2.0 Flouremeter (Invitrogen, UK) and 
diluted to 25 ng/µl by DNase free water. The extracted GDNAs were stored at -20 ºC 
until the further analysis. 
3.7.2 Total RNA isolation and cDNA synthesis 
Total RNAs were isolated from 1-mL sludge sampled using Charge Switch RNA 
extraction kit (Invitrogen, UK) according to recommended procedure. Concentration 
of isolated RNAs was measured using Quant-It RiboGreen RNA Assay Kit with 
Qubit 2.0 Flouremeter (Invitrogen, UK). cDNAs were synthesized from isolated 
RNAs immediately. The rest of isolated RNAs was stored at -80ºC. 
cDNAs were synthesized using Superscript Vilo cDNA synthesis kit (Invitrogen, UK) 
by reverse Transcription Polymerase Chain Reaction (RT-PCR) using hexamer 
primers. cDNA synthesis was run for 10 minutes at 25 °C, one hour at 42 °C and 5 
minutes at 85 °C. The cDNA samples were stored at –20 °C until further analysis. 
3.7.3 PCR amplification of 16S rDNA  
Amplication of bacterial and archaeal 16S rDNA was performed by PCR using 
specific primers. The primers and annealing temperatures are given in Table 3.5.  
Amplification was occurred in a 50-µl reaction volume including 50 ng of DNA, 10 
pmol of each primer, 10 mM of each deoxynucleoside triphosphate, 1.5 mM MgCl2, 5 
μl of 10×Taq buffer and 4 U of Taq DNA polymerase (iTaq, U.K.). Nested PCR 
approach was applied to enhance specifity in archaeal 16S rDNA amplification. For 
the second-round nested amplification 1 μl of the first-round product was used as 
template, with reaction composition being the same as previously. PCR amplification 
was performed in a Techne TC-5000 thermal cycler (Barloworld Scientific Ltd., 
U.K.) with an initial denaturation at 94°C for 5 min followed by 30 cycles of 
denaturation at 94°C for 1 min, annealing for 1 min and extension at 72°C for 2 min 
and a final extension at 72°C for 10 min. PCR products were visualized by 
electrophoresis (Thermo-Scientific Ltd., U.K.) on a 1% (w/v) agarose gel in 1× Tris–
borate–EDTA buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8.3) at 7 V 
cm
1
 and gel images were recorded using a Chemi-Smart 3000 gel documentation 
system (Vilber Lourmat, France) after staining with ethidium bromide. 
 
  55 
Table 3.5: Primers using in PCR amplification and their annealing temperatures. 
Primer Target 
Experimental 
Stage 
Annealing 
(°C) 
Position1 Reference 
Bact341f_GC2 
Bacterial 
16S rDNA 
DGGE 
55 
341-357 Muyzer et al., 
1993 Bact534r 534-518 
Bact8f 
Cloning 
8-27 
Lane, 1991 
Bact1541r 1541-1522 
Bact342f Sequencing 342-361 
Edwards et 
al., 1988 
Arch46f 
Archaeal 
16S rDNA 
First round of 
nested PCR 
40 
46-61 
Øvreas et al., 
1997 
Arch1017r 1017-999 
Barns et al., 
1994 
Arch344f 
Cloning 
53 
344-358 
Raskin et al., 
1994 
Arch855r 855-836 
Shinzato et 
al., 1999 
Arch344f_GC2 
DGGE 
344-358 
Raskin et al., 
1994 
Univ522r 522-504 
Amann et al., 
1995 
M13f B-
galactosidase 
Clone screening 54 – 
Schrenk et al., 
2003 M13r 
1
Escherichia coli numbering. 
25΄-GC clamp on Arch344f and Bact341f 
(GCCCGCCGCGCGCGGCGGGCGGGGCGGGGGCACGGGGGGACGGGG). 
3.7.4 Cloning, sequencing and phylogenetic analysis 
The bacterial and archaeal PCR products of the seed sludge of acute and chronic tests 
obtained using Bact8f-Bact1541r and Arch344f-Arch855r, respectively, were cloned 
by TOPO TA cloning kit (Invitrogen Ltd.,
 
UK) according to manufacturer's 
instructions. Before cloning, the PCR products were purified by PureLink PCR 
Purification Kit (Invitrogen, UK). To select the positive ones, 200 clones were 
collected from each clone library and colony PCR were applied using the vector-
specific primers M13f and M13r. Bact341f_GC- Bact534r nad Arch344f_GC-
Univ522r primers were used to re-amplify positive bacterial and archaeal inserts, 
respectively. The re-amplified PCR products were loaded to DGGE gels to select the 
respresentative OTUs. Then, the PCR products to be sequenced were purified by 
ethanol precipitation and sequenced using the ABI prism Big Dye Terminator Cycle 
Sequencing Ready Reaction Kit on an ABI Prism 377 DNA sequencer (Applied 
Biosystems, USA) using primers Bact342f and Arc344f generating 500bp and 800bp 
of bacterial and archaeal sequence
 
data, respectively. 
Partial 16S rRNA gene sequences were analyzed and manually edited in Amplify 3X 
software package version 3.14 (http://engels.genetics.wisc.edu/amplify). Homology 
searches of the EMBL and GenBank DNA
 
databases for the 16S rRNA gene 
sequences were performed with FASTA
 
(Pearson, 1988) provided by the European 
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Bioinformatics Institute (http://www.ebi.ac.uk/fasta33/nucleotide.html) to identify 
putative close phylogenetic relatives.
 
Sequence data were aligned by ClustalW tool at 
website of European Bioinformatics Institute. Distance analyses using the Jukes and 
Cantor (1969) correction and bootstrap resampling (1000 times) were done using the 
MEGA Software package version 5.1 (http:// http://www.megasoftware.net/) and trees 
were generated from distance matrices using the neighbour-joining method (Saitou 
and Nei, 1987).  
16S rRNA gene sequences showing 99% similarity or higher were considered to 
belong to the same phylotype. Related 16S rRNA gene sequences were placed within 
tentative taxa (between Phylum and Order) by determining the taxonomic class (using 
the NCBI taxonomy database) of the closest relative in GenBank of sequences that 
formed a phylogenetic clade. Sequences that showed no or low (below 70%) 
relateness with known bacterial or archaeal phylogenetic groups were listed as 
unclassified. 
Coverages of the clone libraries were calculated as 1 – (n1/N), where n1 is the number 
of clone types that was encountered only once in the library and N is the total number 
of clones analyzed (Good 1953).  
The nucleotide sequences obtained from this study have been deposited to EBI Gene 
database under accession numbers FR836435 to FR836459 for the bacterial 16S 
rDNA and FR836460 to FR836475 for the archaeal 16S rDNA. 
3.7.5 Denaturing gradient gel electrophoresis (DGGE) 
Existing and active community profiles of the sludges were determined by DGGE 
analysis as described by Muyzer et al. (1993). The bacterial and archaeal PCR 
products obtained from GDNAs and cDNAs by Bact341f_GC-Bact534r and 
Arch344f_GC-Arch855, respectively. 
PCR product (10 μl) was mixed in equal volumes with loading buffer (0.25% 
bromophenol blue, 0.25% xylene cyanol FF, 15% Ficoll in water) and run on a 10% 
polyacrylamide gel (acrylamide–N,N'-methylenebisacrylamide ratio, 37.5:1) in 1× 
TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA; pH 8.0) over a chemical 
denaturing gradient of urea and formamide equivalent to 30–60% denaturant (100% 
denaturant is 7 M urea and 40% (v/v) formamide). To aid the conversion and 
normalization of gels, a marker consisting of 16S rDNA mix from archaeal and 
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bacterial clone libraries was added on the outside of the gel as well as after every four 
samples. Electrophoresis was performed using the D-Code system (Bio-Rad 
Laboratories, Ltd., UK) at 200 V constant current at 60°C, for 4.5 h. Gel images were 
recorded using a Chemi-Smart 3000 gel documentation system (Vilber Lourmat, 
France) after stained with SybrGold (1:10000 diluted; Molecular Probes Inc., UK) 
according to the supplier's instructions.  
Images were converted, normalized and analyzed by using the
 
Bionumerics 5.0 
software (Applied Maths, Belgium), and data were exported
 
to excel and used for 
numerical analysis with Minitab (Minitab Inc.) and Past 
(http://folk.uio.no/ohammer/past/) softwares. Similarities between tracks were 
calculated by Pearson product-moment correlation coefficients (r) and UPGMA 
clustering.  
3.7.6 Quantitative real time polymerase chain reaction (Q-PCR)  
3 primer sets targeting the bacteria, archaea and methanogens were used to quantify 
existing and active microbial community by using the template extracted GDNAs and 
synthesized cDNA, respectively. Furthermore 3 primer sets targeting metabolic genes 
encoding formylterahydrofolate synthetase (FTHFS), methyl-coenzyme M reductase 
(mcrA) and acetyl-coA synthetase (ACAS) were also used to determine the inhibition 
level on mRNA expression of the homoacetogenesis, methanogenesis and specifically 
acetoclastic methanogenesis, respectively. All primers using Q-PCR analysis were 
given in Table 3.6. 
The procedure recommended by Roche was followed and a Light Cycler Master Kit 
(Roche, Applied Science, Switzerland) was used to set up the reaction (2.0 μl master 
mix, 1.6 μl MgCl2 1.0 μl Primer F and R, 13.4 μl H2O, 1 μl sample). Absolute 
quantification analysis of the GDNA was carried out with a LightCycler 480 
Instrument (Roche Applied Science, Switzerland). The amplification protocol was as 
follows: initial denaturation for 10 min at 94 ºC followed by 45 cycles of 10 s at 94 
ºC, 5 s at specific annealing temperature as given in Table 5.5, 16 s at 72 ºC. The 
standard curves for Q-PCR.  
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Table 3.6: Q-PCR primers 
Primer Sets Target Annealing (°C) Reference 
Bac519f- Bac907r 16S rDNA 53 Lane, 1991 
Arc 349f- 
Arc 806r 
16S rDNA 60 Takai, 2000 
Met 348f- 
Met 786r 
16S rDNA 55 
Sawayama, 
2006 
fhs_f 
fhs_r 
FTHFS 53 
Lovell and 
Leaphart, 2005 
mcrA_f 
mcrA_r 
mcrA 51 
Luton et al., 
2002 
MSaeta_Aco-A _f 
MSaeta_Aco-A _r 
ACAS 56 Ince et al., 2011 
Standard curves for Q-PCR constructed from clones of PCR products. PCR products 
that are to be sequenced were purified by ethanol precipitation and then were 
sequenced using the ABI prism Big Dye Terminator Cycle Sequencing Ready 
Reaction Kit on an ABI Prism 377 DNA sequencer (Applied Biosystems, USA) using 
primer MSaeta_Aco-A _f. After the primer specificity was confirmed by the sequence 
analysis, these amplicons were used as standards. Dilution series of the purified PCR 
product were used as calibration standards for real time PCR quantification after their 
DNA concentrations were determined by the fluorometer (Qubit, Invitrogen, 
Carlsband, CA, USA). Standard curves were constructed in each PCR run and the 
copy numbers of the genes in each sample were interpolated using these standard 
curves. 
For each PCR run with SYBR Green I detection, a melting curve analysis was 
performed to confirm the specificity in each reaction tube by the absence of primer 
dimers and other nonspecific products. Reactions for all samples were shown to have 
only one melting peak, which indicated a specific amplification making it suitable for 
accurate quantification. 
3.7.7 Fluorescence in situ hybridization (FISH) 
Relative quantification in terms of bacteria, archaea and methanogenic sub-groups 
were done by FISH. Sludge samples were transferred into sterile containers with the 
addition of absolute ethanol (1:1, v/v) on-site. Samples were transferred to the 
laboratory in cool-boxes maintained at 4 C or less. Upon arrival, 1mL aliquots of the 
sample were fixed in freshly prepared 4% paraformaldehyde (PFA) in PBS (130 mM 
NaCl, 10 mM sodium phosphate, pH 7.2) for at least 3 hours at 4 C. After fixation, 
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cells were washed once with PBS, resuspended in PBS-absolute ethanol (1:1, v/v) and 
stored at -20 C (Harmsen et. al., 1996). 16S rRNA-targeted oligonucleotide probes 
were used for identification of microbial domain and groups were given in Table 3.7.  
10 l of 100 times dilution of the fixed sample which resulted in between about 50 and 
300 cells per field of view was spotted onto a gelatin-coated slide and air dried. Cells 
were dehydrated at room temperature in increasing concentrations of ethanol (50%, 
80% and 98%). Dehydrated cells were prehybridized in hybridization buffer (0.9 mol 
l
-1
 NaCl, 2 mg ml
-1
 Ficoll, 2 mg ml
-1
 Bovine Serum Albumin, 2 mg ml
-1
 polyvinyl 
pyrrolidone, 5 mmol l
-1
 EDTA, pH 8.0, 25 mmol l
-1
 NaH2PO4, pH 7.0, 0.1% SDS, 5-
35% deionised formamide) at the intended hybridisation temperature for 20 min 
(Amann et al., 1990; Manz et al., 1992). After prehybridisation, probe at a final 
concentration of 5 ng l
-1
 was added into the hybridization buffer and incubated at the 
optimal hybridisation temperature for 3 hours. Following hybridization, 2 l of 4‘,6-
diamidino-2-phenylindole (DAPI) DNA stain (final concentration of 3.3 g/ml) was 
added into the hybridization buffer and incubated at room temperature for 10 minutes. 
The cells were washed twice in wash buffer containing 20 mmol l
-1
 Tris-HCl (pH 
7.2), 0.01% SDS, 5 mmol l
-1
 EDTA and between 0.9 mol l
-1
 and 56 mmol l
-1
 NaCl 
according to the formula of Lathe (1985) for 15 min at the optimal washing 
temperature before a final wash with deionized water. Slides were air dried and one 
drop of Citifluor  antifadent (Citifluor Ltd., U.K.) was added to the sample. Slides 
were examined under Olympus BX 50 Epifluorescence Microscope equipped with a 
100 W high-pressure mercury lamp and U-MWIB/U-MWG filter cubes. Images were 
captured using a Spot RT charged coupled device (CCD) camera using the software 
supplied by the camera manufacturer (Diagnostic Instruments Ltd., UK). The images 
were processed and analyzed using Image-Pro Plus version 5.1 image analysis 
software (Media Cybernetics, U.S.A.). For all times, triplicate samples were collected 
from the reactor. Counts for 10 random fields of view were obtained for each sample, 
and the average cell count was calculated. 
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Table 3.7: Oligonucleotide probes. 
Probe Target Group Probe sequence (5’-3’) 
Labelling 
(5’) 
Reference 
EUBMIX Bacteria GCTGCCTCCCGTAGGAGT Fluorescein 
Amann et 
al.,1990 
ARC915 Archaea GTGCTCCCCCGCCAATTCCT CY3 
Stahl et al., 
1988 
MC1109 Methanocaccaceae GCAACATAGGGCACGGGTCT CY3 
Raskin et al., 
1994 
MB310 Methanobacteriaceae CTTGTCTCAGGTTCCATCTCCG CY3 
Raskin et al., 
1994 
MG1200 Methanomicrobiaceae CGGATAATTCGGGGCATGCTG CY3 
Raskin et al., 
1994 
MS821 Methanosarcina CGCCATGCCTGACACCTAGGCCAGC CY3 
Raskin et al., 
1994 
MX825 Methanosaeta spp. TCGCACCGTGGCCGACACCTAGC CY3 
Raskin et al., 
1994 
NON338 Non sense probe ACTCCTACGGCAGGCAGC TAMRA 
Manz et al., 
1992 
3.8 Statistical Analysis 
To determine the significant inhibition of the acute and chronic tests, gas production 
rate of the batch tests and COD removal efficiencies of the ASBRs were compared 
using ONE WAY ANOVA test, which was followed by running a Post-hoc Dunnett's 
test and student's T-test, respectively. Graphpad Prism 4 software was used for all 
statistical analysis. 
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4. RESULTS AND DISCUSSION 
In the first section of the results and discussion part (Section 4.1), stock anaerobic 
sequencing batch reactor operation data were represented in terms of conventional 
operation parameters. The seed sludge obtained from an alcohol distillery industry 
was acclimated to a defined synthetic wastewater, which was also used in the other 
steps of the study. 
In the section 4.2, the data about the characterization of seed sludges were 
represented. Two different seed sludges were used in this study. One of them was 
taken from an alcohol distillery industry and used for the inoculation of stock ASBR, 
which was explained in the previous section. The second seed was obtained from the 
stock ASBR and used for inoculation of the following experiments; acute and chronic 
tests. The second seed sludge was investigated in terms of microbiological approaches 
and specific activity tests. The first one was only investigated by molecular tools to 
determine the microbial shifts during the operation of stock ASBR. 
In the section 4.3, the acute effects of the selected antibiotics were discussed. The 
short-term effects of the compounds on only acetoclastic methanogens and 
homoacetogens with methanogens were investigated in terms of biogas production, 
biogas composition, COD and VFAs removal efficiencies. 
In the last section (4.4), the chronic effects and/or biodegradability characteristics of 
the antibiotics were particularly discussed. To investigate the long-term effects, 
conventional engineering approaches were used together analytical measurement of 
antibiotics and DNA and RNA based molecular tools. 
4.1 Stock Anaerobic Sequencing Batch Reactor 
4.1.1 Performance of the reactor 
The ASBR that served as the stock reactor for biomass seeding was operated at an 
organic loading rate (OLR) 4.5 g COD/L by a defined synthetic wastewater including 
starch, glucose, butyrate, propionate and acetate. The aim of using these substrates 
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was set to work in each stage of anaerobic treatment to investigate specific inhibition 
step. Starch, glucose, butyrate, propionate and acetate were used to run hydrolysis, 
fermentation, acetogenesis and methanogenesis steps (Speece, 1996, Batstone et al., 
2002).  
The reactor was operated with 2.8-day HRT and short settling time (5 min) resulted in 
good biomass settling conditions and low effluent suspended solids. Prior the steady-
state condition, the influent COD was increased in a stepwise manner from 1400 
mg/L COD to 4400 mg/L COD. At steady-state, it exhibited a stable performance, 
with an average effluent soluble COD of 285±75 mg/L corresponding to a COD 
removal of around 93% and an average biogas production of 1.79±0.4 L/d as seen in 
Figure 4.1 and 4.2. During this period, the methane content in the biogas averaged 
75±1.4%. This corresponds to an average specific methane production of 0.32 L 
methane per g COD removed, which is consistent with previously reported values 
(Tchobanoglous et al., 2003). 
 
Figure 4.1: Stock ASBR performance in terms of influent and and effluent soluble 
COD concentration. 
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Figure 4.2: Stock ASBR performance in terms of biogas production and COD 
removal efficiency. 
4.2 Characterization of Seed Sludge 
Seed sludge which was used in acute and chronic tests were characterized in terms of 
poteantial methane production capacity and dominant microbial spacies. Spesific 
methanogenic activity (SMA) test was applied to determine the potential methane 
production capacity of the seed sludge. For the microbial characterization, bacterial 
and archaeal 16S rDNA clone libraries were constructed. DGGE analysis was applied 
to compare the detected microbial species by clone libraries to all OTUs in the sludge 
samples. Additionally, bacterial, archaeal and methanogenis groups were quantified 
by Q-PCR and FISH.  
4.2.1 Specific methanogenic activity (SMA) test 
To determine the potential acetoclastic methanogenic activity of the seed sludge, 
acetate concentrations between 1000-5000 mg/L were tested by SMA test. Also VFA 
mixtures (butyrate:propionate:acetate) which the concentrations varied between 1000 
to 5000 mg/L were applied to the seed sludge to measure the maximum methane 
production capacity. 4000 mg/L of acetate and 3000 mg/L of VFA mixture were 
found as optimum concentrations for the next analysis. 
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4.2.2 Bacterial and archaeal 16S rDNA clone libraries 
To identify the microbial community of seed sludge and to explore the 
microorganisms which associated with degradation and/or having resistance of the 
chosen antibiotics in the following steps, bacterial and archaeal 16S rDNA gene clone 
libraries were constructed from the seed sludge of acute and chronic tests and 
phylogenetic analysis performed according to sequencing results. Additionally, the 
clone libraries were compared with DGGE profiles of not only seed of acute and 
chronic test but also seed of the stock ASBR.  
All clones were screened by DGGE and this analysis showed that 22 different OTUs 
were obtained from 120 bacterial clones and 25 different OTUs were found in 140 
archaeal clones. Bacterial and archaeal coverages of the clone librariers were 
calculated as 91.6% and 97.1%, respectively. All different OTUs were sequenced and 
the closest relatives of the sequencing results of bacterial and archaeal were given in 
Table 4.1 and 4.4, respectively. 
The majority of sequences obtained from the bacterial clone library represented 
Firmicutes (61%) as seen in Figure 4.3. The second most abundant phylum was 
Bacteroidetes (21%). Members of Verrucomicrobia, unclassified bacteria, 
Chloroflexi, Actinobacter and Proteobacteria were distrubeted as 6%, 6%, 4%, 1% 
and 1%, respectively. 57% of Firmicutes members belonged to Clostridium sp., which 
are sulfide reducing bacteria and found in different places.  
The dominant Firmicutes OTU, B9 (FR836443), related cluster, represented by 
33.64% of all bacterial clones was most closely related to the Clostridium sp. Kas107-
1 which was isolated from gramineous plants‘ root as a member of anaerobic N2 
fixing consortium (Minamisawa et al., 2004). Other close relatives of Firmicutes 
phylum were mosty isolated and/or identified from different anaerobic reactors in 
which domestical wastewater sludge, manure and slaughter house wastes, brewery 
industry wastewater  and synthetical wastewaters were treated (Briones et al., 2007; 
Sousa et al., 2007; Riviere et al., 2009; Bagge et al., 2010). Other OTUs related to 
Firmicutes phylum mostly closed to isolates from soil, digesting system of mouse and 
cleaning room (Rawls et al., 2006; Rui et al., 2009; Probst et al., 2010). The second 
abundant phylum was Bacteroidetes and this phylum was represented by three OTUs. 
The dominant OTU was B7 (FR836441) and it represented 14.95% of all bacterial 
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clones. It is most closely related (97%) to an unclassified Porphyromonadaceae 
sequnce obtained from an anaerobic bioreactor treating cassava pulp and pig manure 
(Panichnumsin et al., 2009). Also second dominant OTU in Bacteroidetes phylum 
which has members using sugars or proteins for producing acetate ans succinate 
(Madigan et al., 2009), B14 (FR836448) in this study was also most closely related 
(97%) to an uncultured Paludibacter clone obtained from same study. The third and 
last OTU, B19 (FR836453) in the Bacteroidetes clustal related (92%) to a culture 
species, Paludibacter propionicigenes, which was isolated from rice paddy soil 
(Akasaka et al., 2003). 
 
Figure 4.3: Distribution of phylogentic phylums from clone sequences of bacterial 
16S rDNA clone library. 
OTUs including the members of Actinobacteria which are responsible to produce of 
propionic acid, acetic acid and CO2 (Madigan et al., 2009); Verrumicrobia which are 
globally distributed and soil bacteria (Hedlund et al., 1997; Hugenholtz et al., 1998; 
Floyd, et al.; 2005); Proteobacteria; Chloroflexi which are formerly known as the 
green nonsulphur bacteria, are associated with extreme habitats, e.g. microbial mats in 
hot springs (Boomer et al., 2002; Nubel et al., 2002) and hypersaline environments 
(Nubel et al., 2001), are known as (ﬁlamentous) anoxygenic photothophs (Hanada et 
al., 2002; Hanada & Pierson, 2002; Nubel et al., 2002); and unclassified Bacteria 
phylums constituted the small clusters. The closest cultured species of  these OTUs 
are given in Table 1. The closest relatives of tho OTUs which are the members of 
these phylums were firstly isolated and/or obtained from different ecosystems such as 
anaerobic reactors, groundwater, sediment, and also fermented milk (Wu et al., 2001; 
  67 
Schwarz et al., 2007; Ueki et al., 2007; Jagevall et al., 2008; Nayak and Kale, 2008; 
Bauer et al., 2009; Cockell, 2010).  
Also, the bacterial OTUs which match the predominant bands of two seed sludges 
(seed sludges of stock ASBR and acute and chronic tests) in the DGGE profiles were 
given in Table 4.1. 11 of  the bacterial OTUs became practically undetectable in the 
DGGE profiles. 
The phylogenetic tree constructed by bacterial clones was given in Figure 4.4. 
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Table 4.1: Affiliation of bacterial clones and their abundance within the seed sludges. 
Clone 
Clone 
Frequency 
(%) 
Accession No 
(This study) 
Closest Relative 
Similarity 
(%) 
Seed 
Sludge_Stock 
Reactor 
Seed Sludge_ 
Acute and 
Chronic Tests 
B1 2.80 FR836435 Clostridium sp. BG-C66 (FJ384378) 96   
B2 0.93 FR836436 Clostridium sp. Kas301-1 (AB114242) 96   
B3 1.87 FR836437 Clostridium intestinale (AM158323) 95 •  
B4 4.67 FR836438 Uncultured Clostridium sp. clone AUCLO214 (AY648564) 96 • • 
B5 1.87 FR836439 Uncultured Firmicutes bacterium clone QEDS2BE07 (CU921543) 93 •  
B6 2.80 FR836440 Uncultured Firmicutes bacterium clone QEDN7DC08 (CU926749) 97  • 
B7 14.95 FR836441 Uncultured bacterium clone BS7_65 (GQ458219) 98 • • 
B8 3.74 FR836442 Syntrophomonas zehnderi strain OL-4 (DQ898277) 89  • 
B9 33.64 FR836443 Clostridium sp. Kas107-1 (AB114241) 96 • • 
B10 5.61 FR836444 Uncultured bacterium clone C3-25 (AM181973) 91 • • 
B11 4.67 FR836445 Bacterium CBIC19I3 (HM240274) 95   
B12 3.74 FR836446 Uncultured bacterium UASB_TL84 (AF254390) 94 • • 
B13 0.93 FR836447 Uncultured Candidatus Cloacamonas sp. clone 8SN (EU887773) 92   
B14 5.61 FR836448 Uncultured bacterium clone BS1_25R (GQ458208) 97 •  
B15 2.80 FR836449 Uncultured bacterium clone aaa97f10 (DQ816701) 96   
B16 0.93 FR836450 Acinetobacter sp. 1B3 (EU337120) 96   
B17 2.80 FR836451 Uncultured Sarcina sp. clone JPL-2_O10 (FJ957591) 89   
B18 0.93 FR836452 Uncultured bacterium clone 30c07 (EF515566) 87   
B19 0.93 FR836453 Paludibacter propionicigenes (AB078842) 92   
B20 0.93 FR836454 Bacterium 061128-OL-KR37-AA 3-0 10000x -1A (FJ037613) 92 • • 
B21 0.93 - Propionibacteriaceae bacterium FH044 (AB298766) 99   
B22 1.87 FR836458 Uncultured bacterium clone D14R15C96 (FM956760) 98   
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Figure 4.4: Neighbor-joining full-length 16S rDNA trees showing the genetic 
distances among individual clones from bacterial 16S rDNA clone 
library. Tha bar scale represents 2 nucleotide substitutions per 100 
nucleotides. 
 
The bacterial diversity indices of the seed sludges were represented in Table 4.2. 
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Table 4.2: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of the seed 
sludges. 
 Stock Reactor Chronic Reactors 
Taxa 27 33 
Shannon-Weaver diversity 3.152 3.449 
Evenness 0.8662 0.9537 
Margalef's richness 4.128 4.954 
The most abundant of sequences obtained from the archaeal clone library represented 
in order of Methanomicrobiales (28%) which has members utilizing H2+CO2, 
alcohols and formate, Methanosarcinales (24%) which mostly acetoclastic 
methanogens belong to this genus, and Methanobacteriales (21%) which has members 
utilizing H2+CO2, formate and methanol+H2 as seen Figure 6. The members of 
unlassified euryarchaeota, unclassified archaea and Methanococcales which has 
members utilizing H2+CO2, pyruvate+CO2 and formate were distributes as 18%, 6% 
and 3%, respectively. 75.36% of OTUs were members of methanogens.  
 
Figure 4.5: Distribution of phylogentic phylums from clone sequences of archaeal 
16S rDNA clone library. 
The dominant Methanomicrobiales OTU, A17 (FR836472), related cluster, 
represented by 9.42% of all archaeal clones was most closely related to an 
unclassified Methanomicrobiales specie, Methanogenic archaeon Prasan1 (Prasanna 
et al., 2010). Other close relatives of Methanomicrobiales were mostly isolated and/or 
identified from anaerobic reactor treating waste(water) (Yang et al., 1985; Klocke et 
al., 2008; Cadillo-Quiroz et al., 2008; Ueki et al., 2009).  
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The most dominant OTU (12.32%), A7 (FR836463), in all clone library belongs to 
the second abundant phylum which was Methanosarcinales. This dominant OTU most 
closely related (97%) to a cultured specie, Methanothrix soehngenii, which utilizes 
acetate to produce CH4 (Eggen et al., 1990). Abundance of the other OTUs belonging 
to this phylum varied between 2.17 and 3.62% and their closest relatives were isolated 
from diifeent ecosystems such as activated sludges, anaerobic digester, groundwater 
and marine canyon sediments (Elberson et al., 1997; Watanabe et al., 2000; 
Fredriksson et al., 2010; Zhang et al., 2010). 
The third abundant phylum was Methanobacteriales and this phylum was represented 
by nine OTUs. The dominant OTU was A18 (FR836473) and it represented  7.25% of 
all archaeal clones. It is most closely related (96%) to Methanobacterium beijingense 
strain 4-1 cultured from the granular sludge of a mesophilic UASB reactor treating 
beer-manufacture wastewater (Ma et al., 2005). Clone frequencies of the other OTUs 
belonging Methanobacteriales phylum changed from 0.72% to 3.62 and they were 
firstly obtained from different anaerobic reactor, animal rumen and freshwater 
samples (Jarvis et al., 2003; Ma et al., 2005; Rastogi and Shouche, 2005; Briee et al., 
2007; Cheng and Zhu, 2008; Kelly et al., 2009). 
OTUs including the members of unlassified euryarchaeota, unclassified archaea and 
Methanococcales phylums constituted small clusters and they were represented by 3, 
1 and 1 OTU(s), respectively. They were obtained from natural and engineering-
designed ecosystems such as freshwater sediment, soil and wastewater treatment 
plants (Kemnitz et al., 2005; Briee et al., 2007; Green and Blank, 2007; Xing et al., 
2010).The closest cultured species of  these OTUs are given in Table 2.  
Also, the archaeal OTUs which match the predominant bands of two seed sludges 
(seed sludges of stock ASBR and acute and chronic tests) in the DGGE profiles were 
given in Table 2. 11 of the archaeal OTUs became practically undetectable in the 
DGGE profiles. 
The archaeal diversity indices of the seed sludges were represented in Table 4.3. 
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Table 4.3: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of the seed 
sludges. 
 Stock Reactor Chronic Reactors 
Taxa 15 13 
Shannon-Weaver diversity 2.599 2.526 
Evenness 0.8966 0.962 
Margalef's richness 2.123 1.901 
The phylogenetic tree constructed by the archaeal clone library was given in Figure 
4.6. 
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Figure 4.6: Neighbor-joining full-length 16S rDNA trees showing the genetic 
distances among individual clones from archaeal 16S rDNA clone 
library. Tha bar scale represents 10 nucleotide substitutions per 100 
nucleotides. 
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Table 4.4: Affiliation of archaeal clones and their abundance within the seed sludges. 
Clone 
Clone 
Frequency 
(%) 
Accession No 
(This study) 
Closest Relative 
Similarity 
(%) 
Seed 
Sludge_Stock 
Reactor 
Seed Sludge_ 
Acute and 
Chronic Tests 
A1 1.45 FR836460 Uncultured archaeon clone OK3 (GQ406364) 94   
A2 2.90 FR836461 Uncultured archaeon clone I17_Rya (HM639831) 98  • 
A3 9.42 FR836462 Methanogenic euryarchaeote Annu4 (FJ896263) 95 • • 
A4 2.90  Methanobacterium formicicum strain S1 (DQ649309) 99   
A5 2.90 FR836464 Uncultured Methanosarcinales archaeon clone:KuA4 (AB077214) 98   
A6 4.35 FR836470 Uncultured euryarchaeote clone MVP-8A-21 (DQ676281) 98   
A7 12.32 FR836463 Methanothrix soehngenii (X51423) 97   
A8 0.72  Uncultured archaeon clone A6T20L208 (DQ262482) 99   
A9 7.25  Methanospirillum hungatei (M60880) 99 • • 
A10 0.72 FR836465 Methanobacterium beijingense strain M4 (EU544027) 97 •  
A11 6.52 FR836467 Methanosphaerula palustris strain E1-9c (EU156000) 95  • 
A12 0.72  Methanobacterium sp. OM15 (AJ550160) 99   
A13 2.17  Methanobacterium beijingense strain 8-2 (AY350742) 100 • • 
A14 3.62 FR836468 Uncultured Methanosarcinales archaeon clone S4 (GU475184) 95  • 
A15 2.90 FR836469 Uncultured archaeon clone Sed-ARC-34 (EU255763) 98   
A16 3.62 FR836471 Uncultured euryarchaeote clone MVP-8A-26 (DQ676246) 96 •  
A17 9.42 FR836472 Methanogenic archaeon Prasan1 (HM630570) 97 • • 
A18 7.25 FR836473 Methanobacterium beijingense strain 4-1 (AY552778) 96   
A19 2.17  Methanosarcina siciliae (U89773) 99 • • 
A20 4.35  Uncultured archaeon clone EOTU21 (FJ896263) 99   
A21 1.45 FR836474 Uncultured archaeon clone OKA6 (GQ465437) 97   
A22 1.45  Uncultured archaeon clone ATB-KM-2942-A18 (EF680353) 99  • 
A23 6.52  Archaeon LL25A3 (AJ745135) 99 • • 
A24 2.17  Uncultured archaeon clone WA10 (AB494239) 99   
A25 0.72 FR836475 Methanogenic euryarchaeote Annu1 (HM630571) 95 •  
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4.2.3 Quantification by Q-PCR and FISH 
Quantitative changes in the 16S rDNA concentrations within two seed sludges using 
in this study were determined by quantitative real-time PCR (Q-PCR) (Figure 4.7). 
The concentrations showed that abundance of all microbial community increased 
during stock ASBR operation. While 16S rDNA gene concentration of bacterial 
community increased sharply from 3.65 X 10
8
 copies/mL to 2.23 X 10
10
 copies/mL 
(~60 fold increasing), abundance of archaeal community changed from 1.00 X 10
7
 
copies/mL to 4.88 X 10
8
 copies/mL (~50 fold increasing). Increase in the 
methanogen population was more than archaea. 16S rDNA gene concentration of 
methanogens ascended 4.05 X 10
6
 copies/mL to 2.68 X 10
8
 copies/mL (~66 fold 
increasing).  
 
 
Figure 4.7: Quantitative changes in bacterial, archaeal, and methanogenic 16S 
rDNA concentrations determined by Q-PCR. 
Also, relative amount of bacteria, archaea and important methanogenic subgroups 
was determined by FISH in the seed sludge of acute and chronic tests (Figure 4.8). 
Relative abundances of bacteria and archaea were 31.4% and 45.9%, relatively. The 
three hydrogen utilizing methanogenic groups, Methanobacteriaceae, 
Methanocaccaceae, Methanomicrobiaceae were distributed 8.6%, 6.1%, 5.4%. 
Acetoclastic methanogens were investigated based on Methanosarcina genus and 
Methanosaeta spp. specific FISH probes. Relative abundances of Methanosarcina 
genus and Methanosaeta spp. were found 18.9% and 10.3%, relatively. 
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Figure 4.8: Relative abundance of methanogenic genus in seed sludge of acute and 
chronic tests. 
4.3 Acute Tests 
These experiments were designed to evaluate the short-term inhibitory impact of the 
selected antibiotics, sulfamethoxazole (SMX), erythromycin (ERY) and tetracycline 
(TET) on the metabolic activity of both homoacetogens and methanogens, which are 
specific trophic groups in the acclimated sludge. The experiments were designed as 
two sets;  
1- acetate feeding to evaluate acetoclastic methanogens,  
2- VFA mixture feeding to evaluate homoacetogens and all methanogens.  
The experiments reflected the effect of the selected antibiotics in the range of  
1 – 1000 mg/L at only one exposure. Batch reactors with an effective volume of 60 
mL were run for six days; together with antibiotic dosage, each reactor was 
inoculated with 4000 mg/L of acetate corresponding to an initial acetate COD of 
around  
4250 mg/L and 3000 mg/L of each VFA; acetate, butyrate and propionate 
corresponding to an initial COD of around 3180, 5400, and 4500 mg/L favoring 
acetoclastic methanogenic activity and homoacetogenic activity with all 
methanogens, respectively. Gas/methane production and COD/VFAs removal were 
selected as relevant parameters monitored. Cumulative biogas generation was 
monitored daily throughout the experiment period. COD/VFA concentrations were 
measured both at the beginning and at the end of the test. 
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4.3.1 Acute effects on acetoclastic methanogenic activity 
4.3.1.1 Cumulative biogas production 
The average cumulative biogas production (CBP) associated with the utilization of 
acetate in the control reactors was 97 mL at the end of six days, which is above the 
minimum required in ISO standards (ISO13641-1, 2003). The corresponding 
cumulative methane production (CMP) was 77 mL, which accounted for around 80% 
of biogas generated in control reactors. The CBM profiles together with the 
corresponding CMP values for the three selected antibiotics are plotted in  
Figures 6.9-6.11.  
The CBP profile in the control reactor related to SMX dosage displayed the typical 
substrate utilization/microbial growth curve observed in similar studies (Lallai et al., 
2002; Ince et al., 2009). The profile reached a plateau with no further biogas 
production after 120 hours indicating the depletion of all organic substrate supplied 
and therefore, confirming that the six-day period selected for the short-term tests was 
appropriate. As shown in Figure 4.9a, SMX dosages of 1 and 10 mg/L generated a 
CBP profile quite close to the control reactor with total biogas volumes close to 90 
mL and methane volumes above 70 mL. The profiles associated with 25 and 50 
mg/L of SMX were clearly different but they still yielded methane levels above 60 
mL. Significant inhibition effect was induced when SMX dosage was increased to 
100 – 250 mg/L. It is interesting to note that the shape of the CBP profile at SMX of 
250 mg/L diverged from the rest showing the end of biogas production and substrate 
depletion much sooner – around 96 hours. Almost complete biogas and methane 
inhibition was observed for SMX dosages of 500 mg/L and higher concentrations. 
The same trend was observed in methane production as shown in Figure 4.9b, which 
displays the change in CMP levels and percent methane levels in the biogas as a 
function of increasing SMX dosages. The plot indicated the significant inhibition 
impact of SMX between 100 and 250 mg/L. 
It should be noted that batch reactors were set as duplicates for each antibiotic 
dosage and they yielded almost identical CBP and CMP results. In fact, the data 
collected from the duplicates for each SMX concentration (1-1000 mg/L) were 
evaluated with one-way analysis of variance and individual p values were calculated 
via Dunnett's multiple comparison test (Conkle et al., 2010 and Libralato et al., 
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2010). The results indicated a highly significant decrease (p < 0.01) in CBP values 
for SMX concentrations equal to or higher than 25 mg/L (Figure 4.9a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Inhibition effect of SMX dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
The experimental CBP profiles and CMP values obtained with the other antibiotics, 
ERY and TET, indicated a similar pattern as the those characterizing SMX (Figures 
6.10 and 6.11), i.e. a significant inhibitory effect starting around 100 mg/L and 
almost total biogas and methane inhibition starting at 500 mg/L. The discrepancy in 
the shape of the CBP profile could be observed at 250 mg/L for both for ERY and 
TET. At this concentration, biogas generation stopped after 72 hours, half way 
through the experimental period. The statistical analysis of the results indicated a 
highly significant decrease in CBP values for all ERY concentrations including 1 
mg/L, and a similar result except 1 mg/L for TET. The methane level of 83±0.5% 
observed in the control reactor persisted up to 100 mg/L TET fed test tubes but it 
a 
b 
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started to decrease and reached a low level of 68 % at the TET dosage of 1000 mg/L. 
However in ERY experiments, the methane percentage did not change with antibiotic 
concentration and it stayed at the level observed in the control reactor (83±0.1%) in all 
ERY fed sets.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Inhibition effect of ERY dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
The EC50 level, i.e. the inhibitor concentration that induces 50% inhibition on 
measured response of the microbial community is a commonly used parameter for 
inhibitory impact (Speir et al., 2007; Arienzo et al., 2009; Ruiz et al., 2009). The 
percent inhibition on CMP levels as a function of dosage, as plotted in Figure 4.12, 
showed that inhibition evaluated in terms of the EC50 values was also quite similar. 
The corresponding EC50 values were calculated as 198.5 mg/L for SMX, 155.4 mg/L 
for ERY and 204.4 mg/L for TET. These results do not confirm the findings of 
Gartiser and his colleques (2007b) reporting that 50% inhibition was observed at 37.3 
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mg/L of TET while no inhibition effect was detected for SMX and ERY up to 100 
mg/L.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11: Inhibition effect of TET dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
 
a 
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Figure 4.12: Inhibition of CMP levels and EC50 values associated with SMX, ERY 
and TET. 
4.3.1.2 Chemical oxygen demand (COD) and acetate removal 
Three parameters were considered in the evaluation of the COD removal pattern in 
the inhibition experiments: (a) the level of acetate COD remaining in the effluent; (b) 
the level of antibiotic COD in the effluent; (c) fraction of the antibiotic COD 
remaining or entrapped with biomass. Total COD and acetate were measured both at 
the beginning and at the end of each experimental run to set the grounds for 
differentiating the nature of remaining COD, i.e. acetate COD or antibiotic COD as 
shown in Figures 6.13-6.15. The results obtained may be summarized as follows: (i) 
Acetate that was initially inoculated as the sole organic carbon source was entirely 
removed in all the runs carried out with SMX and ERY; it was also entirely removed 
in the TET runs, except in reactors started with a TET dosage of above 250 mg/L, 
where less than 300 mg/L of acetate COD was measured to remain at the end of the 
observation period. Thus, while methane generation – i.e. the end product of 
methanogenic activity - was severely impaired, removal of acetate was not affected 
by the inhibitory action of antibiotics. (ii) Measurements always detected remaining 
COD at the end of the experiments, which mostly reflected the presence of 
antibiotics, together with residual soluble microbial products generated in the course 
of biochemical reactions (Germirli Babuna et al., 1998), because parallel direct 
analyses revealed no acetate. (iii) The remaining part of the antibiotic represented 
only a fraction of the initially inoculated dosage; 0.19, 0.29 and 0.48 for SMX, ERY 
and TET, respectively, this fraction was relatively smaller for SMX, gradually 
increasing for ERY and TET; The results suggested that they mostly remained 
entrapped/adsorbed by the microbial community, based on the assumption that they 
EC
50
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are practically non-biodegradable with short-term exposure to non-acclimated 
biomass (Alexy et al., 2003; Alexy et al., 2004; Gartiser et al., 2007b). 
 
 
Figure 4.13: Initial and final COD concentrations in SMX experiments. 
 
Figure 4.14: Initial and final COD concentrations in ERY experiments. 
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Figure 4.15: Initial and final COD concentrations in TET experiments. 
The results indicated that the short-term inhibitory impact of antibiotics was 
observed as a significant reduction in methane production, while acetate removal was 
not impaired. The seemingly conflicting results may be better interpreted in terms of 
two different approaches: (i) the basic process stoichiometry that defines the 
relationship between methane generation and acetate utilization for metabolic 
activities, (ii) conceptual understanding of the inhibition mechanism. 
The evaluation should also recognize the possibility of a metabolic shift – 
competitive growth of alternate species under inhibitory stress – likely to occur in the 
bottle reactors due to antibiotic dosage. In this scenario, high dosages of antibiotics 
would affect acetoclastic methanogens and would favor competitive utilization of 
acetate by homoacetogenic bacteria, which are capable of producing hydrogen and 
CO2 from acetate (Girffin et al., 1998). This process would produce the substrate for 
hydrogen utilizing methanogens; however, no H2 was detected at the end of test. The 
main reason could be that hydrogenotrophic methanogens may have used H2 and 
CO2 on the instant, as they were produced. In view of the results obtained however, 
this scenario does not look as a viable option because, the methane percent in the 
biogas always remained in the range of 80–86%, although significantly reduced with 
increasing antibiotic additions, leaving substrate binding by uncompetitive inhibition 
as the only biochemical mechanism.  
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4.3.2 Acute effects on methanogenic activity 
4.3.2.1 Cumulative biogas production 
The CBP and CMP in control reactor at the end of the test duration were reached to 
445 mL and 312 mL, respectively. CH4 portion in the biogas was accounted for 
around 70%. When the total VFAs fed in the reactor were utilized completely, the 
theoretical CH4 production should be 315 mL. The CBP and CMP profiles for all 
selected antibiotics are given in Figure 4.16-6.18.  
CBP profiles in test tubes with respect to SMX dosage were similar to substrate 
utilization curve of other studies in the literature (Amin et al., 2006 and Shimada et 
al., 2008). The biogas production reached to maximum in 6 days and stopped. The 
result indicated that all organic substrate was completely utilized and the duration is 
appropriate for short-term inhibition tests.  
While total biogas production of 1 and 10 mg/L of SMX added test bottles was quite 
close to control, the profiles of 25 and 50 mg/L of SMX added reactors were 
different as seen in Figure 4.16. However their methane productions were still higher 
than 150 mL. Significant inhibition effect of the SMX on the VFA utilization under 
anaerobic conditions was detected after 100 mg/L. Also 250 mg/ almost and higher 
concentration of SMX addition almost completely inhibited the metabolic activity. 
The plot indicated the significant inhibition impact of SMX at two different points, 
between 10 and 25 mg/L, and between 100 and 250 mg/L (Figure 4.16). The 
methane ratio in the biogas was detected almost same with control reactor as 
70±1.5%. 
Dunnett's multiple comparison test was used to evaluate the duplicate data with one-
way analysis of variance and individual p values (Conkle et al., 2010 and Libralato  
et al., 2010). The results indicated a highly significant decrease (p < 0.01) in total 
biogas production values for SMX concentrations equal to or higher than 10 mg/L  
(Figure 4.16a).  
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Figure 4.16: Inhibition effect of SMX dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
The experimental CBP profiles and CMP values obtained with the other antibiotics, 
ERY and TET, indicated different patterns as the characterizing SMX (Figures 6.17 
and 6.18). In the ERY sets, a significant inhibitory effect was started 1 mg/L (p < 
0.01) and complete biogas and methane inhibition were not observed, also in 1000 
mg/L ERY fed reactors. The biogas and methane inhibition reached to 82.5% in 250 
mg/L fed reactor and the inhibition effect was detected 83.5±0.9% up to 1000 mg/L. 
Two discrepancies in the shape of the CBP profile could be observed at 250 mg/L 
and after 250 mg/L for ERY. The methane level in ERY fed reactor was almost 
stable as %62±1 while in the control reactor was 70%. 
a 
b 
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Figure 4.17: Inhibition effect of ERY dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
The biogas production profile of TET fed reactor were different from SMX and ERY 
because the inhibition effect of the antibiotic started from 1 mg/L and increased 
stepwise in the parallel of rising concentration as seen Figure 4.18. Also, 1000 mg/L 
concentration of TET was stopped the gas production distinctively. The significant 
decrease in the CBP was begun from 1 mg/L antibiotic addition like ERY fed 
reactors. While the methane percentage in the biogas was the same between 1-250 
mg/L as 58%±1.7 and it started to decrease after 250 mg/L TET concentration until 
43% at the TET dosage of 1000 mg/L. 
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Figure 4.18: Inhibition effect of TET dosage on (a) cumulative biogas production 
profiles (b) total biogas and methane production. 
Also EC50 values which show the 50% inhibition in the system was determined 
(Speir et al., 2007). The inhibition profiles as percent were represented in Figure 4 
and EC50 values of the compound are highlighted. EC50 values of the selected 
antibiotics were calculated as 55.4 mg/L for SMX, 85.8 mg/L for ERY and 46.2 
mg/L for TET. Gartiser et al. (2007b) found the EC50 value of TET as 37.3 mg/L 
and this value is close to the result obtained from this study. However, they could not 
detect EC50 value for SMX and ERY, while Xu et al. (2011) showed that the EC50 
value of SMX in natural river sediments 40.9 mg/L. 
 
a 
b 
b 
 88 
 
Figure 4.19: Inhibition of CMP levels and EC50 values associated with SMX, ERY 
and TET. 
4.3.2.2 Chemical oxygen demand (COD) and volatile fatty acid (VFA) removal  
Soluble COD and VFAs were measured both at the beginning and at the end of the 
experimental run sets as shown in Figure 4.20-6.25 for each compound. The results 
indicated that all VFAs were completely utilized in SMX and ERY runs until 250 
mg/L of antibiotic dosage. 250 mg/L of SMX/ERY and above, it is clear that VFA 
removal mechanism was directly affected. Most of the propionic acid accumulation 
was detected. In 500 mg/L and higher concentrations, butyric acid, also iso-butyric 
acid, started to accumulate. The removal of acetic acid was not effected even in the 
presence of very high concentrations of the two compounds as seen Figure 4.21 and 
6.23. Acetic acid results in this study are also similar to only acetic acid fed as sole 
carbon source runs (Cetecioglu et al., submitted). In these runs, valeric acid, caproic 
acid and heptanoic acid, which are higher than four carbons, were determined despite 
they were not fed to the reactors. This result indicated that effluent COD included 
not only antibiotics and VFAs, which were used as carbon sources but also microbial 
metabolites (Aquino and Stuckey, 2004). 
COD results showed that after 25 mg/L of SMX concentration and 10 mg/L of ERY 
concentration COD removal efficiency started to decrease. However, VFAs 
determined 250 mg/L and higher SMX and ERY dosages. The measured COD in the 
effluent may be antibiotics and/or residual soluble microbial products generated in 
the course of biochemical reactions (Germirli Babuna et al., 1998 and Aquino and 
Stuckey, 2004). 
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Figure 4.20: Initial and final COD concentrations in SMX experiments. 
 
 
Figure 4.21: VFA concentration in effluents of SMX experiments. 
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Figure 4.22: ERY initial and final COD concentrations in ERY experiments. 
 
Figure 4.23: VFA concentration in effluents of ERY experiments. 
COD and VFA concentrations of TET effluents were different from SMX and ERY. 
VFA accumulation started from 25 mg/L TET dosage and not only butyrate and 
propionate utilization pathways but also acetic acid utilization was affected as seen 
Figure 4.25. The results obtained from this study showed different profile about 
acetate utilization than only acetate fed batch tests (Cetecioglu et al, submitted). 
Cetecioglu and her colleagues (submitted) detected acetate accumulation in the 
system 250 mg/L and higher TET concentration. The reason of the detected acetate 
in the lower concentration can be the utilization of other VFAs by homoacetogens 
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(Speece, 1996 and Batstone, 2002). COD results obtained from TET fed test bottles 
were also parallel to VFA results (Figure 4.24). COD value in the effluents started to 
increase 25 mg/L and higher TET concentrations. 500 mg/L and higher 
concentrations COD results were measured higher than detected VFA 
concentrations. This difference could be as a result of the TET concentrations in the 
effluent. The lower concentration of TET probably was absorbed to the sludge (De 
Liguoro et al., 2003 and Zhao et al., 2010). 
 
Figure 4.24: Initial and final COD concentrations in TET experiments. 
 
Figure 4.25: VFA concentration in effluents of TET experiments. 
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The quantification of methanogen subgroups in the seed sludge showed that the 
acetoclastic methanogens, Methanosarcina and Methanosaeta spp., were dominant. 
However, hydrogenotrophic methanogens were detected in the system while no 
hydrogen was measured in the biogas analysis. It indicated that hydrogen can be 
converted to CH4 instantly by this group. 
4.4 Chronic Tests 
Four lab scale anaerobic sequencing batch reactors were inoculated with the seed 
sludge taken from lab scale stock ASBR. One of these reactors was operated as 
control reactor, which was only fed by synthetic wastewater. Other reactors were fed 
by synthetic wastewater with particular antibiotic; sulfamethoxazole, erythromycin, 
tetracycline. Performance of the antibiotic fed reactors with a comparison of the 
control reactor in terms of COD removal efficiency, biogas production, volatile fatty 
acids (VFAs) accumulation, antibiotic degradation were discussed in this section. 
Also long-term effects of antibiotics on the microbial community and specific 
metabolic pathways were presented.  
4.4.1 Sulfamethoxazole 
4.4.1.1 Performance of the Sulfamethoxazole (SMX) reactor 
The performance of control and SMX reactors which were operated with 2.8-day 
HRT and 50-day SRT during 168 days was given in Figure 4.26 and 6.27. After 
inoculation, ASBRs were started with an initial organic loading rate (OLR) of 1.4 g 
COD/L*d. OLR was increased to 2.2 g COD/L*d in a stepwise manner during first 
22 days and then stable reactor performance was observed for both of the reactors, 
with an average effluent soluble COD 75.9±27.2 and 81.2±33.8 mg/L corresponding 
to a removal efficiency of 96.5% and 96.1% and average biogas production of 
1045±23 mL/d and 977±15 mL/d for control and SMX reactor, respectively. 
Chelliapan et al. (2006) showed that the OLRs up to 2.5 gCOD/L*d are proper for 
the treatment of pharmaceuticals wastewater containing antibiotics. High loading rate 
with low HRT is directly affects removal efficiency. The average methane content of 
biogases obtained from control and SMX reactors was 65.7%±3.3. This corresponds 
to an average specific methane production of 0.32 and 0.3 L methane per g COD 
removed at control and SMX reactors, respectively. These values are consistent with 
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reported in the literature (Tchobanoglous et al., 2003). VSS concentration and pH 
were stable during all operation. 
 
Figure 4.26: Performance of Control and SMX reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L SMX, Phase b: 
1 mg/L SMX, Phase c: 10 mg/L SMX, Phase d: 25 mg/L SMX, Phase 
e: 30 mg/L SMX, Phase f: 35 mg/L SMX, Phase g: 40 mg/L SMX, 
Phase h: 45 mg/L SMX). 
Starting on day 78, 1 mg/L of SMX (Phase b) was added to the influent of one of the 
ASBR to evaluate the long-term influence and biodegradability characteristics during 
the acclimation period SMX on reactor performance, microbial ecology and 
anaerobic pathways. After 78
th
 day, the SMX concentration in the influent was 
increased up to 45 mg/L (Phase h) in a stepwise manner. After first SMX addition to 
the reactor, the reactor was operated during 90 days. Soluble COD removal 
efficiency and biogas production were not affected significantly (p>0.05) by the 
addition of SMX from 1 to 25 mg/L to the ASBR influent (Phase b and c, days 78-
92). The first remarkable effect of SMX on the reactor performance was detected 
after 25 mg/L of SMX addition on day 92. A mild increase in the effluent soluble 
COD concentration to 151.6±28.7 mg/L in SMX reactor was observed at Phase d, 
while effluent soluble COD concentration of control reactor was 62.4±41.2 mg/L 
(p<0.001). After obtained steability in the SMX reactor, antibiotic concentration was 
increased to 30 and 35 mg/L by gradually on day 101 and operated at this 
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concentration to day 115 (Phase e and f). Almost stable COD removal efficiency 
observed during these phases and no significant change was determined in terms of 
effluent soluble COD and biogas production in the SMX reactor (p>0.05). However 
significant effect of SMX was detected at these parameters in the comparison to 
control reactor (p<0.01). Subsequently reactor performance decreased substantially 
after 45 mg/L of SMX addition between 127
th
 and 168
th
 days. The average effluent 
soluble COD concentration of SMX reactor was 815.5±591.6 mg/L while effluent 
soluble COD concentration of control reactor was 44.6±18.6 mg/L. 
In contrary of this result, Sponza and Demirden (2007) found that the COD removal 
efficiency decreased from 87% to 68% when the sulfamerazine concentration was 
increased from 10 mg/L to 90 mg/L. This contradiction could be originated from 
different anaerobic reactor types, operation conditions or different sulfonamid 
compound using in the studies. 
Figure 4.27: Performance of Control and SMX reactors in terms of biogas 
production and COD removal efficiency (Phase a: 0 mg/L SMX, 
Phase b: 1 mg/L SMX, Phase c: 10 mg/L SMX, Phase d: 25 mg/L 
SMX, Phase e: 30 mg/L SMX, Phase f: 35 mg/L SMX, Phase g: 40 
mg/L SMX, Phase h: 45 mg/L SMX). 
Biogas production was also parallel to effleunt soluble COD concentration and it was 
also dramaticaly dropped in the last phase. Also Shi et al. (2011) showed that 
methane production in the anaerobic digester, which treated manure from pig farms 
at 25 °C during 20 days, decreased approximately 33.3% at 25-50 mg/L of 
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sulfamethoxydiazine concentration, which is an antibiotic of sulfonamid group. In 
another study, different antibiotics effect including sulfonamids on the anaerobic 
lagoons was examined (Loftin et al., 2005). According to this study, these 
compounds had the inhibitory effects changed between 20% and 45% on methane 
production under different concentrations varied 1 mg/L to 25 mg/L. The opposite of 
this represented study, the previous studies in the literature showed the inhibition in 
COD removal and biogas production even if low sulfonamid concentrations up to 25 
mg/L.  
During all operation days, methane content of biogas was stable (64.2%±4.7) in this 
study. However, Sponza and Demirden (2007) showed that the methane percentage 
in the system increased from 60% to 76% with respect to the sulfamerazine 
concentration. 
The reactors had been inoculated with granular sludge. Throughout the entire period 
of rector operation, these granules remained stable and no significant dispersed 
growth and biofilm formation on the reactor walls was observed.  
4.4.1.2 Volatile fatty acids 
During the 168-day operation period, VFA could not detected in the effluent of 
control reactor. Also in the SMX reactor, after first SMX addition to the influent on 
day 78, no VFAs were detected in the effluent until 128
th
 day. On this day, SMX 
concentration in the influent was increased to 45 mg/L as last phase. After that, the 
reactor performance in terms of not only VFA accumulation but also COD removal 
efficiency and biogas production started to decrease.  
In the phase h, propionic acid accumulation was observed from the beginning. While 
propionic acid concentration in the effluent was observed in the beginning of the 
phase h_1 as 35 mg/L, it was increased during the operation stepwise and reached to 
438 mg/L at the end of the operation period. After 146
th
 day (Phase h_2), acetic acid 
accumulation started and the concentration reached to 342 mg/L at the end of the 
phase. Also this observed increase in VFA concentration represented approximately 
50% of the effluent COD. The discrepancy between measured VFA and soluble 
COD in the effluent suggests that the increase of the effluent soluble COD could 
result from soluble microbial products (SMP) and residual antibiotic. The terms SMP 
is used for the organic compounds, which are the end products of substrate 
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metabolism and biomass decay excluding known intermediates such as VFAs 
(Barker and Stuckey, 1999). The composition of SMP is changed according to 
system and also is not characterized completely. Increase in the SMP concentration 
has been observed in the systems, which were exposed to toxic compounds (Aquino 
and Stuckey, 2004). 
The results indicated that SMX affected the propionic acid degradation and acetic 
acid utilization pathways in the higher concentrations. Also valeric acid and butyric 
acid were measured in the effluent obtain from phase h, however their concentrations 
were less than 20 mg/L. Sponza and Demirden (2007) also found similar results 
while sulfamerazine, which is another antibiotic from sulfonamid group, was being 
fed to the anaerobic system, an increase in VFA accumulation was observed with 
respect to rising of antibiotic concentration. In that study, VFA accumulation around 
420 mg/L was observed at10 mg/L of sulfamerazine addition and the value increased 
to 600 mg/L at higher than 65 mg/L of antibiotic concentration. 
4.4.1.3 Antibiotic measurement 
Antibiotic measurement was carried out for wastewater and sludge samples taken 
from different phases of SMX reactor. The results of the measurment is given in 
Figure 4.28. 
Figure 4.28: Antibiotic measurement results of SMX reactor. 
As seen in Figure 4.28, in the first phases SMX was removed in the reactor in high 
efficiency. However, the sorption rate increased in the last two pahses, Phase h_3 
and Phase h_4 suddenly. In the same time, COD removal effciiency of the reactor 
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decreased dramatically. It is clear that the long-term antibiotic feeding to the reactor 
caused an increase in accumulation of the antibiotic within the sludge and it directly 
affected reactor efficiency. 
4.4.1.4 Specific methanogenic activity tests 
Different microbial groups have different roles in the anaerobic degradation. It was 
anticipated that the sensitivity of these groups to SMX might vary. To further 
investigate this, the long-term effect of SMX on the utilization of particular substrate 
was investigated by specific methanogenic activity tests. 
Utilization of Acetate: 
Acetate utilization rates of anaerobic sludges taken from different operation days of 
the SMX reactor were observed during six days to identify long-term effect of SMX 
on the activity of acetoclastic methanogens. The cumulative biogas and methane 
productions were given in Figure 4.29. The acetoclastic activity of the seed sludge of 
chronic tests was found 77 mL of methane as given in section 4.2. After chronic 
study started, the methane production capacity of the sludge fed by 10 mg/L SMX 
decreased to 51 mL. The results show that low concentration of SMX had a clear 
adverse influence on acetoclastic methanogens. However, the acetate utilization 
capability increased with time and also surprisingly SMX concentration. As seen 
Figure 4.29, the cumulative biogas and methane productions were the lowest as 68 
mL and 51 mL, respectively, in the phase c, in which 10 mg/L SMX was fed to the 
system. The values increased with the SMX concentration and reached the maximum 
at the end of the operation as 116 mL and 87 mL for biogas and methane production, 
respectively. The cumulative methane production obtained from the last samples was 
near to the theoretical produced methane. When 4000 mg/L of acetate utilized 
completely in the system, 97 mL of methane can be produced. The methane 
percentage in the biogas was the same in all sets, 70%. 
As a result, the removal of acetic acid was not effected in higher SMX 
concentrations, presumably because it was accomplished by acetoclastic 
methanogens resistant to SMX.  
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Figure 4.29: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production.  
Utilization of VFA mixture 
VFA mixture utilization rates of anaerobic sludges taken from different operation 
days of the SMX reactor were also determined during six days to identify long-term 
effect of SMX on the homoacetogenic and methanogenic pathways. The cumulative 
biogas and methane productions were given in Figure 4.30. Theoretical methane 
production from this mixture is 315 mL. The results showed a clear inhibition effect 
of SMX of these metabolic pathways. Also the highest CMP value was also 40% of 
this theoretical value as seen in Figure 4.30b. 
Even the inhibition effect of the SMX on the utilization of VFA mixture was more 
noticable compared to acetate utilization, the gas profiles of these two data sets were 
a 
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similar. The lowest CBP and CMP were obtained from the sludge of phase c. The 
values increased with the SMX concentration and reached the highest values as 190 
mL and 123 mL for CBP and CMP, respectively, at the end of the operation. Sponza 
and Demirden (2007) was found that specific methanogenic activity of the 
sulfamerazine, which is another antibacterial from sulfonamid group, fed anaerobic 
sludge increased approximately 2.5 fold 0 to 65 mg/L of sulfamerazine. However, the 
authors observed a decrease in SMA results after 65 mg/L of the compound. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane 
production. 
Also, the methane percentage in the biogas changed with the concentration of the 
SMX. While 60% of methane was detected in phase c, this ratio increased to 65% in 
the phase h. The results indicated that homoacetogens and hydrogenotrophic 
a 
b 
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methanogens could be more sensitive to SMX, however the system was recovered 
itself and acclimated to the compound even if high concentration. 
Decreased utilization of butyrate and propionate is consistent with the fact that these 
substrates are used directly by bacteria, homoacetogens. SMX also has a 
bacteriostatic inhibition effect on folic acid production of especially gram positive 
and negative cocci (Sweetman. 2009). VFAs are not directly used by methanogens, 
however different groups of syntrophic bacteria use specific VFAs. 
Biomass that had been exposed to SMX longer time exhibited a much higher 
methane production. Thus for the saturated fatty acid-beta acid oxidizing bacteria, 
long term exposure to SMX resulted in an adaptation which could be caused either 
by the development of the resistance in existing bacteria or by an increase in the 
abundance of resistant populations. However, this increased resistance to SMX was 
not universal for all populations, since the COD removal efficiency and biogas 
production in the ASBR did not recover for the duration of experiment. 
4.4.1.5 Microbiological approach 
16S rDNA and rRNA microbiological analysis were done to determine the effects of 
SMX on existing and active microorganisms, relatively. In this scope, genomic 
DNAs and total RNAs were extracted from the samples collected form different 
phases of the SMX reactor and RNAs were converted to cDNAs by reverse 
transcriptase PCR (RT-PCR). Amplicons were obtained using 16S rRNA gene 
spesific primers for further analysis on DGGE. Furthermore, GDNAs and cDNA 
were used to quantify total bacteria, archaea and methanoges by Q-PCR. 
Predominant bands in the DGGE patterns 
To assign the composition of the predominant community and its shift during the 
operation time in terms of existing and active species, 16S rDNA and rRNA DGGE 
profiles of the samples were compared to bacterial and archaeal clone libraries of the 
seed sludge, which were given in the section 6.2. The comparison results of bacterial 
and archaeal 16S rDNA DGGE band patterns were given in Table 4.5 and 4.6, 
respectively. 
13 of the bacterial OTUs detected in the 16S rDNA DGGE profiles. According to 
these results, the matched Clostridum species (AB114241, AM158323, and 
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AY648564) almost detected during the operation and their intensities  did not 
noticebly change with respect to SMX concentration and opertaion time. Clostridium 
species frequently presence in the anaerobic systems and they are resposible to 
fermentation and some species especielly produce the ethanol. Addition of them, 
Clostridium spesice have the role on the starch degradation by exo-enzymes 
(Hungate, 1982; Payton and Haddock, 1986). So, the results are not surprise for this 
system fed by a synthetic wastewater including starch. Other OTUs detected in the 
samples almost belong to the uncultured clones or unclassfied bacterial clutured 
species. 
Differently from 16S rDNA bacterial DGGE pattern,  the intensity of matched 
archaeal DGGE predominant band were higher as seen in Table 4.6. 14 of the 
archaeal OTUs detected in the 16S rDNA DGGE profiles. According to the results, 
acetoclastic methanogen species (U89773, FR836463, FR836464, and FR836468) 
disappered at the last phases. However, the abundance of hydrogenotrophic 
methanogens, especially Methanobacterium species, and methanogenic archeons 
(AY350742, AY552778, HM630570, FR836462, and FR836467) were higher and 
they seemed almost in every steps. When compared to the results obtained from 
rector operation and SMA tests, it was expected that acetoclastic methanogens were 
dominant in the system. Especially, the SMA test results indicated that acetoclastic 
methanogenic activity increased with respect to SMX concentration. 
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Table 4.5: Affiliation of bacterial clones and their abundance at the different phases of the SMX reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative Similarity (%) Phase b Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96        
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96        
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 • • • • • • • 
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 • •• •• • • •  
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone QEDS2BE07 
(CU921543) 
93   •  • • • 
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone QEDN7DC08 
(CU926749) 
97   •    • 
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98        
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89  • •• •    
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96 • •• ••  • • • 
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91 • • • •    
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95        
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 •  •   •  
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Table 4.5 (continued): Affiliation of bacterial clones and their abundance at the different phases of the SMX reactor. 
Clone  
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative Similarity (%) 
Phase 
b: 82nd 
day 
Phase 
d: 93rd 
day 
Phase g: 
128th 
day 
Phase h: 
136th 
day 
Phase 
h: 
145th 
day 
Phase h: 
158th 
day 
Phase h: 
166th 
day 
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 
8SN (EU887773) 
92               
B14 5.61 FR836448 
Uncultured bacterium 
clone BS1_25R 
(GQ458208) 
97   • • •       
B15 2.80 FR836449 
Uncultured bacterium 
clone aaa97f10 
(DQ816701) 
96               
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96               
B17 2.80 FR836451 
Uncultured Sarcina sp. 
clone JPL-2_O10 
(FJ957591) 
89     •   • ••   
B18 0.93 FR836452 
Uncultured bacterium 
clone 30c07 (EF515566) 
87               
B19 0.93 FR836453 
Paludibacter 
propionicigenes 
(AB078842) 
92               
B20 0.93 FR836454 
Bacterium 061128-OL-
KR37-AA 3-0 10000x -
1A (FJ037613) 
92           • • 
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 
(AB298766) 
99               
B22 1.87 FR836458 
Uncultured bacterium 
clone D14R15C96 
(FM956760) 
98           •   
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Table 4.6: Affiliation of archaeal clones and their abundance at the different phases of the SMX reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94        
A2 2.90 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98 ••       
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95 •••• ••• ••• •• •• •••••• •• 
A4 2.90  
Methanobacterium formicicum 
strain S1 (DQ649309) 
99        
A5 2.90 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 (AB077214) 
98     ••   
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98  ••      
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97 ••       
A8 0.72  
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99        
A9 7.25  
Methanospirillum hungatei 
(M60880) 
99        
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97        
A11 6.52 FR836467 
Methanosphaerula palustris strain 
E1-9c (EU156000) 
95  •• •• •• •••  •• 
A12 0.72  
Methanobacterium sp. OM15 
(AJ550160) 
99        
A13 2.17  
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 ••  ••• ••• •••• ••• ••• 
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Table 4.6 (continued): Affiliation of archaeal clones and their abundance at the different phases of the SMX reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarit
y (%) 
Phase b Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95 •• 
      
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 
    
••• 
  
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 •• ••• 
     
A17 9.42 FR836472 
Methanogenic archaeon Prasan1 
(HM630570) 
97 ••• 
  
•• ••• •• •• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 •• 
 
•• ••• ••• •• ••• 
A19 2.17 
 
Methanosarcina siciliae 
(U89773) 
99 
  
•• •• 
 
•• 
 
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
       
A21 1.45 FR836474 
Uncultured archaeon clone OKA6 
(GQ465437) 
97 
       
A22 1.45 
 
Uncultured archaeon clone ATB-
KM-2942-A18 (EF680353) 
99 
       
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 ••• ••• ••• ••• ••• •• •• 
A24 2.17 
 
Uncultured archaeon clone WA10 
(AB494239) 
99 
       
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95               
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Also to determine the active species and their shift and/or changes in the SMX 
reactor with respect to the SMX concentration and operation time, the amplicons 
obtained from 16S rRNAs were compared with the bacterial and archaeal clone 
libraries. The comparison results were given in Table 4.7 and 6.8, respectively. 
13 of the bacterial OTUs detected in the 16S rRNA DGGE profiles. However, 3 of 
these OTUs were not the same with 16S rDNA DGGE comparison which is given in 
Table 4.5.  
According to 16S rRNA DGGE results, the uncultured Clostridum species, which 
were detected in 16S rDNA results (AM158323 and AY 648564), also existed in 
every phase, however their abundance were decreasing with respect to the SMX 
concentration and operation time. This result also confirm the results obtianed from 
reactor performance and SMA tests. While the COD removal efficiency decreased, 
methanogenic activity increased. Also the bacterial 16S rRNA results showed that 
the inhibition of SMX firstly strated in the fermentation step of the anerobic 
degradation pathway. Clostridium species are the important group responsible in the 
fermentation in the anerobic systems (Hungate, 1982; Payton and Haddock, 1986). 
While Acinetobacter sp. 1B3 (EU337120) was deetcted in the seed sludge, it 
coulndn‘t be matched in DGGE band patterns of the samples taken from the SMX 
reactor. However, Acinetobacter spp. were found in the pharmaceutical industry and 
hospital effluents and it has been known that they are adapted to high concentration 
of antibiotics because of the resistance (Guardabassi et al., 1998). Other predominant 
bacterial clones were mostly uncultured species. These uncultured bacterial clones 
may probably be species responsible to fermentation and homoacetogenesis, 
especieally VFA-oxidizing syntrophs (Speece, 1996; Madigan et al., 2009).  
In the archaeal 16S rRNA samples, only one acetoclastic methanogen (U897731) 
was detected in only one sample, phase h_2 surprisingly. Hydrogenotrophic 
methanogens represented different patterns. While Methanobacterium beijingense 
(AY350742) were highly dominant, abundance of other hydrogenotrophic 
methanogens decreased. Other detected species were mostly uncultured archaeal 
clones as seen in Table 4.8. In anaerobic digestion, degradation of organic 
compounds to CO2 and CH4 relies greatly on methanogenic archaea for ultimate 
stage (Madigan et al., 2009). So, the results was expected excluding not detected 
acetoclastic methanogens. Generally, 70% of CH4 is produced from acetate in the 
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anaerobic reactors (Whiticar et al., 1986), and also in biogas composition of the 
SMX reactor during the operation, H2 was not observed. Additionally, VFA 
concentration in the effluent indicated that acetate accumulation in the reactor  
started in Phase h_2 and SMA test results also indicated that acetoclatic activity 
increaaed especially in the last phases. This concept put forward to another pathway; 
homoacetogenesis with hydrogenotrophic methanogenesis. Acetate could be 
converted to H2 +CO2 by homoacetogens; and H2 might be used to produce methane 
in also early phase of the operation. Hydrogenotrophic methanogens have been also 
detected during the anaerobic treatment of pharmaceutical industry wastewater and 
manure digestion especially including antibiotics (Gomez-Silvan et al., 2010; Stone 
et al., 2010). 
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Table 4.7: Affiliation of bacterial clones and their abundance within the active community at the different phases of the SMX reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96       
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96       
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 •••• •••• ••• •• • •• 
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 •••• •••• •••• •••  • 
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone 
QEDS2BE07 (CU921543) 
93 •••   ••• •• • 
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone 
QEDN7DC08 (CU926749) 
97 ••• ••• •••  ••  
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98 •••••••••• ••••••••• ••••••••• •••••• ••• ••• 
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89 •• •• •••    
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96       
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91 ••      
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95       
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Table 4.7 (continued): Affiliation of bacterial clones and their abundance within the active community at the different phases of the SMX 
reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 •• 
   
•• • 
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 8SN 
(EU887773) 
92 
      
B14 5.61 FR836448 
Uncultured bacterium clone 
BS1_25R (GQ458208) 
97 ••• ••• ••• 
   
B15 2.8 FR836449 
Uncultured bacterium clone 
aaa97f10 (DQ816701) 
96 
      
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96 
      
B17 2.8 FR836451 
Uncultured Sarcina sp. clone 
JPL-2_O10 (FJ957591) 
89 ••• 
     
B18 0.93 FR836452 
Uncultured bacterium clone 
30c07 (EF515566) 
87 
      
B19 0.93 FR836453 
Paludibacter 
propionicigenes (AB078842) 
92 
  
••• 
   
B20 0.93 FR836454 
Bacterium 061128-OL-
KR37-AA 3-0 10000x -1A 
(FJ037613) 
92 
    
• 
 
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 
(AB298766) 
99 
      
B22 1.87 FR836458 
Uncultured bacterium clone 
D14R15C96 (FM956760) 
98     •••       
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Table 4.8: Affiliation of archaeal clones and their abundance within the active community at the different phases of the SMX reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase d Phase g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94       
A2 2.90 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98    •••   
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95   ••••  •••• •••• 
A4 2.90  
Methanobacterium formicicum 
strain S1 (DQ649309) 
99       
A5 2.90 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 (AB077214) 
98       
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98       
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97       
A8 0.72  
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99       
A9 7.25  
Methanospirillum hungatei 
(M60880) 
99       
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97 •••••• •••  •••   
A11 6.52 FR836467 
Methanosphaerula palustris strain 
E1-9c (EU156000) 
95 •••••  ••••••    
A12 0.72  
Methanobacterium sp. OM15 
(AJ550160) 
99   ••••    
A13 2.17  
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 •••••• •••••••••• •••••••• •••••••••• •••••••••• •••••••••• 
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Table 4.8 (continued): Affiliation of archaeal clones and their abundance within the active community at the different phases of the SMX 
reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase d 
Phas
e g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95             
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 •• ••• ••• ••• ••• 
 
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 
      
A17 9.42 FR836472 
Methanogenic archaeon Prasan1 
(HM630570) 
97 ••• •••• •••• ••••• ••••• •••• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 •••• •••••• ••••••• •••••••• •••••• ••••• 
A19 2.17 
 
Methanosarcina siciliae (U89773) 99 
   
•••• 
  
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
      
A21 1.45 FR836474 
Uncultured archaeon clone OKA6 
(GQ465437) 
97 
      
A22 1.45 
 
Uncultured archaeon clone ATB-
KM-2942-A18 (EF680353) 
99 
      
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 •••••• ••••• ••••• •••• ••••• ••••• 
A24 2.17 
 
Uncultured archaeon clone WA10 
(AB494239) 
99 
      
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95             
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Cluster analysis of DGGE banding pattern 
Microbial diversity and shifts in bacterial and archaeal communities, which 
presented in the SMX reactor during the operation time, were estimated based on the 
DGGE patterns of the partial 16S rDNA amplicons. A total of eight sludge samples 
were compared: The seed sludge of the chronic reactors and the sludges of SMX 
reactors. Result of DGGE analysis suggested that bacterial community was 
respectively, more diverse than archaeal diversity in the reactor; 71 bacterial and 51 
archaeal bands were remarked in the SMX reactor samples.  
Bacterial and archaeal diversities and species richness in seed sludge and sludges of 
SMX reactors were measured by the Shannon-Weaver diversity index and 
Margalef‘s species richness, respectively. The values were given in Table 4.9  
and 4.10.  
In seed sludge, while 33 of different bacterial species were detected, this number 
decreased to 7 at the end of operation as seen in Table 4.9. Also archaeal species 
number changed during the operation time; in the phase be, it increased to 21 from 
13 (in seed sludge). However the archaeal spesices number dramatically decreased to 
in the last period of the operation. However the change in both bacterial and archaeal 
OTUs was not steady. After the addition of SMX to the reactor, bacterial and 
archaeal species were generally stable until the 45 mg/L of SMX concentration 
(phase h). In the last phase (phase h), both of them firstly increased and then 
dramatically decreased.  
The results indicated that SMX addition to the acclimated sludge affected to species, 
especially bacterial ones, only in the highest concentration, 45 mg/L. In the previous 
phases, the diversity was almostly held steady. The sharp decrease in bacterial OTUs 
was observed at the beginning of the phase h. The diversity was recovered in a while, 
but it was not prevented decrease in bacterial OTUs again at the end of the operation. 
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Table 4.9: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the SMX reactor. 
 
Seed_Chro
nic 
Reactors 
Phase 
b 
Phase 
d 
Phase 
g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
Taxa 33 27 18 34 13 25 26 7 
Shannon-
Weaver 
diversity 
3.449 3.093 2.734 3.406 2.329 3.166 3.225 1.928 
Evenness 0.9537 
0.816
6 
0.855
6 
0.886
6 
0.789
5 
0.948
2 
0.967
7 
0.982
3 
Margalef's 
richness 
4.954 4.08 2.797 5.064 2.265 3.967 4.274 1.33 
Table 4.10: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the SMX reactor. 
 
Seed_Chronic 
Reactors 
Phase 
b 
Phase 
d 
Phase 
g 
Phase 
h_1 
Phase 
h_2 
Phase 
h_3 
Phase 
h_4 
Taxa 13 21 13 13 10 19 10 10 
Shannon-
Weaver 
diversity 
2.526 3.009 2.525 2.501 2.256 2.907 2.272 2.159 
Evenness 0.962 0.9655 0.9605 0.9379 0.9544 0.963 0.9698 0.8666 
Margalef's 
richness 
1.901 2.933 1.825 1.826 1.478 2.568 1.43 1.354 
 
The DGGE analyses were done by Pearson product-moment correlation coefficients 
and UPGMA clustering. The bacterial and archaeal 16S rDNA phylogenetic trees 
obtained from SMX reactor were given in Figure 4.31 and 4.32. The analysis of 
DGGE band patterns from the SMX reactor sludge samples revealed that the samples 
differentiated not only by SMX addition but also by operation time.  
The changes in bacterial community during the operation reflect the clusters obtained 
from DGGE band patterns, which were divided into two clusters. The clusters were 
defined by less than 70% pattern similarity. One of them included Phase d, g and 
h_1. This cluster also divided into two sub-clusters based on their population origin, 
which were defined by a similarity pattern varied between 87.4% and 94.2. The other 
cluster including seed sludge and Phase b, h_2, h_3 and h_4 samples divided two 
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sub-clusters. In the first sub-cluster, seed sludge and Phase h_3 samples were defined 
by 81% similarity. In the second sub-cluster, Phase b, h_2 and h_4 samples were 
defined by the similarities changed 85.4% to 94.8%. As seen in dendogram (Figure 
4.31), the pattern similarity of the samples did not change very distinctly. 
 
Figure 4.31: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment 
correlation coefficients and UPGMA. 
As for the Bacteria, clustering of 16S rDNA gene DGGE banding pattern revealed 
two main clusters defined by less than 60% similarity for Archaea (Figure 4.32). In 
the first cluster, seed sludge and Phase_3 sample were defined by a similarity 56.2% 
These samples gave different patterns compared to others. The second cluster also 
divided into two sub-clusters. One of them included Phased, g and h_1 samples and 
the samples defined by the similarities varied between 77.1% and 83.8%. The second 
sub-cluster also gave similar profile and the samples in this subcluster, Phase b, h_2 
and h_4, defined the similarities varied 85.6% to 89.4%. Differently from the bacterial 
dendogram, the archaeal pattern similarity of the samples changed more distinctly. 
 
Figure 4.32: Cluster analysis and similarity matrix of archaeal 16S rDNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
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DGGE analysis was also performed to find out the active community changes during 
the operation of the SMX reactor. The bacterial and archaeal 
phylogeneticdendograms obtained from DGGE band patterns were represented in 
Figure 4.33 and 4.34, respectively. 
The bacterial band patterns obtained from 16S rRNA gave the similar result to 16S 
rDNA band patterns. Phase h_3 sample differentiated from other samples obviously. 
As seen in Figure 4.33, Phase h_3 samples was defined by a similarity as 65.1% to 
the closest sample, Phase h_4. The closest phases in terms of active bacterial 
community were Phase g and h_1, which were defined by a similarity 78.3%. 
 
Figure 4.33: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
In the archaeal phylogenetic tree of 16S rRNA, the dendogram structures and 
similarities were different from the dendogram of archaeal 16S rDNA. As seen in 
Figure 4.34, the distribution of the active archaeal community reflected the clusters, 
which were divided into two. One of this cluster included Phase h_3 and h_4 
samples, which defined by a similarity 93.6%. The second cluster also divided into 
two sub-clusters. While Phase h_2 sample formed one sub-cluster defined by a 
similarity less than 90% to other sub-cluster. The second sub-cluster was constituted 
by two other clusters including Phase d, g and h_1 samples and these clusters were 
defined by the similarities varied between 92.3% and 97.8%. 
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Figure 4.34: Cluster analysis and similarity matrix of archaeal 16S rRNA gene 
DGGE banding patterns based on Pearson product-moment 
correlation coefficients and UPGMA. 
No significant changes in 16S rDNA and 16S rRNA profile of bacterial and archaeal 
communities were detected. However, the microbial shift especially in the acitve 
community was expected, and thus this result is surprising.  
Quantification by Q-PCR 
Quantitative changes of 16S rDNA and 16S rRNA concentrations in terms of 
bacteria, archaea and methanogens were also determined by Q-PCR. The 
concentration profiles showed the temporal variations in the microbial community 
and the active population at different phases of the SMX reactor. As seen in Figure 
4.35-4.37, the bacterial, archaeal and methanogenic populations increased after the 
reactor operation started. Also there is a decrease for all of them in Phase h_1. In the 
same Phase, COD removal efficiencey started to decrease in the reactor. The reason 
of the increase in the microbial community in Phase b could be adaptation of the new 
conditions. However, this adaptation was not observed in the reactor efficiency. The 
bacterial, archaeal and methanogenic community varied from 3.03 X 10
8
 to 1.23 X 
10
10
, from 1.00 X 10
7
 and to 2.53 X 10
9
, and from 4.05 X 10
6
 to 1.12 X 10
9
, 
respectively. As seen in Figure 4.37, the highest methanogenic population was 
determined in Phase b. When compared to seed sludge, the amount of methanogens 
was increased approximately 275 times in Phase b. Also more oscillation in the 
microbial groups was observed in methanogens. 
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Figure 4.35: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the SMX reactor. 
 
Figure 4.36: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the SMX reactor. 
 
 
Figure 4.37: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the SMX reactor. 
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Besides quantification of 16S rDNA concentration, 16S rRNAs were quantified to 
determine the effects of SMX on the specific microbial groups. Quantification results 
of bacteria, archaea and methanogens were given in Figure 4.38-4.40, respectively. 
While the reactor operation data and SMA test results changed during the operation 
time, 16S rRNA expression level in the system was not changed noticeably.  
 
Figure 4.38: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the SMX reactor. 
 
 
Figure 4.39: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the SMX reactor. 
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Figure 4.40: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the SMX reactor. 
Enzyme expression 
To detect the inhibition effect of the SMX on the anaerobic pathways three enzymes 
were selected based on mRNA level from the different metabolic pathways of the 
anaerobic degradation. Formylterahydrofolate synthetase (FTHFS), methyl-
coenzyme M reductase (mcrA) and acetyl-coA synthetase (ACAS) were selected to 
determine the inhibition on homoacetogenesis, methanogenesis and specifically 
acetoclastic methanogenesis, respectively.  
Despite acetate and other VFAs were not observed in effluent and active 
methanogenic species were detected in the system, FTHFS expression was 
surprisingly not observed in the mRNA level.  
Expression of mcrA gene was detected in every phase of the SMX reactor. While 
biogas production was really low at the end of the reactor operation, expression level 
of mcrA gene was also very low (1.03 X 10
2
 copies/mL) as seen in Figure 4.41. A 
stepwise decrease was observed in the mcrA gene expression with respect to SMX 
concentration. This result was supported by reactor operation data in terms of biogas 
production. 
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Figure 4.41: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the SMX reactor. 
ACAS gene expression results were given in Figure 4.42. Differently from mcrA, 
ACAS couldn‘t be detected at the end of the reactor operation. Surprisingly, the 
expression level of ACAS was higher than mcrA at Phase d, g, and h_1. However, in 
DGGE analysis of archaeal 16S rRNA, cultured Methanosaeta couldn‘t be detected.  
ACAS gene expression results were given in Figure 4.42. Differently from mcrA, 
ACAS couldn‘t be detected at the end of the reactor operation. Surprisingly, the 
expression level of ACAS was higher than mcrA at Phase d, g, and h_1. However, in 
DGGE analysis of archaeal 16S rRNA, cultured Methanosaeta couldn‘t be detected. 
The main reason of this discrepancy between DGGE analysis and Q-PCR results 
could be the potential bias of the molecular tools with differences in DNA extraction 
efficiency, gene copy number or PCR amplification and primer biases, must be 
considered. However, cultivation-independent, molecular techniques currently 
provide the best approach for analysis of complex natural microbial communities and 
in this study, sludge samples investigated were processed using identical techniques 
and data analyses, and biases are likely to have been similar, thus differences 
detected would be significant and would arise from structural differences in the 
examined samples. 
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Figure 4.42: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the SMX reactor. 
The acetyl-coA pathway has been known to be operational in acetate assimilation, 
and thereby, the FTHS expression can reflect the outgrowth of such bacteria. (Drake, 
1994). However the temporal expression of this gene rules out the possibility that the 
expression was accounted for by assimilative metabolism (Akuzawa et al., 2010).  
4.4.2 Erythromycin 
4.4.2.1 Performance of the Erythromycin (ERY) reactor 
To evaluate the long-term effect of ERY on anaerobic systems, an ERY fed reactor 
was operated during 154 days with a control reactor. The performances of both 
reactors in terms of COD and biogas are given in Figure 4.43 and 4.44. After the 
start-up, the OLR was increased gradually from 1.4 g COD/L*d. OLR was increased 
to 2.25 g COD/L*d in first 22 days. In a previous study focusing on the influence of 
ERY to the anaerobic systems, OLR was selected as 2.9 g COD/L*d, which was 
close to this study (Amin et al., 2006). Also in other studies evaluated anaerobic 
treatment of pharmaceutical industry wastewaters, the anaerobic reactors were 
operated by OLRs in a range between 0.43-3.73 g COD/L*d (Chelliapan et al., 2006; 
Sponza and Demirden, 2007; Shimada et al., 2008) and Chelliapan et al. (2006) 
found that high OLR with low HRT is positively affects COD removal efficiency in 
the anaerobic systems fed by pharmaceutical industry wastewater. Then, both of the 
reactors were operated at the steady-state until 78
th
 day with an average effluent 
soluble COD 75.9±27.2 and 84.4±24.6 mg/L corresponding to a removal efficiency 
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of 96.5% and 96.5% and average biogas production of 1045±23 mL/d and 1041±12 
mL/d for control and ERY reactor, respectively. Also methane percentage of the 
biogases produced in the Control and ERY reactors were 64.8%±2.6. This 
corresponds to an average specific methane production of 0.32 L CH4/g 
COD_removed at control and ERY reactors before the feeding of antibiotic to the 
system. These values are consistent with reported in the literature (Tchobanoglous et 
al., 2003). VSS concentration and pH were stable during all operation. 
Figure 4.43: Performance of Control and ERY reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L ERY, Phase b: 1 
mg/L ERY, Phase c: 2 mg/L ERY, Phase d: 3 mg/L ERY, Phase e: 0 
mg/L ERY). 
On 78
th
 day, ERY addition was started to ERY reactor. After first ERY addition, the 
reactor was operated during 76 days. Until 90
th
 day, 1 mg/L of ERY was fed to the 
system (Phase b). No significant change was observed in COD removal efficiency 
and biogas production at Phase b. While effluent COD concentrations and COD 
removal efficiencies of control and ERY reactors were 50.1±18.3 and 70.5±38.9 
mg/L, 97.7% and 96.8%, respectively; biogas production of the reactors during phase 
b was measured as 1058±9 mL and 1049±20 mL for control and ERY reactor, 
respectively. Methane content of the biogas produced in ERY reactor was the same 
with control reactor as 64%. 
After 90
th
 day, ERY concentration was increased to 2 mg/L and the ERY reactor was 
operated with this condition during 25 days (Phase c). Also no significant inhibition 
in terms of COD removal efficiency and biogas production was detected at this 
a                       b                c                 d              e 
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phase.  However, COD conversion to methane rate decreases from 0.32 to 0.3 L 
CH4/g COD_removed. 
The remarkable effect of ERY was detected at Phase d in which ERY concentration 
was increased to 3 mg/L. As seen in Figure 4.43 and 4.44 biogas production, effluent 
COD in connection with COD removal efficiency of ERY reactor was decreased 
dramatically and the highly significant effect was observed when compared to 
control reactor (p<0.0001). During phase d, COD removal efficiency and biogas 
production decreased day to day and reached to 23.6% and 204 mL at the end of the 
Phase d, respectively. During this period, performance of control reactor was stable. 
COD removal efficiency and biogas production of the control reactor were 
97.8±1.1% and 1063±12 mL, respectively. While the methane content of biogas was 
64±1.6% in the control reactor, this value was decreased to 52±8.2% in the ERY 
reactor.  
After the COD removal efficiency decreased in phase d, the ERY addition was 
stopped and this period was showed as Phase e in Figure 4.43 and 4.44. Ass seen in 
the figures, the reactor performance could not be increase again even ERY was not 
added.  
Figure 4.44: Performance of Control and ERY reactors in terms of biogas 
production and COD removal efficiency (Phase a: 0 mg/L ERY, 
Phase b: 1 mg/L ERY, Phase c: 2 mg/L ERY, Phase d: 3 mg/L ERY, 
Phase e: 0 mg/L ERY). 
a            b           c        d            e 
 124 
Amin and his colleagues (2006) examined the chronic inhibition effect of ERY on 
ASBR. However, the authors increased ERY concentration in the system suddenly 
from 2 g/L to 200 mg/L. The system responded to this shock effect by increased 
COD concentration in the effluent. The authors mentioned that the biogas production 
was stable like in the previous step in which 1 mg/L ERY addition. However in this 
study, the anaerobic system was dramatically collapsed even 3 mg/L of ERY was 
added and could not recovered the performance again. 
In another study, chronic effect of tylosin, which is an antibiotic belonging to 
macrolide group, was determined (Shimada et al., 2008). The experimental approach 
in this study was also similar to Amine et al. (2006). Tylosin concentration in the 
system was suddenly increased 100 times and the reactor performance decreased in 
terms of COD removal efficiency and VFA accumulation. Chelliapan et al. (2006) 
also focused on performance of up-flow anaerobic stage reactor (UASR) treating 
pharmaceutical industry wastewater containing macrolide antibiotics. They showed 
that COD removal efficiency decreased when OLR rate increased 1.86 g COD/L*d 
to 2.48 g COD/L*d under the operation conditions with low HRT (4 –day). 
Additionally, LaPara et al. (2002) mentioned that pharmaceutical wastewater 
especially containing high amount of fermentation by-products requires long HRT 
for efficient treatment. As a result, ERY reactor was operated high OLR with low 
HRT and this operation conditions could cause this dramatically collapsed. Loftine et 
al. (2005) also studied effect of tylosin tartrate on methane production in the 
anaerobic lagoons. According their results, this macrolide antibiotic inhibited the 
methane production as 23-30% with changing the concentration from 1 mg/L to 25 
mg/L. 
4.4.2.2 Volatile fatty acids 
During the Phase a with OLR of 2.25 g COD/L*d without ERY addition, no VFA 
was detected in the effluent of ERY reactor. The first VFA in the effluent of ERY 
reactor was measured on 116
th
, the second day of Phase d, as 61 mg/L of propionic 
acid. In the 120
th
 day, while the propionic acid concentration increased to 412 mg/L, 
butyric and valeric acids were determined in first time as 6 and 14 mg/L, 
respectively. During the Phase d, propionic acid concentration increased day to day 
and reached to 685 mg/L at the last day of this phase. During this period, addition of 
propionic acid, only butyric and valeric acid were observed lower than 10 mg/L. In 
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Phase e, where the ERY addition was stopped, surprisingly acetic acid accumulation 
was started and increased from 56 mg/L to 570 mg/L day to day until reactor 
operation was terminated. The propionic acid concentration was decreased at the 
beginning of phase a however increased again and reached to 1185 mg/L at the end 
of the operation. Butyric acid and valeric acid concentrations in Phase e were similar 
to Phase d, lower than 20 mg/L.  
During Phase d and e, no VFA was detected in the effluent of the control reactor as 
mentioned in the previous section.  
Differently from this study, Amin et al. (2006) found that acetic, butyric and iso-
butyric acids were accumulated when ERY concentration was increased from 1 mg/L 
to 200 mg/L. However they mentioned that while butyric acid utilization was mostly 
affected in the long-term operation, propionic acid degradation was inhibited in SMA 
tests.  
Also the results obtained from this study support previous works which inhibition of 
acetate, butyrate and propionate degradation was observed in the presence of 
macrolide antibiotic at pH 7-8.5 (Sanz et al., 1996; Shimada et al., 2008). 
The results obtained from this study showed that, when ERY concentration was 
increased to 3 mg/L in long-term operation, propionic acid degradation was firstly 
affected. Despite the general opinion about ERY, this compound is more effective on 
Gram-positive bacteria (Oleinick, 1975), propionic acids are mostly utilized by 
Gram-negative bacteria such as Syntrophobacter species (Stams and Dong, 1995). 
So, i the presence of ERY-sensitive propionate oxidizers, homoacetogenic bacteria 
and acetoclastic methanogens can be caused this inhibiton. 
4.4.2.3 Antibiotic measurement 
Antibiotic measurement was carried out for wastewater and sludge samples taken 
from different phases of ERY reactor. The results of the measurement is given in 
Figure 4.45. 
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Figure 4.45: Antibiotic measurement results of ERY reactor. 
As seen in Figure 4.45, in Phase d_2 (at the end of the antibiotic feeding period), 
ERY sorption in the sludge increased. In the same time, removal of antibiotic 
impaired gradually with COD removal efficiency. Instead of feeding of ERY was 
stopped, the reactor performance was not recovered, however the eRY concentration 
within sludge decreased to 0 mg/L suddenly. 
4.4.2.4 Specific methanogenic activity tests 
Long-term effects of ERY on the methanogens were examined by specific 
methanogenic activity (SMA) test. For this purpose, the inhibitory effect of this 
compound on different trophic groups was tested. Also SMA test provide the 
information on the potential loading capacity of the reactors treating similar 
wastewaters. 
Utilization of Acetate 
SMA test was performed to determine the acetate utilization capacity of the 
anaerobic sludge taken from different operation phase of the ERY reactor. Biogas 
production in the test tubes was monitored during 6 days. The biogas and methane 
production profiles of the SMA tests are given in Figure 4.46. The inhibitory 
influence of the ERY on acetoclastic methanogens was clear. The methane 
production capacity decreased obviously at Phase d in which 3 mg/L of ERY was 
added to reactor. In the Phase e, where antibiotic addition was terminated, the sludge 
capacity was going to worse instead of getting better.  
The acetoclastic activity of the seed sludge of chronic tests was found 77 mL of 
methane as given in section 4.2. After ERY addition started, the activity decreased 
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60 mL at Phase b and c. A dramatical decrease was observed at Phase d, the 
acetoclastic methanogenic activity was 40 mL methane. Also this decrease continued 
after addition of ERY was stopped, and the activity was determined as 30 mL 
methane at Phase e. Contrary of SMX influence, ERY inhibited anaerobic systems 
even in the low concentrations, this influence cannot be recovered. The methane 
percentage was the same in all test bottles as 70%.  
In this study, at the end of the operation, acetoclastic methanogenic capacity 
decreases as approximately 40% according to seed sludge. However, Amin et al. 
(2006) mentioned that the removal of acetic acid in the SMA test was not effected in 
even in the presence of high ERY concentration such as 200-500 mg/L.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.46: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production.  
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Utilization of VFA Mixture  
Influence of ERY on all methanogenic activity was examined via VFA mixture 
utilization. The profiles of the cumulative biogas and methane production were 
similar to acetate fed set as seen in Figure 4.47. However, an important decrease 
between phase b and c was observed in this set. Theoretical methane production from 
VFA mixtures fed to the system is 315 mL. Even in the low concentration of ERY 
had a clear influence on methane production. While CMP value was 89 mL at Phase 
b, it gradually decreased and reached to 19 mL at Phase e. Also the highest CMP 
value was also 19% of this theoretical value as seen in Figure 4.47b. Also methane 
content of the biogas was also decreased stepwise manner. Whereas, 56% methane 
was measured at Phase b, this value declined to 50%, 49% and 48% at Phase c, d and 
e, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.47: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane 
production. 
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The SMA results indicated that all methanogens were affected by ERY. However 
when compared to acetate utilization set, two possible explanations are: 
 
i) ERY has more influence on hydrogenotrophic methanogens  
ii) Propionate and acetate oxidizers could be inhibited. 
However, limited information is available on the importance of this pathway in the 
anaerobic degradation. Previous studies have shown that the indirect production of 
methane from acetate via homoacetogenic bacteria and hydrogenotrophic 
methanogens is significant for streaa conditions such as thermophilic conditions or in 
systems with high ammonia levels (Griffin et al., 1998; Angenent et al., 2002). 
Furthermore, the decreased utilization of other VFAs in the presence of erythromycin 
(propionic and butyric acid) is consistent with the fact that these substrates are used 
by bacteria, and furthermore, agrees with the general observation that erythromycin 
is more effective against Gram-positive bacteria (Oleinick, 1975). VFAs are not 
directly used by methanogens, but thet-y are a direct relation between proton 
reducing syntrophic bacteria. Different groups of syntrophic bacteria utilize specific 
VFAs, hence accumulation of particular VFAs is a proof for the erythromycin 
sensitivity of relevant syntrophs.  
The reactor operation data also supported the SMA results, because in the Phase d, 
propionate accumulation was observed. 
4.4.2.5 Microbiological Approach 
16S rDNA and rRNA microbiological analysis were done to determine the effects of 
ERY on existing and active microorganisms, relatively. In this scope, genomic 
DNAs and total RNAs were extracted from the samples collected form different 
phases of the ERY reactor and RNAs were converted to cDNAs by reverse 
transcriptase PCR (RT-PCR). Amplicons were obtained using 16S rRNA gene 
spesific primers for further analysis on DGGE. Furthermore, GDNAs and cDNA 
were used to quantify total bacteria, archaea and methanoges by Q-PCR. 
Predominant Bands in the DGGE Patterns 
To evaluate the species having role on the ERY fed system, predominant bacterial 
and archaeal band patterns obtained from different Phases of the ERY reactor were 
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compared to 16S rDNA clone libraries of the seed sludge. While16S rDNA band 
patterns reflected the existing species; 16rRNA samples indicated the active ones. 
Also their abundance was evaluated according to intensity of each band on DGGE 
gel because the intensity of the bands might correspond at least semiquantitatively 
with the abundance of the corresponding species (Heuer et al., 1997). The 
comparison results of bacterial and archaeal 16S rDNA DGGE band patterns were 
given in Table 4.11 and 4.12, respectively. 
62 different bacterial OTUs were detected in the 16S rDNA DGGE profiles. 
According to comparison results to 16S rDNA clone library, 11 of bacterial OTUs 
from bacterial DGGE profile of the RRY reactor matched to the library OTUs. 
Clostridum species (FR836437, FR83648 and FR836443) existed in the system as 
expected because the system was fed with a synthetic wastewater including starch 
and glucose. Clostiridium species have role on hydrolysis steps for polysaccharides 
and also β-oxidation process (Hungate, 1982; Payton and Haddock, 1986). Most of 
them existed in the every Phase with same abundance, however only at Phase c and 
d_2, two of them were not detected. Also, Paludibacter propionicigenes (AB078842), 
which is responsible to produce propionate, was detected most of the steps. So, the 
results are not surprise for this system fed by a synthetic wastewater including starch 
and glucose. Other OTUs detected in the samples almost belong to the uncultured 
clones or unclassfied bacterial cultured species. 
Similar to SMX reactor results, the intensities of matched archaeal DGGE 
predominant bands were higher than 16S rDNA bacterial DGGE bands. The 
comparison results of the archaeal 16S rDNA DGGE band patterns and the clone 
library is given in Table 4.12, 16 of the 47 archaeal OTUs in the DGGE profile were 
matched to 16S rDNA archaeal clone library. According to results, acetoclastic 
methanogen species (FR836463, FR836464, FR836468, U89773) existed in each 
phase. Also hydrogenotrophic species were detected in different phases. However 
their abundance in each phase was different and there was no correlation between the 
operation data. Uncultured methanogenic euryarchaeote (FR836462), a 
hydrogenotrophic species Methanobacterium beijingense strain 8-2 (AY350742) and 
an archeon clone (AJ745135) were detected in every step. So, ERY could be 
unpredictable inhibition effect on the archaela species. Also SMA test results 
supported these results. Methanogenic activity in terms of acetoclastic and 
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hyrrogenotrophic decreased with respect to ERY concentrations and could not be 
recovered when ERY addition was stopped.  
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Table 4.11: Affiliation of bacterial clones and their abundance at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96       
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96       
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 •  •  •  
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 ••     • 
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone QEDS2BE07 
(CU921543) 
93      • 
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone 
QEDN7DC08 (CU926749) 
97 • •  • • • 
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98       
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89       
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96 • • • •  • 
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91 •     • 
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95       
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Table 4.11 (continued): Affiliation of bacterial clones and their abundance at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 • •         
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 8SN 
(EU887773) 
92 
      
B14 5.61 FR836448 
Uncultured bacterium clone 
BS1_25R (GQ458208) 
97 
 
• 
  
• 
 
B15 2.8 FR836449 
Uncultured bacterium clone 
aaa97f10 (DQ816701) 
96 
      
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96 
      
B17 2.8 FR836451 
Uncultured Sarcina sp. clone 
JPL-2_O10 (FJ957591) 
89 • 
     
B18 0.93 FR836452 
Uncultured bacterium clone 
30c07 (EF515566) 
87 
      
B19 0.93 FR836453 
Paludibacter propionicigenes 
(AB078842) 
92 • • 
 
• • 
 
B20 0.93 FR836454 
Bacterium 061128-OL-KR37-
AA 3-0 10000x -1A 
(FJ037613) 
92 
 
• 
 
• • • 
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 (AB298766) 
99 
      
B22 1.87 FR836458 
Uncultured bacterium clone 
D14R15C96 (FM956760) 
98             
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Table 4.12: Affiliation of archaeal clones and their abundance at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94 
      
A2 2.9 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98 
  
•• •• 
  
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95 •••• ••••• •••• •••• ••••• •• 
A4 2.9 
 
Methanobacterium formicicum 
strain S1 (DQ649309) 
99 
      
A5 2.9 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 
(AB077214) 
98 
     
•• 
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98 
     
•• 
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97 
  
•• •• 
  
A8 0.72 
 
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99 
   
•• 
  
A9 7.25 
 
Methanospirillum hungatei 
(M60880) 
99 
      
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97 
 
•••• 
    
A11 6.52 FR836467 
Methanosphaerula palustris 
strain E1-9c (EU156000) 
95 
 
•• •• ••• 
 
••• 
A12 0.72 
 
Methanobacterium sp. OM15 
(AJ550160) 
99 
      
A13 2.17 
 
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 ••• •• •• •• •• •• 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95 
 
•• ••• ••• 
 
•• 
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Table 4.12 (continued): Affiliation of archaeal clones and their abundance at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 
      
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 
 
•• ••• •• •••• •• 
A17 9.42 FR836472 
Methanogenic archaeon 
Prasan1 (HM630570) 
97 
  
•• ••• 
 
••• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 
 
•• •• •• •• •• 
A19 2.17 
 
Methanosarcina siciliae 
(U89773) 
99 
 
•• •• •• ••• 
 
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
      
A21 1.45 FR836474 
Uncultured archaeon clone 
OKA6 (GQ465437) 
97 
    
•• 
 
A22 1.45 
 
Uncultured archaeon clone 
ATB-KM-2942-A18 
(EF680353) 
99 
      
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 •• ••• ••• ••• ••• ••• 
A24 2.17 
 
Uncultured archaeon clone 
WA10 (AB494239) 
99 
      
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95 
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Also to determine the active species and their shift and/or changes in the ERY 
reactor with respect to the antibiotic concentration and operation time, the amplicons 
obtained from 16S rRNAs were compared with the bacterial and archaeal clone 
libraries. The comparison results were given in Table 4.13 and 4.14, respectively. 13 
of the bacterial OTUs were matched to the 16S rRNA DGGE profiles. However, 3 of 
these OTUs were not the same with 16S rDNA DGGE comparison which is given in 
Table 4.11.  
According to 16S rRNA DGGE results, the uncultured Clostridum species, which 
were detected in 16S rDNA results were detected in the first phases however all of 
them excluding uncultured Sarcina clone (FR836451) disappeared at the end of the 
operation. Despite some of the Clostridium species were detected as DNA level, 
these species were directly inhibited by ERY. Clostidium species have an important 
role on the fermentation of carbonhydrates and VFA production (Hungate, 1982; 
Payton and Haddock, 1986). These finding supported the reactor results which the 
COD removal efficiency decreased with respect to the antibiotic concentration and 
the reactor performance could not be recovered even ERY addition was stopped. 
Uncultured Paludibacter clone (FR836453) which is responsible to propionate production 
disappeared at Phase e. Other predominant bacterial clones were mostly uncultured 
species. These uncultured bacterial clones may probably be species responsible to 
fermentation and homoacetogenesis, especieally VFA-oxidizing syntrophs (Speece, 1996, 
Madigan et al., 2009). In the archaeal 16S rRNA samples, mostly uncultured species was 
detected as seen in Table 4.14. Detected acetoclastic methanogens appeared in the 
beginning or the middle of the operation. No active acetoclastic species appeared at the 
end of the ERY reactor operation. Also hydrogenotrophic species didn‘t seem active 
existing of Methanobacterium beijingense strain 8-2 (AY350742) which was detected in 
all phases and their abundances were high. Other detected active species in the last phases 
were uncultured species. 
As mentioned before, degradation of organic compounds to CO2 and CH4 relies greatly on 
methanogenic archaea for ultimate stage (Madigan et al., 2009). So, the results was 
supported SMA test and VFA data. Additionally, VFA concentration in the effluent 
indicated that acetate and propionate accumulation in the reactor  started in Phase e and 
SMA test results also indicated that methanogenic activity decreased gradually even 
antibiotic addition to reactor stopped. 
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Table 4.13: Affiliation of bacterial clones and their abundance within the active community at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96       
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96       
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 •••••      
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 ••• ••  •• •  
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone QEDS2BE07 
(CU921543) 
93  •••     
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone 
QEDN7DC08 (CU926749) 
97 ••••• ••  • •  
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98 •••••• ••••••• •••••••  •••• •• 
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89 •      
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96  ••     
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91       
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95       
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Table 4.13 (continued): Affiliation of bacterial clones and their abundance within the active community at the different phases of the ERY 
reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 •• 
     
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 8SN 
(EU887773) 
92 
      
B14 5.61 FR836448 
Uncultured bacterium clone 
BS1_25R (GQ458208) 
97 ••• ••• 
   
• 
B15 2.8 FR836449 
Uncultured bacterium clone 
aaa97f10 (DQ816701) 
96 
      
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96 
      
B17 2.8 FR836451 
Uncultured Sarcina sp. clone 
JPL-2_O10 (FJ957591) 
89 
 
••• ••• •• 
 
••• 
B18 0.93 FR836452 
Uncultured bacterium clone 
30c07 (EF515566) 
87 
      
B19 0.93 FR836453 
Paludibacter propionicigenes 
(AB078842) 
92 ••• ••• •• •• 
  
B20 0.93 FR836454 
Bacterium 061128-OL-KR37-
AA 3-0 10000x -1A 
(FJ037613) 
92 
 
•• •• •• •• • 
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 (AB298766) 
99 
      
B22 1.87 FR836458 
Uncultured bacterium clone 
D14R15C96 (FM956760) 
98   ••         
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Table 4.14: Affiliation of archaeal clones and their abundance within the active community at the different phases of the ERY reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94    •••   
A2 2.90 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98    •••   
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95    •••••••• •••• ••• 
A4 2.90  
Methanobacterium formicicum 
strain S1 (DQ649309) 
99       
A5 2.90 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 (AB077214) 
98    ••   
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98       
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97   •••    
A8 0.72  
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99       
A9 7.25  
Methanospirillum hungatei 
(M60880) 
99       
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97 •••• •••• •••••    
A11 6.52 FR836467 
Methanosphaerula palustris strain 
E1-9c (EU156000) 
95 •••••• ••••• •••••    
A12 0.72  
Methanobacterium sp. OM15 
(AJ550160) 
99       
A13 2.17  
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 ••••• •••• ••••• ••••• •••••••• •••••• 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95       
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Table 4.14 (continued): Affiliation of archaeal clones and their abundance within the active community at the different phases of the ERY 
reactor. 
 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 ••• 
 
••• 
 
••• 
 
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 
   
•• 
  
A17 9.42 FR836472 
Methanogenic archaeon Prasan1 
(HM630570) 
97 •••• ••••• ••••• ••• •••••• •••• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 •••• •••• •••• ••• 
  
A19 2.17 
 
Methanosarcina siciliae (U89773) 99 
   
••• 
  
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
      
A21 1.45 FR836474 
Uncultured archaeon clone OKA6 
(GQ465437) 
97 
      
A22 1.45 
 
Uncultured archaeon clone ATB-
KM-2942-A18 (EF680353) 
99 
      
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 ••••• •••• ••••• ••• •••••• ••••• 
A24 2.17 
 
Uncultured archaeon clone WA10 
(AB494239) 
99 
      
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95 
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Cluster analysis of DGGE banding pattern 
DGGE technique was used in this study to assess the stability and/or change in 
microbial community and active species at different phases of the ERY reactor. A 
total of seven sludge samples collected from different phases of the reactor were 
compared in terms of bacterial and archaeal communities: The seed sludge of the 
chronic reactors and the sludges collected from different phases of the ERY reactor. 
Result of DGGE analysis suggested that bacterial community was respectively, more 
diverse than archaeal diversity in the reactor; 62 bacterial and 47 archaeal bands 
were remarked in the ERY reactor samples.  
Bacterial and archaeal diversities and species richness in seed sludge and sludges 
obtained from ERY reactor were measured by the Shannon-Weaver diversity index 
and Margalef‘s species richness, respectively. The values were given in Table 4.15 
and 4.16.  
In seed sludge, while 33 of different bacterial species were detected, this number 
decreased to 23 at the end of operation as seen in Table 4.15. Bacterial species 
number dramatically decreased to 7 at the first part of Phase d, in which ERY 
concentration was firstly increased to 3 mg/L, however an increase was detected 
during Phase d. Also archaeal species number changed during the operation time; at 
the Phase b, in which 1 mg/L of ERY was firstly added, the archaeal species number 
dramatically decreased to 9. However it increased gradually to 18 at the end pf Phase 
d. Also the archaeal spesices number slightly decreased to 16 at the end of the 
operation. However the change in both bacterial and archaeal OTUs was not steady. 
After the addition of SMX to the reactor, bacterial and archaeal species were 
generally stable until the 45 mg/L of SMX concentration (phase h). In the last phase 
(phase h), both of them firstly increased and then dramatically decreased.  
Eichner et al. (1999) mentioned that microbial diversity in the biological systems 
decreased after the shock loadings. The results indicated that ERY addition even in 
low concentrations affected to archaeal species than bacterial ones. However 
bacterial and archaeal community were recovered during the operation, however this 
situation could not reflect the operation of the reactor.  
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Table 4.15: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the ERY reactor. 
 
Seed_Chronic 
Reactors 
Phase 
b 
Phase 
c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
Taxa 33 29 32 7 19 23 23 
Shannon-
Weaver 
diversity 
3.449 3.254 3.365 1.925 2.913 2.975 3.1 
Evenness 0.9537 0.8933 0.904 0.9797 0.9693 0.8514 0.9656 
Margalef's 
richness 
4.954 4.364 4.847 1.385 3.205 3.547 3.772 
Table 4.16: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the ERY reactor. 
 
Seed_Chronic 
Reactors 
Phase 
b 
Phase 
c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
Taxa 13 9 14 18 18 17 16 
Shannon-
Weaver 
diversity 
2.526 2.088 2.559 2.845 2.854 2.744 2.749 
Evenness 0.962 0.8966 0.9233 0.956 0.9639 0.915 0.9765 
Margalef's 
richness 
1.901 1.265 1.984 2.512 2.518 2.332 2.3 
Pearson product-moment correlation coefficients with UPGMA clustering were used 
to quantify the similarity of the community fingerprints between each sample. The 
bacterial and archaeal 16S rDNA phylogenetic trees obtained from ERY reactor with 
seed sludge sample were given in Figure 4.48 and 4.49, respectively.  
The analysis of DGGE band patterns from the ERY reactor sludge samples revealed 
that the samples differentiated with ERY addition. 
The changes in bacterial community during the operation reflect the clusters obtained 
from DGGE band patterns, which were divided into two clusters. The clusters were 
defined by less than 70% pattern similarity. One of them included seed sludge Phase 
b, c and e_2. This cluster also divided sub-clusters. Seed sludge belonged to one sub-
cluster as solo and it was similar to Phase b, c and e_2 samples as 79.1%, 79.8%, and 
70.6%, respectively. 
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Phase d_1, d_2 and e_1 also belonged to the second cluster. This cluster also divided 
into two sub-clusters based on their population origin, which were defined by a 
similarity pattern varied between 93.3% and 96.4%. As seen in dendogram (Figure 
4.48), the pattern similarity of the samples did not change very distinctly in the 
clusters. However there was a community change during the operation. After the 
reactor operated with 3 mg/L of ERY, the bacterial community was shifted. Also in 
the beginning of Phase e, in which ERY addition was terminated, the bacterial 
community was similar to Phased. However at the end of the operation (Phase e_2), 
the bacterial community was similar to Phase c as 91.2% as seen in the dendogram 
(Figure 4.48). 
 
Figure 4.48: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment 
correlation coefficients and UPGMA. 
Archaeal cluster analysis obtained from DGGE banding pattern was different form 
bacterial cluster analysis of the ERY reactor. The archaeal banding patters revealed 
two main clusters defined by less than 60% similarity (Figure 4.49). In one of these 
clusters, only Phase b sample was defined. It was most similar to Phase c sample as 
65.7%. The second cluster also divided into two sub-clusters. One of them included 
seed sludge and Phase e_2 and the samples defined by the similarity as 81.2%. The 
second sub-cluster divided more sub-clusters. Phase c, d_1, d_2 and e_1 samples 
belonged to this cluster and their similarity varied between 72.6% and 93.1%. 
Differently from the bacterial dendogram, the archaeal pattern similarity of the 
samples changed more distinctly. 
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Figure 4.49: Cluster analysis and similarity matrix of archaeal 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment 
correlation coefficients and UPGMA. 
DGGE analysis was also performed to find out the active community changes during 
the operation of the ERY reactor. The bacterial and archaeal phylogenetic 
dendograms obtained from DGGE band patterns were represented in Figure 4.50 and 
4.51, respectively. 
The bacterial band patterns obtained from 16S rRNA gave the different result from 
16S rDNA band patterns. Phase e_2 differentiated from other samples obviously. As 
seen in Figure 4.50, Phase e_2 samples was defined by a similarity as 85.6% to the 
closest sample, Phase e_1. Also the similarity in the dendogram represented active 
bacterial community varied between 72.3% and 97.9%. The most similar samples 
based on bacterial 16S rRNA were Phase c and d_1. 
 
Figure 4.50: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
In the archaeal phylogenetic tree of 16S rRNA, the dendogram structures and 
similarities were different from the dendogram of archaeal 16S rDNA. As seen in 
Figure 4.49, the distribution of the active archaeal community reflected the clusters, 
which were divided into two like dendogram of 16S rDNA. One of this cluster 
included only Phase d_2 sample, which was defined by a similarity as 79.8% to the 
closest sample, Phase d_1. In the contrary of this result, Phase b sample 
differentiated from other samples and represented a cluster lonely. The second 
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cluster also divided into two sub-clusters. While Phase e_1, and e_2 belonged to one 
of this sub-cluster with a similarity defined as 96.2%, Phase b, c and d_1 samples 
represented the second one with a similarity changed from 95.8% to 98.4% 
 
Figure 4.51: Cluster analysis and similarity matrix of archaeal 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA.  
As seen in the results obtained from cluster analysis; 
1- Similarities in the 16S rDNA dendograms were more distinct from 16S rRNA 
results.  
2- The cluster analysis reflected to ERY concentration within the system and 
operation time. 
A change in the microbial community can be explained by environmental conditions 
(LaPara et al., 2001). Also it was found that the flexibility of microbial community 
leads to more stable reactor operation (Fernandez et al., 2006). However compared 
the microbiological data with reactor efficiency, the change in the microbial 
community was not enough to continue reactor stability in this study.  
Quantification by Q-PCR 
Quantitative changes of 16S rDNA and 16S rRNA concentrations in terms of 
bacteria, archaea and methanogens were also determined by Q-PCR during operation 
time. The concentration profiles showed the temporal variations in the microbial 
community and the active population at different phases of the ERY reactor as given 
in Figure 4.52-4.57.  
While bacterial 16S rDNA concentration increased at Phase b and c compared to 
seed sludge and reached to 3.53 X 10
10
 copies/mL, the bacterial amount decreased at 
Phase d, in which ERY concentration was 3 mg/L. The concentration of bacteria at 
Phase e, in which the ERY addition was terminated, increased again 1.97 X 10
10
 
copies/mL. Bacterial change during the operation of the ERY reactor was not 
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remarkable.  However archaeal and methanogenic community changes were related 
to reactor performance and SMA results. There was a slight increase in Phase b and 
c. While archaeal community was detected as 1.52 X 10
8
 copies/mL and 2.38 X 10
9
 
copies/mL at Phase b and c, respectively, methanogenic community was quantified 
as 6.52 X 10
7
 copies/mL and 1.22 X10
9
 copies/mL at Phase b and c, respectively. As 
seen in Figure 4.53 and 4.54, archaeal and methanogenic community dramatically 
decreased approximately 90% at the beginning of Phase d. 
 
Figure 4.52: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the ERY reactor. 
 
Figure 4.53: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the ERY reactor. 
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Figure 4.54: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the ERY reactor. 
Besides quantification of 16S rDNA concentration, 16S rRNAs were quantified to 
determine the effects of ERY on the active microbial groups. Quantification results 
of bacteria, archaea and methanogens were given in Figure 4.55-4.57, respectively.  
Bacterial 16S rRNA expression level showed that the activity of bacterial community 
was affected at the Phase c and d_1 of the operation, while ERY concentration was 
added as 2 and 3 mg/L. 
 
Figure 4.55: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the ERY reactor. 
1,E+00
1,E+01
1,E+02
1,E+03
1,E+04
1,E+05
1,E+06
1,E+07
1,E+08
1,E+09
1,E+10
1
6
S
 r
D
N
A
 (
co
p
ie
s/
m
L
)
1,E+00
1,E+01
1,E+02
1,E+03
1,E+04
1,E+05
1,E+06
1,E+07
1,E+08
1,E+09
1,E+10
1,E+11
1,E+12
Phase b Phase c Phase d_1 Phase d_2 Phase e_1 Phase e_2
1
6
S
 r
R
N
A
 (
co
p
ie
s/
m
L
)
 148 
 
Figure 4.56: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the ERY reactor. 
 
Figure 4.57: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the ERY reactor. 
However, during Phase d, the expression level of the bacterial community was 
increased and then bacterial 16S rRNA expression was conserved after ERY addition 
stopped. The reactor operation data and SMA test results changed during the 
operation time reflected 16S rRNA expression level of archaea and methanogens in 
the system noticeably. The remarkable decrease in the expression of archaeal and 
methanogenic 16S rRNA was observed at Phase d. Also CMP values of the SMA 
tests dramatically decreased during 3 mg/L of ERY addition to the system. In Phase 
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e, expression level of archaeal and methanogenic 16S rRNA increased as CMP value 
of Phase e in the SMA test. 
Enzyme expression 
To detect the inhibition effect of ERY on the anaerobic pathways three enzymes 
were selected based on mRNA level from the different metabolic pathways of the 
anaerobic degradation. Formylterahydrofolate synthetase (FTHFS), methyl-
coenzyme M reductase (mcrA) and acetyl-coA synthetase (ACAS) were selected to 
determine the inhibition on homoacetogenesis, methanogenesis and specifically 
acetoclastic methanogenesis, respectively.  
Despite acetate and other VFAs were not observed in effluent and active 
methanogenic species were detected in the system at the Phase b and c, FTHFS 
expression was surprisingly not observed in the mRNA level during all operation 
time.  
Expression of mcrA gene was detected in every phase of the ERY reactor except of 
Phase d_2 as seen in Figure 4.58. The expression level of mcrA gene in the ERY 
reactor was similar during Phas b and c as 7 X 10
3
 and 8 X 10
3
 copies/mL. While a 
slight decrease was observed as 37.5% in the beginning of the Phase d (Phase d_1 
sample), no mRNA encoded by mcrA gene was detected at the end of Phase d. 
However the expression level again increased surprisingly and reached to 6.47 X 10
4
 
copies/mL at the end of the Phase e while the reactor could not produce biogas. Also 
SMA test result obtained from both sole acetate fed and VFA mixture fed test bottles 
showed that the methanogenic activity was increased at Phase e.  
ACAS gene expression results are given in Figure 4.59. The expression profile of 
ACS gene was similar to expression of mcrA and ACAS was detetcted at Phase d_2 
additively. Surprisingly, the expression level of ACAS was higher than mcrA during 
all operation. However, in DGGE analysis of archaeal 16S rRNA, Methanosaeta 
species could not detected in every Phase.  
The main reason of this discrepancy between DGGE analysis and Q-PCR results 
could be the potential bias of the molecular tools with differences in DNA extraction 
efficiency, gene copy number or PCR amplification and primer biases, must be 
considered. The biases were discussed in detail (Reysenbach et al., 1992; Farrelly et 
al., 1995; Suzuki and Giovannoni, 1996). 
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Figure 4.58: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the ERY reactor. 
 
Figure 4.59: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the ERY reactor. 
4.4.3 Tetracycline 
4.4.3.1 Performance of the Tetracycline (TET) reactor 
To examine the chronic effect of TET on anaerobic systems, an ASBR fed by 
synthetic wastewater and TET was operated with a control reactor, which was fed by 
only synthetic wastewater. The performance of control and TET reactor are given in 
Figure 4.60 and 4.61. After the start-up, the OLR was increased gradually from 1.4 g 
COD/L*d. OLR was increased to 2.2 g COD/L*d in first 22 days as explained in the 
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section 6.4.2. Then ERY reactor was operated with OLR of 2.2 g COD/L*d ay 
steady-state until 78
th
 day. Also control reactor as mentioned previous sections was 
operated. Average effluent soluble COD, COD removal efficiency, and biogas 
production of ERY reactor between 22
nd
 and 78
th
 were observed as 74.9±19, 96.5%, 
and 1046±10 mL. The data obtained from control reactor was given in Section 4.4.1 
and 4.4.2. Besides, the methane percentage of TET reactor was 66.2%±3.2. This 
corresponds to an average specific methane production of 0.32 L CH4/g 
COD_removed at TET reactor before the feeding of antibiotic to the system. This 
value is confirming to reported in the literature (Tchobanoglous et al., 2003). VSS 
concentration and pH were stable during all operation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.60: Performance of Control and TET reactors in terms of influent and 
effluent soluble COD concentration (Phase a: 0 mg/L TET, Phase b: 1 
mg/L TET, Phase c: 2 mg/L TET, Phase d: 3 mg/L TET, Phase e: 0 
mg/L TET). 
1 mg/L of TET addition to the reactor was started on 78
th
 day continued until 91
st
 
day. During this period (Phase b), no significant changed in COD removal efficiency 
and biogas production was observed compared to control reactor (P>0.05). In Phase 
b, while biogas production was 951±12 mL/d, average effluent soluble COD and 
COD removal efficiency were detected as 71.2±28.0 mg/L and 96.8%. However, a 
slight decrease in the methane content of biogas was determined. The methane 
content of biogas in TET reactor was 59.8% during Phase b. 
On the 91
st
 day, TET concentration in the reactor was increased to 2 mg/L an 
operated the reactor with this concentration until 115
th
 day (Phase c). Also noticeable 
      a       b            c                     d                            e 
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difference between control and TET reactors in terms of COD removal efficiency 
and biogas production was not detected (P>0.05). Effluent soluble COD, COD 
removal efficiency and biogas production was 57.4±36.8 mg/L, 97.4% and 864±21 
mL/d, respectively. The average biogas production decreased as 6% as seen in Figure 
4.61. The methane content of biogas during Phase c was similar to Phase b as 58.5%. 
The reactor was operated with 3 mg/L o TET from 115
th
 day to 143
rd
 day and this 
concentration was significantly affected to reactor performance (P<0.001). The COD 
removal efficiency and daily produced biogas decreased dramatically in a stepwise 
manner from 96.4% and 853 mL to 9.1% and 71 mL, respectively. The average 
specific methane production decreased also 0.23 L CH4/g COD_removed in TET 
reactor. 
At the end of Phase d, TET addition was stopped to the reactor to recover the 
performance again, but the COD removal efficiency and biogas production couldn‘t 
be increased again and the reactor operation was ended on day 154 (Phase e). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.61: Performance of Control and TET reactors in terms of biogas production 
and COD removal efficiency (Phase a: 0 mg/L TET, Phase b: 1 mg/L 
TET, Phase c: 2 mg/L TET. 
A limited study about effect of TET on anaerobic wastewater treatment systems in 
the literature was found. The compound and its derivates are commonly used as 
promotor in animal growth, so most of the studies have focused on the anaerobic 
digestion of manure, which contains this compound (Masse et al., 2000; Arikan et al, 
2006; Arikan et al., 2007; Arikan 2008; Stone et al., 2009; Wu et al., 2011; Shi et 
                    a           b          c              d                    e 
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al., 2011; Hu et al., 2011). However the result of those studies are different from the 
results obtained from this study. Masse et al. (2000) operated psychrophilic ASBR 
treating swine manure and they mentioned that 25% removal efficiency in TET was 
achieved and any significant inhibition was not detected in the system as well on 21 
g/L of TET. In another study, the fate and effect of oxytetracycline, which is an 
antibiotic from tetracycline group, on anaerobic digestion of manure was focused 
(Arikan et al., 2006), this compound was degraded biologically under mesophilic 
conditions and converted to transformation products. Also the concentration of those 
transformation products was decreased by the time. The author indicated that 27% 
biogas production was decreased with 22 mg/kg/day. Stone et al. (2009) mentioned 
that 28 mg/L of chlortetracycline inhibited the methane production as approx 28% in 
an anaerobic reactor digesting manure. 70% of tetracycline was degraded by 
biologically in a pilot scale anaerobic digestor composting swine manure (Wu et al., 
2011). The author explained that TET was also converted to transformation products 
and also they were degraded in the reactor as mentioned before by Arikan et al. 
(2006). Wu and his colleagues did nit mention any inhibition in the system. In 
another study, no influence of TET on composting was detected while the compound 
was biologically degraded more than 93% (Hu et al., 2011). 
Contrary of the knowledge obtained from literature, TET inhibited the anaerobic 
reactor treating wastewater even lower concentration as 3 mg/L in this study. This 
compound also considered being non-biodegradable under anaerobic conditions in 
wastewater treatment systems (Gartiser et al., 2007). However, it should be taken 
consider that TET has an unstable character because of its unique chemical structure 
and may withstand abiotic degradation with different environmental conditions such 
as pH, temperature or chemical oxidation and photolytic reactions and then it is 
converted to transformation products (Kuhne et al., 2001; Halling-Sorenson et al., 
2003). 
Additionally, a few studies have been focused on the effect of TET on activated 
sludge systems. They indicated that TET is non-biodegradable and non-toxic under 
aerobic conditions up to 40 mg/L TOC, it inclines to sorption into sludge (Prado et 
al., 2009a and b). This discrepancy between literature and this study can be 
explained by specific experimental conditions such as SRT, temperature variations, 
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ions and salinity, the different waste typed should be taken into consideration (Cirja 
et al., 2008).  
4.4.3.2 Volatile fatty acids 
No VFA in the effluent was detected until Phase d like the ERY reactor explained in 
Section 6.4.2. Differently from SMX and ERY reactors, not only propionic acid but 
also acetic acid utilization pathway was inhibited by TET. At the first day (on day 
116) after TET concentration was increased to 3 mg/L, acetic acid and propionic acid 
accumulation started as 27 and 28 mg/L, respectively. Acetic acid concentration in 
the effluent increased to 110 mg/L at the end of Phase d and reached to 457 mg/L at 
the end of the operation, Phase e.  
 
Propionic acid accumulation has also similar trend however, the concentration was 
higher than acetic acid. Its concentration was measured as 750 mg/L at the end of 
Phase d. However propionic acid concentration decreased in the Phase d and it was 
detected as 385 mg/L at the end of operation.  
Also butyric and valeric acids were observed in the effluent of the TET reactor at 
Phase d and e. While butyric acid concentration varied between 4 and 20 mg/L, 
valeric acid concentration increased from 14 mg/L to 70 mg/L slowly until the end of 
operation.  
A clear effect of TET on acetoclastic methanogens, which utilize acetate to produce 
methane, was observed in the VFA results. Specifically TET ceases aminoacyl-tRNA 
interaction with acceptor site on the mRNA-ribosome complex to inhibit the protein 
synthesis via binding ribosome of bacteria (Chopra and Robertes, 2001; Loftin et al., 
2005). So the direct effect of TET would not expected. However, Sanz et al. (1996) 
indicated that chlortetracycline, which is an antibiotic from the same group of TET, 
inhibited acetoclastic methanogens and was considered a potential inhibitor of 
archaea. Furthermore, Stone et al. (2009) speculated that chlortetracycline might 
have contributed to inhibition of acetoclastic methanogens. In the same study, the 
VFA concentration during the operation of anaerobic digestor increased.  
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4.4.3.3 Antibiotic measurement 
As seen in Figure 4.62, sorption of TET increased with operation time and TET 
concnetration in the influent. Also COD removal efficiency of the reactor decreased 
with respect to time and TET concentration. However TET was removed in the 
system in early phases, even though it mentioned that TET is not biodegradable 
under anaerobic conditions (Gartiser et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.62: Antibiotic measurement results of TET reactor 
4.4.3.4 Specific methanogenic activity tests 
To evaluate long-term effect of TET on different trophic group, specific 
methanogenic activity (SMA) test was performed with only acetate and acetate-
butyrate-propionate mixture.  
Utilization of acetate 
To determine TET effect on acetoclastic metahogenic activity, SMA test was 
performed with sludges taken from different operation phases of the TET reactor. 
Acetate was used as sole carbon sources. CBP and CMP profiles obtained from the 
SMA test are given in Figure 4.63. CMP value of the seed sludge was determined as 
77 mL. As seen Figure 6b, there was a decrease in CMP values even in 1 mg/L TET 
fed sludge and detected as 55 mL. Approximately 30% reduction was occurred after 
TET addition (Phase b). While a gradually reduction on CBP and CMP values was 
occurred during operation with respect to TET concentration, they increase after TET 
addition was stopped at Phase e. CBP values were determined as 86 and 80 mg/L at 
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Phase b and c, respectively. A dramatic decrease was observed in CBP, thereby 
CMP; at Phase d. CBP was reduced more than 50% and detected as 41 mL at Phase 
d. However, after TET addition in the reactor was stooped, the activity of the sludge 
increased as 69 mL of CBP (Phase e).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.63: Specific methanogenic activity (SMA) test using 4000 mg/L of acetate 
(a) cumulative biogas production profiles (b) cumulative methane 
production. 
The methane content of the biogas was also decreased gradually depending on TET 
concentration. While the methane percent was 65%, 60% and 58% at Phase b, c and 
d, respectively, the value increased to 63% again at Phase e, in which TET addition 
was terminated.  
The SMA results, except for Phase e, supported the reactor performance and VFA 
data obtained from TET added ASBR. Also, the reactor efficiency decreased 
a 
b 
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gradually with TET concentration and 3 mg/L of TET addition was almost 
terminated the COD removal. VFA analysis reflected that fatty acid accumulation, 
especially acetate, was started in the beginning of Phase d. Also anaerobic digestor 
studies in the literature mention that tetracycline group antibiotics inhibit acetoclastic 
methanogens (Sanz et al., 1996; Stone et al., 2009).  
The results obtained from this study also showed inhibitory affect of TET on 
acetoclastic methanogenic activity. Even the increase in CBP and CMP values of 
sludge from Phase e is a proof to reflect that while TET addition is stopped, 
acetoclastic methanogens can recover themselves. The differences between the 
reactor operation and SMA test in Phase e may be explained that SMA test focused 
only acetoclastic activity. However, all syntrophic groups in terms of bacterial and 
archaeal species were evaluated together.  
Utilization of VFA Mixture 
To evaluate the TET effect on homoacetogens and all methanogens, SMA test was 
performed with VFA mixture. The CBP and CMP profiles of SMA test are given in 
Figure 4.64. Even 1 mg/L of TET addition to the ASBR was affected utilization 
capacity of VFA. While CMP value of the seed sludge for utilization of VFA was 
315 mL, the values dramatically decreased to 93 mL (70% reduction). The decrease 
continued until the Phase e and CBP and CMP values of the sludge taken from Phase 
d were 29 mL and 14 mL, respectively. The results were supported to the TET 
reactor data, which almost ceased at the end of Phase d. Contrary of the ERY reactor, 
the VFA utilization activity increased to 105 mL of CBP after TET addition was 
terminated at Phase e. The results were indicated that TET also inhibited the bacterial 
group as expected. In all SMA test tubes, methane content of biogas was same as 
50%.  
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Figure 4.64: Specific methanogenic activity (SMA) test using 3000 mg/L of VFAs 
(a) cumulative biogas production profiles (b) cumulative methane production. 
4.4.3.5 Microbiological approach 
Molecular tools based on 16S rDNA and 16S rRNA were used to find out the effects 
of TET on existing and active microorganisms, relatively. In this scope, genomic 
DNAs and total RNAs were extracted from the samples collected form different 
phases of the TET reactor and RNAs were converted to cDNAs by reverse 
transcriptase PCR (RT-PCR). Amplicons were obtained using 16S rRNA gene 
spesific primers for further analysis on DGGE. Furthermore, GDNAs and cDNA 
were used to quantify total bacteria, archaea and methanoges by Q-PCR. 
Predominant bands in the DGGE patterns 
To find out the microorganisms having role on the TET reactor, predominant 
bacterial and archaeal 16S rDNA/rRNA band patterns of the different phases of TET 
reactor were compared to 16S rDNA clone libraries of the seed sludge. The reason to 
use both 16S rDNA and 16S rRNA is evaluation of the existing and active species in 
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the system, respectively. Also their abundance was evaluated according to intensity 
of each band on DGGE gel because the intensity of the bands might correspond at 
least semiquantitatively with the abundance of the corresponding species (Heuer et 
al., 1997). The comparison results of bacterial and archaeal 16S rDNA DGGE band 
patterns were given in Table 4.17 and 6.18, respectively. 
According to comparison results to 16S rDNA clone library, 12 of bacterial OTUs 
from bacterial DGGE profile of the TET reactor matched to the library OTUs. 3 
uncultured Clostridium clones (FR836437, FR836438 and FR836443) were detected 
in the TET reactor at different phases. While all of them existed at Phase b and c, the 
clone with accession number as FR836443 was detected at the last Phase e_2. 
Clostridium spp. have the important role both the fermentation of starch and also 
production of volatile fatty acids by β-oxidation pathway (Hungate, 1982; Payton 
and Haddock, 1986). Also, Paludibacter propionicigenes (AB078842), which is 
responsible to produce propionate, was detected at Phase b, c and e. So, the results 
are not surprise for this system fed by a synthetic wastewater including starch and 
glucose. At last three phases, Uncultured Syntrophomonas clone, which is probably 
responsible to degrade the long-chain fatty acids, were made out (Sousa et al., 2007). 
Other OTUs detected in the samples almost belong to the uncultured clones or 
unclassfied bacterial cultured species. 
The comparison results of the archaeal 16S rDNA DGGE band patterns and the 
clone library is given in Table 4.18. 13 of archaeal OTUs in the DGGE profiles of 
TET reactor were matched to 16S rDNA archaeal clone library. According to results, 
acetoclastic methanogen species (FR836463, FR836468, U89773) existed in the 
system. Hydrogenotrophic methanogens were observed in different phases, however 
their abundance was less existing of Methanobacterium beijingense strain 8-2 
(AY350742). This hydrogenotrophic specie was detected with uncultured 
Methanosphaerula clone (FR836467). 
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Table 4.17: Affiliation of bacterial clones and their abundance at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96       
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96       
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 • •     
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 ••      
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone QEDS2BE07 
(CU921543) 
93      •• 
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone 
QEDN7DC08 (CU926749) 
97 •• •  • • • 
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98  ••     
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89    • • • 
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96 • •    • 
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91       
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95       
 
 
 
 
161 
Table 4.17 (continued): Affiliation of bacterial clones and their abundance at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase 
b 
Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 • • 
  
• 
 
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 8SN 
(EU887773) 
92 
      
B14 5.61 FR836448 
Uncultured bacterium clone 
BS1_25R (GQ458208) 
97 
      
B15 2.8 FR836449 
Uncultured bacterium clone 
aaa97f10 (DQ816701) 
96 
      
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96 
      
B17 2.8 FR836451 
Uncultured Sarcina sp. clone 
JPL-2_O10 (FJ957591) 
89 
 
•• 
    
B18 0.93 FR836452 
Uncultured bacterium clone 
30c07 (EF515566) 
87 
      
B19 0.93 FR836453 
Paludibacter propionicigenes 
(AB078842) 
92 • • 
  
• • 
B20 0.93 FR836454 
Bacterium 061128-OL-KR37-
AA 3-0 10000x -1A 
(FJ037613) 
92 
 
• 
    
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 (AB298766) 
99 
      
B22 1.87 FR836458 
Uncultured bacterium clone 
D14R15C96 (FM956760) 
98   •       • 
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Table 4.18: Affiliation of archaeal clones and their abundance at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94       
A2 2.90 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98   •• ••   
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95 •••• •••• •••• ••• •••• •• 
A4 2.90  
Methanobacterium formicicum 
strain S1 (DQ649309) 
99       
A5 2.90 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 (AB077214) 
98       
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98  ••   •• • 
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97    ••   
A8 0.72  
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99       
A9 7.25  
Methanospirillum hungatei 
(M60880) 
99       
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97       
A11 6.52 FR836467 
Methanosphaerula palustris strain 
E1-9c (EU156000) 
95  •• ••• •••   
A12 0.72  
Methanobacterium sp. OM15 
(AJ550160) 
99       
A13 2.17  
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 ••  ••• ••• •• •• 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95 •• •• ••• •••  •• 
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Table 4.18 (continued): Affiliation of archaeal clones and their abundance at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 
    
••• 
 
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 
 
•• 
 
••• •••• •• 
A17 9.42 FR836472 
Methanogenic archaeon Prasan1 
(HM630570) 
97 
  
•• ••• 
 
•• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 
  
•• 
  
•• 
A19 2.17 
 
Methanosarcina siciliae (U89773) 99 •• 
 
•• •• ••• •• 
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
      
A21 1.45 FR836474 
Uncultured archaeon clone OKA6 
(GQ465437) 
97 
      
A22 1.45 
 
Uncultured archaeon clone ATB-
KM-2942-A18 (EF680353) 
99 
      
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 •• ••• ••• ••• •• •• 
A24 2.17 
 
Uncultured archaeon clone WA10 
(AB494239) 
99 
      
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95             
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To find out the active OTUs and their changes in the TET reactor with respect to antibiotic 
concentration and operation time, the PCR amplicons obtained from cDNAs of 16S rRNA 
were compared to bacterial and archaeal 16S rDNA clone libraries constructed from the 
seed sludge. The comparison results are represented in Table 4.19 and 6.20, respectively. 
13 of the bacterial OTUs were detected in the 16S rRNA DGGE profiles. However, 2 of 
these OTUs (FR836444 and FR836448) were not the same with 16S rDNA DGGE 
comparison which is given in Table 4.17. According to 16S rRNA DGGE results, 3 of the 
uncultured Clostridum species (FR836437, FR836438 and FR836443) were detetcted in 
the TET fed system. However only FR836443 was detetcted at the last phase. The other 
two uncultured Clostridium clones were only observed in the Phase b, c and d_1 and also 
their abundance was getting lower. Clostidium species converte carbonhydrates to VFAs 
by fermentation and also β-oxidation process (Hungate, 1982; Payton and Haddock, 
1986). These finding supported the reactor results which the COD removal efficiency 
decreased with respect to the antibiotic concentration and the reactor performance could 
not be recovered even TET addition was stopped. Addition of Clostridum spcies, 
Uncultured Syntrophomonas clone (FR836442) was only onserve at Phase d_2, while it 
was detected at Phase d_2, e_1 and e_2 by 16S rDNA level. Uncultured Paludibacter 
clone (FR836453), which is responsible to propionate production, was detected only at 
Phase e_1. Other detected bacterial clones were mostly uncultured species. These 
uncultured bacterial clones may probably be species responsible to fermentation and 
homoacetogenesis, especieally VFA-oxidizing syntrophs (Speece, 1996; Madigan et al., 
2009). In the archaeal 16S rRNA DGGE profiles, hydrogenotrophic OTUs (FR836465, 
FR836467, FR836473, AJ550160, AY350742) were dominant mostly each step, 
acetoclastic methanogenic OTUs (FR836468 and U89773) were observed only at Phase e. 
While acetoclastic methanogens are capable of growth under low acetate concentration bu 
have a high affinity for acetate (Jetten et al., 1992), their abundance and especialy decrease 
with respect to time and TET concentration. Stone et al. (2009) showed that acetoclastic 
methanogens were affected by chlortetracycline during anaerobic swine manure digestion. 
The authors also mentioned that activity and abundance of hydrogenotrophic species 
increased. The results indicated that hydrogenotrophic methanogens were not inhibited by 
TET even in the last phase. However VFA and SMA test results reflected there was a 
general inhibition in the system without recovering system perfomance even if antibiotic 
addition was stopped. 
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Table 4.19: Affiliation of bacterial clones and their abundance within the active community at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B1 2.80 FR836435 
Clostridium sp. BG-C66 
(FJ384378) 
96       
B2 0.93 FR836436 
Clostridium sp. Kas301-1 
(AB114242) 
96       
B3 1.87 FR836437 
Clostridium intestinale 
(AM158323) 
95 ••••      
B4 4.67 FR836438 
Uncultured Clostridium sp. 
clone AUCLO214 
(AY648564) 
96 •• •••• ••    
B5 1.87 FR836439 
Uncultured Firmicutes 
bacterium clone QEDS2BE07 
(CU921543) 
93       
B6 2.80 FR836440 
Uncultured Firmicutes 
bacterium clone 
QEDN7DC08 (CU926749) 
97 •• •• •• •• • • 
B7 14.95 FR836441 
Uncultured bacterium clone 
BS7_65 (GQ458219) 
98 •••••••     • 
B8 3.74 FR836442 
Syntrophomonas zehnderi 
strain OL-4 (DQ898277) 
89    •   
B9 33.64 FR836443 
Clostridium sp. Kas107-1 
(AB114241) 
96      • 
B10 5.61 FR836444 
Uncultured bacterium clone 
C3-25 (AM181973) 
91   •• •  • 
B11 4.67 FR836445 
Bacterium CBIC19I3 
(HM240274) 
95       
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Table 4.19 (continued): Affiliation of bacterial clones and their abundance within the active community at the different phases of the TET 
reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase 
b 
Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
B12 3.74 FR836446 
Uncultured bacterium 
UASB_TL84 (AF254390) 
94 
   
•• • • 
B13 0.93 FR836447 
Uncultured Candidatus 
Cloacamonas sp. clone 8SN 
(EU887773) 
92 
      
B14 5.61 FR836448 
Uncultured bacterium clone 
BS1_25R (GQ458208) 
97 
 
•••• ••• •• • • 
B15 2.8 FR836449 
Uncultured bacterium clone 
aaa97f10 (DQ816701) 
96 
      
B16 0.93 FR836450 
Acinetobacter sp. 1B3 
(EU337120) 
96 
      
B17 2.8 FR836451 
Uncultured Sarcina sp. clone 
JPL-2_O10 (FJ957591) 
89 
   
•• 
  
B18 0.93 FR836452 
Uncultured bacterium clone 
30c07 (EF515566) 
87 
      
B19 0.93 FR836453 
Paludibacter propionicigenes 
(AB078842) 
92 
    
• 
 
B20 0.93 FR836454 
Bacterium 061128-OL-KR37-
AA 3-0 10000x -1A 
(FJ037613) 
92 
   
• 
  
B21 0.93 - 
Propionibacteriaceae 
bacterium FH044 (AB298766) 
99 
      
B22 1.87 FR836458 
Uncultured bacterium clone 
D14R15C96 (FM956760) 
98     •••       
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Table 4.20: Affiliation of archaeal clones and their abundance within the active community at the different phases of the TET reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A1 1.45 FR836460 
Uncultured archaeon clone OK3 
(GQ406364) 
94 ••••   ••   
A2 2.90 FR836461 
Uncultured archaeon clone 
I17_Rya (HM639831) 
98    ••   
A3 9.42 FR836462 
Methanogenic euryarchaeote 
Annu4 (FJ896263) 
95     ••• •••• 
A4 2.90  
Methanobacterium formicicum 
strain S1 (DQ649309) 
99       
A5 2.90 FR836464 
Uncultured Methanosarcinales 
archaeon clone:KuA4 (AB077214) 
98       
A6 4.35 FR836470 
Uncultured euryarchaeote clone 
MVP-8A-21 (DQ676281) 
98       
A7 12.32 FR836463 
Methanothrix soehngenii 
(X51423) 
97       
A8 0.72  
Uncultured archaeon clone 
A6T20L208 (DQ262482) 
99       
A9 7.25  
Methanospirillum hungatei 
(M60880) 
99       
A10 0.72 FR836465 
Methanobacterium beijingense 
strain M4 (EU544027) 
97 ••••••• •••••••• •••• ••••••   
A11 6.52 FR836467 
Methanosphaerula palustris strain 
E1-9c (EU156000) 
95  ••••• •••••    
A12 0.72  
Methanobacterium sp. OM15 
(AJ550160) 
99  •••  ••   
A13 2.17  
Methanobacterium beijingense 
strain 8-2 (AY350742) 
100 ••••• ••••• •••• ••••• ••••••••• •••••••• 
A14 3.62 FR836468 
Uncultured Methanosarcinales 
archaeon clone S4 (GU475184) 
95     •••••  
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Table 4.20 (continued): Affiliation of archaeal clones and their abundance within the active community at the different phases of the TET 
reactor. 
Clone 
Clone 
Frequency 
(%) 
Accession 
No (This 
study) 
Closest Relative 
Similarity 
(%) 
Phase b Phase c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
A15 2.9 FR836469 
Uncultured archaeon clone Sed-
ARC-34 (EU255763) 
98 ••• 
   
••• ••• 
A16 3.62 FR836471 
Uncultured euryarchaeote clone 
MVP-8A-26 (DQ676246) 
96 
 
••• ••• •• 
  
A17 9.42 FR836472 
Methanogenic archaeon Prasan1 
(HM630570) 
97 •••• •••• ••• ••• ••••••• ••••• 
A18 7.25 FR836473 
Methanobacterium beijingense 
strain 4-1 (AY552778) 
96 •••• ••••• ••• •••• •••••• ••••••• 
A19 2.17 
 
Methanosarcina siciliae (U89773) 99 
     
••••• 
A20 4.35 
 
Uncultured archaeon clone 
EOTU21 (FJ896263) 
99 
      
A21 1.45 FR836474 
Uncultured archaeon clone OKA6 
(GQ465437) 
97 
   
•• 
 
••• 
A22 1.45 
 
Uncultured archaeon clone ATB-
KM-2942-A18 (EF680353) 
99 
      
A23 6.52 
 
Archaeon LL25A3 (AJ745135) 99 ••••• ••••• •••• ••• ••••• •••••• 
A24 2.17 
 
Uncultured archaeon clone WA10 
(AB494239) 
99 
      
A25 0.72 FR836475 
Methanogenic euryarchaeote 
Annu1 (HM630571) 
95             
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Cluster analysis of DGGE banding pattern 
DGGE technique was used in this study to assess the stability and/or change in 
microbial community and active species at different phases of the TET reactor. A 
total of seven sludge samples collected from different phases of the reactor were 
compared in terms of bacterial and archaeal communities: The seed sludge of the 
chronic reactors and the sludges collected from different phases of the TET reactor. 
Result of DGGE analysis suggested that bacterial community was respectively, more 
diverse than archaeal diversity in the reactor as found in sludge of SMX and ERY 
reactors; 62 bacterial and 46 archaeal bands were remarked in the TET reactor 
samples.  
Bacterial and archaeal diversities and species richness in seed sludge and sludges 
obtained from the TET reactor were measured by the Shannon-Weaver diversity 
index and Margalef‘s species richness, respectively. The values were given in Table 
4.21 and 6.22.  
In seed sludge, while 33 of different bacterial species were detected, this number 
decreased to 19 at Phase b, in which 1 mg/L of TET was fed to system, as seen in 
Table 4.21. While, at Phase c, the number increased to 38 because of presumptive 
acclimation, it decreased to 12 dramatically when TET concentration was increased 
to 3 mg/L. As discussed in the reactor operation section, 4.4.3.1, the reactor 
performance also decreased in this period, Phase d. At the end of the operation, the 
bacterial OTUs reached to 23 despite the reactor efficiency was near to zero. Also 
situation of the archaeal OTUS was similar to bacterial profile. In the first TET 
addition period, the number decreased from 13 to 7. After a probable acclimation 
period, the archaeal OTU number increased to 16. At the end of the operation, a 
slight change was observed in the archaeal species number as 13.  
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Table 4.21: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for bacterial DGGE profiles of sludges 
taken from different phases of the TET reactor. 
  
Seed_Chronic 
Reactors 
Phase 
b 
Phase 
c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
Taxa 33 19 38 12 15 20 23 
Shannon-
Weaver 
diversity 
3.449 2.802 3.504 2.449 2.65 2.736 3.055 
Evenness 0.9537 0.8671 0.8747 0.9645 0.9433 0.7711 0.9222 
Margalef's 
richness 
4.954 3.03 5.535 2.17 2.574 2.996 3.686 
Table 4.22: Shannon-Weaver diversity indices, Margalef‘s species richness measure, 
and eveness measure estimates for archaeal DGGE profiles of sludges 
taken from different phases of the TET reactor. 
  
Seed_Chronic 
Reactors 
Phase 
b 
Phase 
c 
Phase 
d_1 
Phase 
d_2 
Phase 
e_1 
Phase 
e_2 
Taxa 13 7 11 15 16 13 13 
Shannon-
Weaver 
diversity 
2.526 1.895 2.359 2.67 2.748 2.474 2.539 
Evenness 0.962 0.9499 0.9619 0.9628 0.9757 0.9132 0.974 
Margalef's 
richness 
1.901 1.038 1.589 2.12 2.211 1.776 1.953 
Pearson product-moment correlation coefficients with UPGMA clustering were used 
to quantify the similarity of the community fingerprints between each sample. The 
bacterial and archaeal 16S rDNA phylogenetic trees obtained from TET reactor with 
seed sludge sample were given in Figure 4.65 and 4.66, respectively.  
DGGE analysis found out that bacterial and archaeal differentiation in TET samples 
occurred according to TET concentration in the reactor and the operation time. 
The changes in bacterial community during the operation reflect the clusters obtained 
from DGGE band patterns, which were divided into two clusters. The clusters were 
defined by less than 60% pattern similarity. One of them included seed sludge, Phase 
b, c and e_2. This cluster also divided sub-clusters. Seed sludge belonged to one sub-
cluster as solo and it was similar to Phase b, c and e_2 samples as 68.3%, 78.4%, and 
62.2%, respectively. 
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Phase d_1, d_2 and e_1 also belonged to the second cluster. This cluster also divided 
into two sub-clusters based on their population origin, which were defined by a 
similarity pattern varied between 88.9% and 97.6%. As seen in Figure 4.65, while 
the pattern similarity of the samples belonging to second cluster did not change very 
distinctly, the distance between the first cluster samples were higher. It was clear that 
a shift in the bacterial community profile occurred during the operation time. After 
the reactor operated with 3 mg/L of TET, the bacterial community was changed. 
Also in the beginning of Phase e, in which TET addition was terminated, the 
bacterial community was similar to Phase d. However at the end of the operation 
(Phase e_2), the bacterial community was similar to Phase c as 84.4% as seen in the 
Figure 4.62. The bacterial community profile of TET samples was similar to ERY 
bacterial DGGE profile. 
 
Figure 4.65: Cluster analysis and similarity matrix of bacterial 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
Archaeal cluster analysis obtained from DGGE banding pattern was different form 
bacterial cluster analysis of the TET reactor. The archaeal banding patters revealed 
two main clusters defined by less than 55% similarity (Figure 4.66). In one of these 
clusters, samples of the seed sludge and Phase b were defined. They were the most 
similar to Phase e_2 sample as 49.6% and 67.1%, respectively. The second cluster 
also divided into two sub-clusters. One of them included only Phase e_2 and the this 
sample was the most closest to Phase c by the similarity as 67.8%. The second sub-
cluster divided more sub-clusters. Phase c, d_1, d_2 and e_1 samples belonged to 
this cluster and their similarity varied between 76.8% and 93.8%. Differently from 
the bacterial dendogram, the archaeal pattern similarity of the samples changed more 
distinctly. 
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Figure 4.66: Cluster analysis and similarity matrix of archaeal 16S rDNA gene 
DGGE banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
DGGE analysis was performed with 16S rRNA amplicon obtained from cDNAs of 
the sludge samples to reveal the active community changes in the TET reactor during 
the operation. The bacterial and archaeal dendograms reflecting the active 
community change are given in Figure 4.67 and 4.68, respectively. 
The bacterial band patterns obtained from 16S rRNA gave slightly different result 
from 16S rDNA band patterns. As seen in the bacterial 16S rDNA dendogram, two 
main clusters defined by less than 80% similarity. One of these clusters included 
only Phase b sample, which differentiated from other samples obviously. The closest 
samples to Phase b was surprisingly Phase d_2 sample by a similarity as 74.3%. The 
second cluster also divided into two sub-clusters. One of the sub-clusters included 
Phase c and d_1 samples, which were define a similarity 94.0%. The second sub-
cluster also divided into two more clusters. While Phase d_2 sample was represented 
in one of these sub-clusters, Phase e_1 and e_2 samples were placed in the second 
one and defined a similarity each other as 93%. 
 
Figure 4.67: Cluster analysis and similarity matrix of bacterial 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
In the archaeal phylogenetic tree of 16S rRNA, the dendogram structures and 
similarities were different from the dendogram of archaeal 16S rDNA. As seen in 
Figure 4.65, the distribution of the active archaeal community reflected the clusters, 
which were divided into two sub-clusters like dendogram of 16S rDNA. The 
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similarity of the clusters defined lees tan 80%. One of these clusters included only 
Phase e samples, e_1 and e_2, which were defined by a similarity as 91.9%. The 
second sub-cluster also divided into clusters in which b, c, d_1 and d_2 samples were 
defined with a similarity varied from 84.7% to 97.3%.  
 
Figure 4.68: Cluster analysis and similarity matrix of archaeal 16S rRNA DGGE 
banding patterns based on Pearson product-moment correlation 
coefficients and UPGMA. 
As seen in the results obtained from cluster analysis; 
1- Similarities in the 16S rDNA dendograms were more distinct from 16S rRNA 
results.  
2- The cluster analysis reflected to effect of TET concentration within the 
system and operation time. 
3- 16S RNA DGGE dendogram showed that TET effect on the archaeal 
community at the end of the operation. 
Environmental conditions and toxic compound loadings to ecosystems are the 
important reason of shift in the microbial community (Eichner et al., 1999; LaPara et 
al., 2001). Also it was found that the flexibility of microbial community leads to 
more stable reactor operation (Fernandez et al., 2006). However compared the 
microbiological data with reactor efficiency, the change in the microbial community 
was not enough to continue reactor stability in this study.  
Quantification by Q-PCR 
Quantitative changes of 16S rDNA and 16S rRNA concentrations in terms of 
bacteria, archaea and methanogens were also determined by Q-PCR during operation 
time of the TET reactor. The concentration profiles showed the temporal variations 
in the microbial community and the active population at different phases of the TET 
reactor as given in Figure 4.69-4.74.  
While bacterial 16S rDNA concentration decreased at Phase b compared to seed 
sludge and reached to 1.3 X 10
8
 copies/mL, the bacterial amount increased to 3.4 X 
Pearson correlation (Opt:0.70%) [0.0%-100.0%]
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10
10
 copies/mL (approx. 260 fold) at Phase c, in which TET concentration was 2 
mg/L in the system. The concentration of bacteria at Phase e_2, in which the TET 
addition was terminated, was found as 1.5 X 10
10
 copies/mL. Bacterial change 
during the operation of the TET reactor was not remarkable. Also similar trend was 
observed in archaeal and methanogenic community changes. There was an increase 
in Phase c. While archaeal community was detected as 4.0 X 10
6
 copies/mL, 9.0 X 
10
6
 copies/mL and 8.1 X 10
8
 copies/mL at the seed sludge, Phase b and c, 
respectively, methanogenic community was quantified as 1.0 X 10
7
 copies/mL, 1.2 X 
10
6
 copies/mL and 5.6 X 10
9
 copies/mL at the seed sludge, Phase b and c, 
respectively. As seen in Figure 4.70 and 4.71, archaeal and methanogenic 
communities were accounted as 1.5 X 10
9
 copies/mL and 1.1 X 10
8
 copies/mL, 
respectively, at the end of the operation. 
 
 
Figure 4.69: Quantitative changes in bacterial 16S rDNA concentrations at different 
phases of the TET reactor. 
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Figure 4.70: Quantitative changes in archaeal 16S rDNA concentrations at different 
phases of the TET reactor. 
 
Figure 4.71: Quantitative changes in methanogenic 16S rDNA concentrations at 
different phases of the TET reactor. 
Besides quantification of 16S rDNA concentration, 16S rRNAs were quantified to 
determine the effects of TET on the active microbial groups. 16S rRNA 
quantification results of bacteria, archaea and methanogens were given in Figure 
4.69-6.71, respectively. Bacterial 16S rRNA expression level increased from 1.4 X 
10
11
 copies/mL (Phase b) to 4.0 X 10
11
 copies/mL (Phase d_2). A slight decrease at 
Phase c was detected as 4.2 X 10
10
 copies/mL. Bacterial 16S rRNA quantification 
results could not reflect the reactor performance. While 16S rRNA expression level 
of archaea had a similar trend to bacterial one, effect of TET on active methanogenic 
1,0,E+00
1,0,E+01
1,0,E+02
1,0,E+03
1,0,E+04
1,0,E+05
1,0,E+06
1,0,E+07
1,0,E+08
1,0,E+09
1,0,E+10
1
6
S
 r
D
N
A
 (
co
p
ie
s/
m
L
)
1,0,E+00
1,0,E+01
1,0,E+02
1,0,E+03
1,0,E+04
1,0,E+05
1,0,E+06
1,0,E+07
1,0,E+08
1,0,E+09
1,0,E+10
1
6
S
 r
D
N
A
 (
co
p
ie
s/
m
L
)
 176 
community was more noticeable when compared to change between Phase b and e_2 
(35% reduction). However none of these results could not shoew the rwactor 
performance and SMA results. 
 
Figure 4.72: Quantitative changes in bacterial 16S rRNA concentrations at different 
phases of the TET reactor. 
 
Figure 4.73: Quantitative changes in archaeal 16S rRNA concentrations at different 
phases of the TET reactor. 
 
 
1,E+00
1,E+01
1,E+02
1,E+03
1,E+04
1,E+05
1,E+06
1,E+07
1,E+08
1,E+09
1,E+10
1,E+11
1,E+12
1,E+13
Phase b Phase c Phase d_1 Phase d_2 Phase e_1 Phase e_2
1
6
S
 r
R
N
A
 (
co
p
ie
s/
m
L
)
1,E+00
1,E+01
1,E+02
1,E+03
1,E+04
1,E+05
1,E+06
1,E+07
1,E+08
1,E+09
1,E+10
1,E+11
1,E+12
Phase b Phase c Phase d_1 Phase d_2 Phase e_1 Phase e_2
1
6
S
 r
R
N
A
 (
co
p
ie
s/
m
L
)
 
177 
 
Figure 4.74: Quantitative changes in methanogenic 16S rRNA concentrations at 
different phases of the TET reactor. 
Enzyme Expression 
To detect the inhibition effect of TET on the anaerobic pathways, three enzymes 
were selected from the different metabolic pathways of the anaerobic degradation 
and quantified their expression level based on mRNA method. 
Formylterahydrofolate synthetase (FTHFS), methyl-coenzyme M reductase (mcrA) 
and acetyl-coA synthetase (ACAS) were selected to determine the inhibition on 
homoacetogenesis, methanogenesis and specifically acetoclastic methanogenesis, 
respectively.  
Despite acetate and other VFAs were not observed in effluent and active 
methanogenic species were detected in the system at the Phase b and c, FTHFS 
expression was surprisingly not observed in the mRNA level during all operation 
time.  
Expression of mcrA gene was not detected at Phase e of the TET as seen in Figure 
4.75. The expression level of mcrA gene in the TET reactor decreased from 3 X 10
5
 
and 5 X 10
4
 copies/mL while TET concentration was increased from 1 mg/L to 3 
mg/L. After TET addition was stopped to the reactor, no mRNA encoded by mcrA 
gene was detected at Phase e. Also reactor performance data and SMA test results 
supported this situation. 
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Figure 4.75: Quantitative changes in methyl-coenzyme M reductase expression level 
at different phases of the TET reactor. 
ACAS gene expression results are given in Figure 4.76. ACAS was detected only at 
Phase b, c, and d_1 and also the expression level decreased gradually whereas TET 
concentration was increased from 1 mg/L to 3 mg/L. Similar to SMX and ERY 
results, the expression level of ACAS was higher than mcrA during all operation of 
the TET reactor. Also in the SMA test results showed that acetoclastic activity 
decreased during the operation time. 
 
Figure 4.76: Quantitative changes in acetyl-coA synthetase expression level at 
different phases of the TET reactor. 
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5. CONCLUSION AND RECOMMENDATIONS 
In the scope of this dissertation, acute and chronic effects of three selected antibiotics 
on anaerobic treatment in terms of conventional parameters and microbial 
community were studied. As a results of this study, the following highligted items 
were obtained: 
- This study reflected that the sludge tolarated higher antibiotic concentration 
in the short-terms studies. The significant short term inhibitory effect was 
started after 50 mg/L and the metabolic activity completely stopped after 500 
mg/L of the antibiotic addition. 
- Short-term inhibitory effect of TET was more different than SMX and ERY. 
While VFA accumulation in the SMX and ERY bottles started after 250 
mg/L of the antibiotic, it observed in TET bottles after 25 mg/L.  
- In the acetate fed acute test bottles, while no aceteta was detected in any 
effluent, the methane production decreased with respect to the antibiotic 
concentration. It was speculated that antibiotics could bind the acetate and 
this complex was sorped to the sludge.  
Also in the chronic test, the results obtained from the ASBRs which were fed by 
different antibotic compounds reflects that the inhibitory effects of these compound 
were conflicting in the long term operation: 
- SMX was fed up to 45 mg/L with synthetic wastewater and then the reactor 
collapsed. VFA accumulation in the SMX reactor started after 35 mg/L of the 
compound addition in terms of propionic acid and acetic acid. Contrary of the 
reactor operation data, specific methanogenic activity increased with respect 
to the SMX concentration and it reached to the maximum value at the end of 
the operation. 
- ERY concentration was increased to 3 mg/L in the ASBR and then the 
reactor performance desreased dramatically. Even ERY addition was stopped, 
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the reactor performance couldn‘t recover again. While propionic acid 
accumulation started after 3 mg/L of ERY, acetic acid was detected in the 
system after ERY addition was terminated. SMA test results showed that the 
activity of the sludge decreased with respect to the ERY concentration, 
however the potential methanogenic activity increased again after ERY 
addition was stopped. 
- Also TET was fed to the ASBR up to 3 mg/L and like ERY, performance of 
the reactor in terms of COD removal efficiency and biogas production was 
suddenly decreased after this concentration. After that TET addition was 
stopped however the reactor performance couldn‘t improve. Also propionic 
acid and acetic acid accumulation started in the system at the same time. 
Even TET addition was stopped, the accumulation continued. Methanogenic 
activity tests reflected that the potential acitivity of the sludge also decreased 
in the parallel with performance of the reactor. 
- Microbiological analysis reflected that the dominanat bacterial species were 
Clostridum in the all three reactor. While hydrogenotrophic methanogens 
were commonly detected in the SMX and TET reactors, acetoclastic 
methanogens with hydrogenotrophic species were dominant in the ERY 
reactor. 
- No FTHFS gene expression on mRNA level was detetcted in all there 
systems. Expression levels of mcrA and ACAS decreased with respect to 
antibiotic concnetration in the three reactors. While this expression level 
increased in the ERY reactor after antibiotic addion was stopped, it continued 
to decrease in TET reactor even at no TET addition phase. 
In the view of the findings of this study, the following recommendations are made 
for future studies: 
- Two phase anaerobic reactor may reflect the inhibition effect on the system 
more detailed in terms of microbial structure. 
- Synergistics effects also should be studies in the future to mimic real systems. 
- Antibiotic resistance gene abundance can be determined to reveal relation 
between antibiotic concentration and resistance genes. 
 
181 
 
REFERENCES 
Akasaka, H., Izawa, T., Ueki, K., Ueki, A., 2003. Phylogeny of numerically 
abundant culturable anaerobic bacteria associated with degradation of 
rice plant residue in Japanese paddy field soil, FEMS Microbiol. 
Ecol., 43(2). 149-61. 
Akuzawa, M., Hori, T., Haruta, S., Ueno, Y., Ishii, M., Igarashi, Y., 2011. 
Distinctive responses of metabolically active microbiota to 
acidification in a thermophilic anaerobic digester, Microbial Ecology, 
61(3). 595-605. 
Al-Ahmad, A., Daschner, F.D., Kummerer, K., 1999. Biodegradability of 
cefotiam, ciprofloxacin, meropenem, penicillin G and 
sulfamethoxazole and inhibition of wastewater bacteria, Arch. 
Environ. Con. Toxicol., 37, 158–163. 
Alder, A.C., McArdell, C.S., Golet, E.M., Ibrics, S., Molnar, E., Nipales, N.S. 
and Giger, W., 2001. Occurrence and fate fluoroquinolone, macrolide 
and sulfonamide antibiotics during wastewater treatment and in 
ambient waters in Switzerland. In Pharmaceuticals and Personal 
Care Products in the Environment. Scientific and Regulatory Issues. 
Daughton, C.G. and Jones-Lepp, T. (eds). Washington D.C.. Am. 
Chem. Soc., 56-69. 
Alexy, R., Scholl, A., Kumpel, T., and Kummerer, K., 2003. Antibiotics in the 
aquatic environment. Testing the biodegradability of selected 
antibiotics, their occurrence in waste water, their potential impact on 
the purification performance of municipal sewage treatment plants 
and identification of associated risks. Final Report. F&E 298 63 722, 
Federal Environmental Agency, Berlin, Germany. 
Alexy, R., Scholl, A., and Kummerer, K., 2004. Elimination and degradability of 
18 antibiotics studied with simple tests, Chemosphere, 57, 505–512. 
Amann, R.I., Binder, B.J., Olson, R.J., Chisholm, S.W., Devereux, R., and Stahl, 
D.A., 1990. Combination of 16S rRNA-targeted oligonucleotide 
probes with flow cytometry for analyzing mixed microbial 
populations, Applied and Environmental Microbiology, 56, 1919–
1925.  
Amann, R.I., Ludwig, W., and Schleifer, K.H., 1995. Phylogenetic identification 
and in situ detection of individual microbial cells without cultivation, 
Microbiol Rev., 59, 143–169. 
American Public Health Association (APHA), 2005. Standard methods for the 
examination of water and wastewater, 21st ed., American Public 
Health Association, Washington, DC. 
 182 
Amin, M.M., Zilles, J. L., Greiner, J., Charbonneau, S., Raskin, L., and 
Morgenroth, E., 2006. Influence of the antibiotic erythromycin on 
anaerobic treatment of a pharmaceutical wastewater, Environ. Sci. 
Technol., 40, 3971-3977. 
Anderson, G., Sallis, P., Uyanik, S., 2003. Anaerobic treatment processes In. 
Handbook of Water and Wastewater Microbiology (Eds). Mara, D. 
and Horan, N. Academic Press, London, 391-426. 
Angenent, L. T., Sung, S. W., Raskin, L., 2002. Methanogenic population 
dynamics during startup of a full-scale anaerobic sequencing batch 
reactor treating swine waste, Water Res., 36 (18), 4648-4654. 
Aquino, S.F. and Stuckey, D.C., 2004. Soluble microbial products formation in 
anaerobic chemostats in the presence of toxic compouns, Water 
Research, 38, 255-266. 
Arienzo, M., Christen, E.W., and Quayle, W.C., 2009. Phytotoxicity testing of 
winery wastewater for constructed wetland treatment, J. Hazar. Mat., 
169, 94-99. 
Arikan, O.A., Sikora, L.J., Mulbry, W., Khan, S.U., Rice, C., Foster, G.D., 2006. 
The fate and effect of oxytetracycline during the anaerobic digestion 
of manure from therapeutically treated calves, Process Biochem., 41 
(7), 1637–1643. 
Arikan, O.A., Sikora, L.J., Mulbry, W., Khan, S.U., Foster, G.D., 2007. 
Composting rapidly reduces levels of extractable oxytetracycline in 
manure from therapeutically treated beef calves, Bioresour. Technol,  
98, 169–176. 
Arikan, O.A., 2008. Degradation and metabolization of chlortetracycline during the 
anaerobic digestion of manure from medicated calves, J. Hazard. 
Mater., 158 (2–3), 485–490. 
Arslan-Alaton, I., Caglayan, A.E., 2006. Toxicity and biodegradability assessment 
of raw and ozonated procaine penicillin G formulation effluent, 
Ecotoxicol. Environ. Safe, 63, 131–140. 
Avisar, D., Lester, Y., Ronen, D., 2009. Sulfamethoxazole contamination of a deep 
phreatic aquifer, Sci. Total Environ., 407, 4278-4282. 
Bagge, E., Persson, M., Johansso K.E., and Johansson, K.E., 2010. Diversity of 
spore-forming bacteria in cattle manure, slaughterhouse waste and 
samples from biogas plants, J. Appl. Microbiol., 109(5), 1549-65. 
Bagley, D.M., Brodkorb, T.S., 1999. Modeling the microbial kinetics in an 
anaerobic sequencing batch reactor; model development and 
experimental validation, Water Environment Research, 71, 1320-
1332. 
Barker, D. J., Stuckey, D. C., 1999. A review of soluble microbial products (SMP) 
in wastewater treatment systems, Water Res., 33 (14), 3063-3082. 
Barns, S.M., Fundyga, R.E., Jeffries, M.W., 1994. Remarkable archaeal diversity 
detected in a yellowstone-nationalpark hot spring environment, Proc. 
Natl. Acad. Sci., 91 (5), 1609–1613. 
 
183 
Batstone, D.J., Keller, J., Angelidaki, I., Kalyuzhnyi, S.V., Pavlostathis, S.G., 
Rozzi, A., Sanders, W.T.M., Siegrist, H., and Vavilin, V.A., 2002. 
Anaerobic Digestion Model No.1, IWA Sci. and Tech. Report No.13, 
IWA Publishing, Bedfordshire. 
Bauer, R., Bekker, J.P., van Wyk, N., du Toit, C., Dicks, L.M., Kossmann, J., 
Bekker, JP., Wyk, N., and Dicks, LM., 2009. Exopolysaccharide 
production by lactose-hydrolyzing bacteria isolated from traditionally 
fermented milk, Int. J. Food Microbiol., 131(2-3), 260-264. 
Bendz, D., Paxeus, N.A., Ginn, T.R., Loge, F.J., 2005. Occurrence and fate of 
pharmaceutically active compounds in the environment, a case study. 
Hoje river in Sweden, Journal of Hazardous Materials, 122, 195–204. 
Benotti, M.J. and Brownawell, B.J., 2009. Microbial degradation of 
pharmaceuticals in estuarine and coastal seawater, Environ. Pollut., 
157, 994–1002. 
Boomer SM, Lodge DP, Dutton BE & Pierson B., 2002. Molecular 
characterization of novel red green nonsulfur bacteria from ﬁve 
distinct hot spring communities in Yellowstone National Park, Appl 
Environ Microbiol., 68, 346–355. 
Boree, A.L., Arnold, W.A., McNeill, K., 2004. Photochemical fate of sulfa drugs in 
the aquatic environment. sulfa drugs containing five-membered 
heterocycylic groups, Environ. Sci. Technol., 38, 3933–3940. 
Borneman, J., Skroch, P.W., O’Sullivan, K.M., Palus, J.A., Rumjanek, N.G., 
Jansen, J.L., Nienhuis, J., Triplett, E.W., 1996. Molecular 
microbial diversity of an agricultural soil in Wisconsin, Appl. Environ. 
Microbiol., 62,1935–1943. 
Bosma, T.N.P., Middeldorp, P.J.M., Schraa, G., Zehnder, A.J.B., 1997. Mass 
transfer limitation of biotransformation. quantifying bioavailability, 
Environmental Science and Technology, 31, 1, 248-252. 
Boyd, G.R., Reemtsma, H., Grimm, D.A., Mitra, S., 2003. Pharmaceuticals and 
personal care products (PPCPs) in surface and treated waters of 
Louisiana, USA and Ontario, Canada, Science of the Total 
Environment, 311, 135–149. 
Briee, C., Moreira, D., and Lopez-Garcia, P., 2007. Archaeal and bacterial 
community composition of sediment and plankton from a suboxic 
freshwater pond, Res. Microbiol., 158(3), 213-227. 
Briones, A.M., Daugherty, B.J., Angenent, L.T., Rausch, K.D., Tumbleson, 
M.E., and Raskin, L., 2007. Microbial diversity and dynamics in 
multi- and single-compartment anaerobic bioreactors processing 
sulfate-rich waste streams, Environ. Microbiol., 9(1), 93-106. 
Brito, A.G., Rodrigues, A.C., Melo, F.L., 1997. Feasibility of a pulsed sequencing 
batch reactor with anaerobic aggregated biomass for the treatment of 
low strength wastewater, Water Science Technology, 35, 1, 193-198. 
 
 
 184 
Burhenne, J., Ludwig, M., Spiteller, M., 1997. Photolytic degradation of 
fluoroquinolone carboxylic acids in aqueous solution. Isolation and 
structural elucidation of polar photometabolites, ESPR – Environ. Sci. 
Pollut. Res., 4, 61–67. 
Cadillo-Quiroz, H., Yashiro, E., Yavitt, J.B., and Zinder, S.H., 2008. 
Characterization of the archaeal community in a minerotrophic fen 
and terminal restriction fragment length polymorphism-directed 
isolation of a novel hydrogenotrophic methanogen, Appl. Environ. 
Microbiol., 74(7). 2059-68. 
Calamari, D., Zuccato, E., Castiglioni, S., Bagnati, R., Fanelli, R., 2003. Strategic 
survey of therapeutic drugs in the rivers Po and Lambro in northern 
Italy, Environ Sci Technol., 37, 1241–1248. 
Capone, D.G., Weston, D.P., Miller, V., Shoemaker, C., 1996. Antibacterial 
residues in marine sediments and invertebrates following 
chemotherapy in aquaculture, Aquaculture, 145, 55–75. 
Cetecioglu, Z., Ince, B., Azman, S., Insel, G., Orhon, D., Ince, O., 2011. Acute 
inhibitory impact of antimicrobials on acetoclastic methanogenic 
activity, Journal of Hazardous Materials, submitted. 
Cetecioglu, Z., Ince, B. K., Kolukirik, M. and Ince, O., 2009. Biogeographical 
Distribution and Diversity of Bacterial and Archaeal Communities 
within Highly Polluted Anoxic Marine Sediments from the Marmara 
Sea, Marine Pollution Bulletin, 3(58). 384-395. 
Chelliapan, S., Wilby, T., Sallis, P.J., 2006. Performance of an upflow anaerobic 
stage reactor (UASR) in the treatment of pharmaceutical wastewater 
containing macrolide antibiotics, Water Res., 40 (3). 507–516. 
Cheng, Y. and Zhu, W., 2008. Methanogens isolated from goat rumen. EBI Gene 
Data Bank. 
Chopra, I., Roberts, M., 2001. Tetracycline antibiotics. mode of action, 
applications, molecular biology, and epidemiology of bacterial 
resistance, Microbiology and Molecular Biology Reviews, 65 (2), 
232–260.  
Christian, T., Schneider, R.J., Färber, H.A., Skutlarek, D., Meyer, M.T., 
Goldbach, H.E., 2003. Determination of antibiotic residues in 
manure, soil, and surface waters, Acta Hydroch. Hydrob., 31, 36–44. 
Cirja, M., Ivashechkin, P., Schaffer, A., Corvini, P.F.X., 2008. Factors affecting 
the removal of organic micropollutants from wastewater in 
conventional treatment plants (CTP) and membrane bioreactor 
(MBR), Review,  Environmental Science Biotechnology , 7 (1), 61–78. 
Clara, M., Strenn, B., Gans, O., Martinez, E., Kreuzinger, N., Kroiss, H., 2005.  
Removal of selected pharmaceuticals, fragrances and endocrine 
disrupting compounds in a membrane bioreactor and conventional 
wastewater treatment plants, Water Research, 39, 4797–4807. 
Cockell, C.S., 2010. Impact disruption and recovery of the deep subsurface 
biosphere, EBI Gene Data Bank. 
 
 
185 
Cokgor, E.U., Karahan, O., Arslan-Alaton, I., Meric, S., Saruhan, H., Orhon, 
D., 2006. Effect of perozonation on biodegradability and toxicity of a 
penicillin formulation effluent. J. Environ. Sci. Heal. A 41, 1887–
1897. 
Cokgor, E.U., Arslan Alaton, I., Erdinc, E., Insel, G., and Orhon, D., 2007. 
Effect of photochemical pre-treatment on COD fractionation of a non-
ionic textile surfactant. Water Science. Technol. 55 155-163. 
Colleran, E., Concannon, F., Goldem, T., Geoghegan, F., Crumlish, B., Killilea, 
E., Henry, M. and Coates, J., 1992. Use of methanogenic activity 
tests to characterize anaerobic sludges, screen for anaerobic 
biodegradability and determine toxicity thresholds against individual 
anaerobic trophic groups and species. Water Sci. Technol. 25, 31-40. 
Conklin, A., Stensel, H.D., Ferguson, J. 2006. Growth Kinetics and Competition 
Between Methanosarcina and Methanosaeta in Mesophilic Anaerobic 
Digestion. Water Environ. Res., 78, 486-496. 
Conkle, J.L., Lattao, C., White, J.R., and Cook, R.L., 2010. Competitive sorption 
and desorption behavior for threefluoroquinolone antibiotics in 
a wastewater treatment wetland soil, Chemosphere 80 1353-1359. 
Cottrell, M.T., Kirchman, D. 2000. Natural assemblages of marine Proteobacteria 
and members of the Cytophaga–Flavobacter cluster consuming low- 
and high-molecular weight dissolved organic matter. Appl. Environ. 
Microbiol. 66, 1692–1697. 
Cunningham, V., 2008. Special characteristics of pharmaceuticals related to 
environmental fate. In. Kummerer, K. (Ed.), Pharmaceuticals in the 
Environment. Sources, Fate, Effects and Risk, third ed. Springer, 
Berlin Heidelberg, pp. 23–34. 
Curtis, T.P., Craine, N.G., 1998. The comparison of the bacterial diversity of 
activated sludge plants. Water Science and Technology, 37, 71-78.  
Dague, R.R., Habben, C.E., Pidaparti, S.R., 1992. Initial studies on the anaerobic 
sequencing batch reactor. Water Science and Technology, 26, 9-11, 
2429-2432. 
Dague, R.R., Banik, G.C., Ellis, T.G., 1998. Anaerobic sequencing batch reactor 
treatment of dilute wastewater at psychrophilic temperatures. Water 
Environment Research, 70, 2, 155-160. 
Dantas, R.F., Contreras, S., Sans, C., Esplugas, S., 2007. Sulfamethoxazole 
abatement by means of ozonation. J. Hazard Mater. 150, 790–794. 
Daughton, C.G., Ternes, T.A., 1999. Pharmaceuticals and personal care products in 
the environment. agents of subtle change? Environmental Health 
Perspectives, 107, 907–938. 
DeBok, F.A.M., Plugge, C.M., Stams, A.J.M., 2004. Interspecies electron transfer 
in methanogenic propionate degrading consortia. Water Research, 38, 
1368-1375. 
 
 
 186 
De Liguoro, M., Cibin, V., Capolongo, F., Halling-Sørensen, B., Montesissa, C., 
2003.Use of oxytetracycline and tylosin in intensive calf farming. 
evaluation of transfer to manure and soil. Chemosphere 52 (1), 203–
212. 
Donoho, A.L., 1984. Biochemical studies on the fate of monensin in animals and in 
the environment. J. Anim. Sci. 58, 1528–1539. 
Drake, H.L., 1994.Acetogenesis. Chapman and Hall, New York. 
Drillia, P., Dokianakis, S.N., Fountoulakis, M.S., Kornaros, M., Stamatelatou, 
K. and Lyberatos, K.G. 2005.On the occasional biodegradation of 
pharmaceuticals in the activated sludge process. The example of the 
antibiotic sulfamethoxazole. J. Haz. Mat. 122, 259-265. 
Eastmen, J.A., Ferguson, P., 1981. Solubilization of particulate carbon during the 
acid phase of anaerobic digestion. Journal of Water Pollution Control 
Federation, 53, 352-366.  
Edhlund, B.L., Arnold, W.A., McNeill, K., 2006. Aquatic photochemistry of 
nitrofuran antibiotics. Environ. Sci. Technol. 40, 5422–5427. 
Edwards, U., Rogall, T., Blocker, H., Emde, M., and Böttger, E.C., 1988. 
Isolation and complete nucleotide determination of entire genes 
Characterisation of a gene coding for 16S ribosomal RNA. Nucleic 
Acids Res 17. 7843–7853. 
Eggen, R., Harmsen, H., de Vos, W.M., 1990. Organization of a ribosomal RNA 
gene cluster from the archaebacterium Methanothrix soehngenii. 
Nucleic Acids Res. 18(5). 1306. 
Eichner, C.A., Erb, R.W., Timmis, K.N., Wagner-Dobler, I., 1999. Thermal 
gradient gel electrophoresis analysis of bioprotection from pollutant 
shocks in the activated sludge microbial community. Appl Environ 
Microbiol 65.102–109. 
Elberson, M.A. and Sowers, K.R., 1997. Isolation of an aceticlastic strain of 
Methanosarcina siciliae from marine canyon sediments and 
emendation of the species description for Methanosarcina siciliae. Int. 
J. Syst. Bacteriol. 47(4). 1258-1261. 
European Federation of Animal Health (FEDESA), 2001. Antibiotic use in farm 
animals does not threaten human health. FEDESA/FEFANA Press 
release, Brussels, 13 July. 
Farrelly, V., Rainey, F.A., Stackebrandt, E., 1995. Effect of genome size and rrn 
gene copy number on PCR amplification of 16S rRNA genes from a 
mixture of bacterial species. Appl. Environ. Microbiol. 61. 2798-2801. 
Felske, A., Wolterink, A., VanLis, R., Akkermans, A.D.L., 1998. Phylogeny of 
the mainbacterial 16S rRNA sequences in Drentse A grassland soils 
(The Netherlands). Appl Environ Microbiol 64, 871–879. 
Fernandez, A.S., Hashsham, S.A., Dollhopf, S.L., Raskin, L., Glagoleve, O., 
Dazzo, F.B., Hickey, R.F., Criddle, C.S., Tiedje, J.M., 2000. 
Flexible community structure correlates with stable community 
fuction in methanogenic bioreactor communities perturbated by 
glucose. Appl. Environ. Microbiol. 66, 4058e4067. 
 
187 
Floyd, M. M., J. Tang, M. Kane, and D. Emerson. 2005. Captured diversity in a 
culture collection. case study of the geographic and habitat 
distributions of environmental isolates held at the American Type 
Culture Collection, Appl. Environ. Microbiol. 71.2813–2823. 
Foye, W.O., Lemke, T.L., Williams, D.A., 1995. Principles of Medicinal 
Chemistry. MD. Williams&Wilkins, Baltimore. 
Fredriksson, N.J., Hermansson, M., and Wilen, B.M., 2010. Diversity and 
dynamics of Archaea in an activated sludge wastewater treatment 
plant. EBI Gene Data Bank. 
Fukui, M., Suwa, Y., Urushigawa, Y., 1996. High survival efficiency and 
ribosomal RNA decaying pattern of Desulfobacter latus, a highly 
specific acetate-utilizing organism, during starvation. FEMS 
Microbiol Ecol 19. 17–25. 
Garcia, J.L., Patel, B.K.C., Ollivier, B., 2000. Taxonomic phylogenetic and 
ecological diversity of methanogenic Archaea. Anaerobe, 6, 4, 205-
226. 
Gartiser, S., Urich, E., Alexy, R., Kuummerer, K., 2007a. Ultimate 
biodegradation and elimination of antibiotics in inherent tests. 
Chemosphere, 67, 604–613. 
Gartiser, S., Urich, E., Alexy, R., and Kummerer, K., 2007b. Anaerobic inhibition 
and biodegradation of antibiotics in ISO test schemes. Chemosphere 
66  1839–1848. 
Gerardi, M.H., 2003. The Microbiology of Anaerobic Digesters, John Wiley & Sons 
Inc. ISBN 0-471-20693-8, 51–57, New Jersey. 
Germirli Babuna, F., Ince, O., Ozgur, D., and Orhon, D., 1998. Assessment of 
iner COD in pulp and paper wastewater under anaerobic conditions. 
Water. Res. 32 3490-3494. 
Giger, W., Alder, A.C., Golet, E.M., Kohler, H.P.E., McArdell, C.S., Molnar, E., 
Siegrist, H., Suter, M.J.F., 2003. Occurrence and fate of antibiotics 
as trace contaminants in wastewaters, sewage sludges, and surface 
waters. Chimia 57, 485–491. 
Gilbertson, T.J., Hornish, R.E., Jaglan, P.S., Koshy, K.T., Nappier, J.L., Stahl, 
G.L., Cazers, A.R., Napplier, J.M., Kubicek, M.J., Hoffman, G.A., 
Hamlow, P.J., 1990. Environmental fate of ceftiofur sodium, a 
cephalosporin antibiotic. Role of animal excreta in its decomposition. 
J. Agric. Food Chem. 38, 890–894. 
Giovannoni, S.J., Britschgi, T.B., Moyer, C.L., Field, K.G., 1990. Genetic 
diversity in Sargasso Sea bacterioplankton, Nature, 345, 60–63. 
Glassmeyer, S.T., Furlong, E.T., Kolpin, D.W., Cahill, J.D., Zaugg, S.D., 
Werner, S.L., Meyer, M.T., Kryak, D.D., 2005. Transport of 
chemical and microbial compounds from known wastewater 
discharges. potential for use as indicators of human fecal 
contamination. Environmental Science & Technology 39, 5157–5169. 
 
 188 
Gobel, A., Thomsen, A., McArdell, C.S., Alder, A.C., Giger, W., Thesis, N., 
Löffler, D. and Ternes, T. 2005. Extraction and determination of 
sulfonamide and macrolide antimicrobials and trimethoprim in sewage 
sludge. J. Chromatogr. A 1085, 179-189. 
Golan, D.E., Tashjian, A.H., Armstrong, E.J., Armstrong, A.W., 2007. Principles 
of Pharmacology The Pathophysiologic Basis of Drug Therapy, 
Kluwer Wolters Lippincott Williams & Wilkins, Philadelphia. 
Golet, E. M., Alder, A.C., Hartmann, A., Ternes, T.A. and Giger, W., 2001. 
Trace determination of fluoroquinolone antibacterial agents in solid-
phase extraction urban wastewater by and liquid chromatography with 
fluorescence detection. Anal. Chem. 73, 3632-3638. 
Golet, E.M., Strehler, A., Alder, A.C., Giger, W., 2002. Determination of 
fluoroquinolone antibacterial agents in sewage sludge and sludge-
treated soil using accelerated solvent extraction followed by solid-
phase extraction. Anal. Chem. 74, 5455–5462. 
Golet, E.M., Xifra, I., Siegrist, H., Alder, A.C. and Giger, W., 2003. 
Environmental exposure assessment of fluoroquinolone antibacterial 
agentsfrom sewage to soil. Environ. Sci. Technol. 37, 3243-3249.  
Gomez-Silvan, C., Molina-Munoz, M., Poyatos, J.M., Ramos, A., Hontoria, E., 
Rodelas, B., Gonzalez-Lopez, J., 2010. Structure of archaeal 
communities in membrane-bioreactor and submerged-biofilter 
wastewater treatment plants. Bioresource Technology 101. 2096–
2105. 
Gonzalez, O., Sans, C., Esplugas, S., 2007. Sulfamethoxazole abatement by photo- 
Fenton toxicity, inhibition and biodegradability assessment of 
intermediates. J. Hazard. Mater. 146, 456–459. 
Good, I.J., 1953. The population frequencies of species and the estimation of the 
population parameters. Biometrika 40, 237–264. 
Gray, N.D., Head, I.M., 1999. New insights on old bacteria. bacterial diversity and 
function in aquatic ecosystems. Hydrobiologia, 401, 97-112. 
Green, S.J. and Blank, J.G., 2007. Characterization of a mesophilic freshwater 
microbial mat developing in serpentinized spring water. EBI Gene 
Data Bank. 
Griffin, M.E., McMahon, K.D., Mackie, R.I., and Raskin, L., 1998. 
Methanogenic population dynamics during start-up of anaero- bic 
digesters treating municipal solid waste and biosolids. Biotechnol. 
Bioeng. 57 342-355. 
Gu, C., Karthikeyan, K.G., 2008. Sorption of the antibiotic tetracycline to 
humicmineral complexes. J. Environ. Qual. 37, 704–711. 
Guardabassi, L., Petersen, A., Olsen, J.E., Dalsgaard, A., 1998.Antibiotic 
resistance in Acinetobacter spp. isolated from sewers receiving waste 
effluent from a hospital and a pharmaceutical plant. Appl. Environ. 
Halling-Sørensen, B., 2000. Algal toxicity of antibacterial agents used in intensive 
farming. Chemosphere 40, 731–739. 
 
189 
Halling-Sørensen, B., Lykkeberg, A., Ingerslev, F., Blackwell, P., Tjørnelund, J., 
2003. Characterisation of the abiotic degradation pathways of 
oxytetracyclines in soil interstitial water using LC–MS–MS. 
Chemosphere 50 (10), 1331–1342. 
Hanada, S. and Pierson, B., 2002.The Family Chloroflexaceae. The Prokaryotes 3, 
Electron Release 3,1. Springer-Verlag, New York. 
Hanada, S., Takaichi, S., Matsuura, K., and Nakamura, K., 2002. Roseiflexus 
castenholzii gen. nov., sp nov., a thermophilic, filamentous, 
photosynthetic bacterium that lacks chlorosomes. Int J Syst Evol 
Micr., 52. 187–193. 
Hungate, R.E., 1982. Methane formation and cellulose digestion and biochemical 
ecology and microbiology of the rumen ecosystem. Experimentia, 38, 
189-192. 
Hansen, P.K., Lunestad, B.T., Samuelsen, O.B., 1992. Effects of oxytetracycline, 
oxolinic acid and flumequine on bacteria in an artificial marine fish 
farm sediment. Can. J. Microbiol. 38, 307–1312. 
Harper, S.R., Pohland, F.G., 1986. Recent developments in hydrogen management 
during anaerobic wastewater treatment. Biotechnology and 
Bioengineering, 27, 585-602. 
Hartig, C., Storm, T. and Jekel, M., 1999. Detection and identification of 
sulphonamide drugs in municipal wastewater by liquid 
chromatography coupled with electrospray ionization tandem mass 
spectrometry. J. Chromatogr. A, 854, 163-173. 
Head, I.M., Saunders, J.R., Pickup R.W., 1998. Microbial evolution, diversity, and 
ecology. A decade of ribosomal RNA analysis of uncultivated 
microorganisms. Microbiology and Ecology, 35, 1–21. 
Hedlund, B. P., J. J. Gosink, and J. T. Staley., 1997. Verrucomicrobia div. nov., a 
new division of the Bacteria containing three new species of 
Prosthecobacter. Antonie Leeuwenhoek 72. 29–38. 
Heise, J., Höltge, S., Schrader, S., Kreuzig, R., 2006. Chemical and biological 
characterization of non-extractable sulfonamide residues in soil. 
Chemosphere 65, 2347–2352. 
Hektoen, H., Berge, J.A., Hormazabal, V., Yndestad, M., 1995. Persistence of 
antibacterial agents in marine sediments. Aquaculture 133, 175–184. 
Henze, M., Harremoes, P., 1983. Anaerobic treatment of wastewater in fixed  film 
reactors; A literature review. Water Science and Technology, 15, 1-
101. 
Heuer, H., Krsek, M., Baker, P., Smalla, K., Wellington, M.H.E., 1997. Analysis 
of actinomycete communities by speciﬁc ampliﬁcation of genes 
encoding 16S rRNA and gelelectrophoretic separation in denaturating 
gradients. Appl. Environ. Microbiol., 63, 3233–3241. 
Hirsch, R., Ternes, T., Haberer, K. and Kratz, K.L., 1999. Occurrence of 
antibiotics in the aquatic environment. Sci.Total Environ. 225, 109-
118. 
 190 
Hofman-Bang, J., Zheng, D., Westermann, P., Ahring, B.K., Raskin, L., 2003. 
Molecular ecology of anaerobic reactor systems. Adv. In Biochem 
Engin. Biotech. 81, 151-203. 
Hu, D., Coats, J.R., 2007. Aerobic degradation and photolysis of tylosin in water 
and soil. Environ. Toxicol. Chem. 26, 884–889. 
Hu, Z., Liu, Y., Chen, G., Gui, X., Chen, T., Zhan, X., 2011. Characterization of 
organic matter degradation during composting of manure–straw 
mixtures spiked with tetracyclines. Bioresource Technology, doi. 
10.1016/j.biortech.2011.05.003. 
Hugenholtz, P., B. M. Goebel, and N. R. Pace., 1998. Impact of culture 
independent studies on the emerging phylogenetic view of bacterial 
diversity. J. Bacteriol., 180.4765–4774. 
Hulshoff Pol, L.W., de Castro Lopes, S.I., Lettinga, G., Lens, P.N.L., 2004. 
Anaerobic sludge granulation. Water Research, 38, 1376–1389. 
Hungate, R.E., 1982. Methane formation and cellulose digestion and biochemical 
ecology and microbiology of the rumen ecosystem. Experimentia, 38, 
189-192. 
Hutnan, M., Mrafková, L., Drtil, M., Derco J., 1999. Methanogenic and 
nonmethanogenic activity of granulated sludge in anaerobic baffled 
reactor. Chemistry Papers, 53, 6, 374-378. 
Ince, O., Kolukirik, M., Cetecioglu, Z., Eyice, O., Tamerler, C., and Ince, B. 
2007. Methanogenic and sulfate reducing bacterial population levels 
in a full-scale anaerobic reactor treating pulp and paper industry 
wastewater using fluorescence in situ hybridization, Wat. Scie. Tech., 
55. 183–191. 
Ince, O., Kolukirik, M., Cetecioglu, Z., Eyice, O., Inceoglu, O., and Ince, B., 
2009. Toluene Inhibition of an Anaerobic Reactor Sludge in Terms 
of Activity and Composition of Acetoclastic Methanogens, Env. Sci. 
Healt Part A 44 1551-1556. 
Ince, B., Koksel, G., Cetecioglu, Z., Oz, N.A., Coban, H., and Ince, O., 2011. 
Inhibition effect of isopropanol on acetyl-CoA synthetase expression 
level of acetoclastic methanogen, Methanosaeta concilii. J. 
Biotechnology, Accepted. 
Ingerslev, F., Halling-Sørensen, B., 2001. Biodegradability of metronidazole, 
olaqiondox, and tylosin, and formation of tylosin degradation products 
in aerobic soil/manure slurries. Ecotoxicol. Environ. Safe 48, 311–
320. 
Ingerslev, F., Torang, L., Loke, M.L., Halling-Sørensen, B., Nyholm, N., 2001. 
Primary biodegradation of veterinary antibiotics in aerobic and 
anaerobic surface water simulation systems. Chemosphere 44, 865–
872. 
Ingianni, A., Petruzzalli, S.,Morandotti, G., Pompei, R., 1997. FEMS Immun 
Med Microbiol 18.61. 
 
 
191 
Iskender, G., Sezer, A., Arslan-Alaton, I., Germirli Babuna, F., Okay, O.S., 
2007. Treatability of cefazolin antibiotic formulation effluent with O3 
and O3/H2O2 processes. Water Sci. Technol., 55, 217–225. 
ISO 13641-1 (2003-05-15). Determination of inhibition of activity of anaerobic 
bacteria. Part 1. General test. 
Jacobsen, P., Berglind, L., 1988. Persistence of oxytetracyline in sediment from 
fish farms. Aquaculture 70, 365–370. 
Jagevall, S., Pedersen, K., Eriksson, S., 2008. EBI Gene Data Bank 
Jarvis, G.N., Skillman, L., Stroempl, C., Naylor, G., Joblin, K.N., and Moore, 
E.R., 2003. Isolation of new rumen methanogens. EBI Gene Data 
Bank. 
Jetten, M.S.M., Stams, A.J.M., Zehnder, A.J.B., 1992. Methanogenesis from 
acetate – a comparison of the acetate metabolism in Methanothrix-
soehngenii and Methanosarcina spp. FEMS Microbiology Reviews 88 
(3–4), 181–197. 
Jukes, T. H., and Cantor, C. R., 1969. Evolution of protein molecules, p. 21-132. In 
H. N. Munro (ed.), Mammalian protein metabolism, vol. 3. Academic 
Press, New York, N.Y. 
Kallenborn, R., Fick, J., Lindberg, R., Moe, M., Nielsen, K.M., Tysklind, M., 
Vasskog, T., 2008. Pharmaceutical residues in Northern European 
environments. consequences and perspectives. In. Kummerer, K. 
(Ed.), Pharmaceuticals in the Environment. Sources, Fate, Effects and 
Risk, third ed. Springer, Berlin-Heidelberg, pp. 61–74. 
Karabay, O., 2009. Türkiye‘de antibiyotik kullanımı ve direnç nereye gidiyor?, 
ANKEM Dergisi, 23(2), 116-120. 
Kato, M., 1994. The anaerobic treatment of low strength soluble wastewaters. Ph.D 
thesis, Wageningen Agricultural University. 
Kelly, O., Hughes, D., O'Flaherty, V., and Collins, G., 2009. Microbial Ecology 
and Community Dynamics of Anaerobic Granular Biofilms Cultivated 
at Low Temperatures Treating Low-strength Sewage-based 
wastewater. EBI Gene Data Bank. 
Kemnitz, D., Kolb, S., and Conrad, R., 2005. Phenotypic characterization of Rice 
Cluster III archaea without prior isolation by applying quantitative 
polymerase chain reaction to an enrichment culture. Environ. 
Microbiol., 7(4). 553-765. 
Khanal, S.K., 2008. Anaerobic Reactor Configurations for Bioenergy Production In. 
Anaerobic Biotechnology for Bioenergy Production Principles and 
Applications (Ed. Khanal, S.K.), Blackwell, Singapore. pp. 93-115. 
Kim, S., Eichhorn, P., Jensen, J.N., Weber, A.S., Aga, D.S., 2005. Removal of 
antibiotics in wastewater. effect of hydraulic and solid retention 
timeson the fate of tetracycline in the activated sludge process. 
Environ. Sci. Technol., 39, 5816–5823. 
 
 
 192 
Kim, S and Aga, D.S., 2007. Potential ecological and human health impacts of 
antibiotics and antibiotic-resistant bacteria from wastewater treatment 
plants. J. Toxic.&Env. Health, Part B, 10, 559-573. 
Klocke, M., Nettmann, E., Bergmann, I., Mundt, K., Souidi, K., Mumme, J., and 
Linke, B., 2008. Characterization of the methanogenic Archaea 
within two-phase biogas reactor systems operated with plant biomass. 
Syst. Appl. Microbiol., 31(3). 190-205. 
Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., 
Barber, L.B., Buxton, H.T., 2002. Pharmaceuticals, hormones, and 
others organic wastewater contaminants in U.S. streams, 1999–2000. 
a national reconnaissance. Environ Sci Technol 36.1202–1211. 
Korolkovas, A., 1976. Essentials of Medicine Chemistry. Wiley, New York. 
Kowalchuk, G.A., Naoumenko, Z.S., Derikc, P.J.L., Felske, A., Stephen, J.R., 
Arkhipchenko, I.A., 1999. Molecular Analysis of Ammonia-
Oxidizing Bacteria of the b Subdivision of the Class Proteobacteria in 
Compost and Composted Materials. App. Environ. Microb., 65(2), 
396-403. 
Kreuzig, R., Holtge, S., 2005. Investigations on the fate of sulfadiazine in manured 
soil. laboratory experiments and test plot studies. Environ. Toxicol. 
Chem., 24,771–776. 
Kuhne, M., Hamscher, G., Körner, U., Schedl, D., Wenzel, S., 2001. Formation 
ofanhydrotetracycline during a high-temperature treatment of animal-
derived feed contaminated with tetracycline. Food Chem., 75 (4), 
423–429. 
Kummerer, K., 2004. Pharmaceuticals in the Environment, Ed. Kummerer, K., 2nd 
Ed. Springer, Verlag. 
Kummerer, K., 2008. Antibiotics in the Environment. Pharmaceuticals in the 
Environment, pp. 3-35, Ed. Kummerer, K., 3rd Ed. Springer, Verlag. 
Kummerer, K., 2008. Pharmaceuticals in the Environment – A Brief Summary. 
Pharmaceuticals in the Environment, pp. 75-93, Ed. Kummerer, K., 
3rd Ed. Springer, Verlag. 
Kummerer, K., 2009. The presence of pharmaceuticals in the environment due to 
human use-present knowledge and future challenges. J. Environ. 
Manag. 90, 2354-2366. 
Kummerer, K., Al-Ahmad, A., Mersch-Sundermann, V., 2000. Biodegradability 
of some antibiotics, elimination of the genotoxicity and affection of 
wastewater bacteria in a simple test. Chemosphere 40, 701–710. 
Kummerer, K., Henninger, A., 2003. Promoting resistance by the emission of 
antibiotics from hospitals and households into effluents. Clin. 
Microbiol. Infec. 9, 1203–1214. 
Lallai, A., Mura, G., and Onnis, N., 2002. The effects of certain antibiotics on 
biogas production in anaerobic digestion of pig waste slurry, Biores. 
Tech. 82 205-208. 
 
193 
Lane, D.J., 1991. 16S/23S rRNA sequencing. In. Stackebrandt, E., Goodfellow, M. 
(Eds.), Nucleic acid techniques in bacterial systematics. Wiley, 
Chichester, England, pp. 205–248. 
Larsson, D.G., de Pedro, C., Paxeus, N., 2007. Effluent from drug manufactures 
contains extremely high levels of pharmaceuticals. J. Hazard. Mater. 
148, 751–755. 
LaPara, T.M., Nakatsu, C.H., Pantea, L.M., Alleman, J.E., 2002. Stability of the 
bacterial communities supported by a seven-stage biological process 
treating pharmaceutical wastewater as revealed by PCR-DGGE,Water 
Res. 36. 638–646. 
Lee, C., Lee, Y., Schmidt, C., Yoon, J., von Gunten, U., 2007. Oxidation of N-
nitrosodimethylamine (NDMA) with ozone and chlorine dioxide. 
kinetics and effect on NDMA formation potential. Environ. Sci. 
Technol., 41, 2056–2063. 
Leclerc, M., Delbes, C., Moletta, R. and Godon J-J., 2001. Single strand 
conformation polymorphism monitoring of 16S rDNA Archaea during 
start-up of an anaerobic digester. FEMS Microbiology Ecology, 34, 
213–20. 
Leclerc, M., Delg`enes, J.P., Godon, J.J., 2004. Diversity of the Archaeal 
community in 44 anaerobic digesters as determined by single strand 
conformation polymorphism analysis and 16S rDNA sequencing. 
Environmental Microbiology, 6, 809–819. 
Lehninger, A.L., Nelson, D.L., Cox, M.M., 2005. Lehninger principles of 
biochemistry, W.H. Freeman, New York. 
Lester, J. N., Stronach, S. M., Rudd, T., 1986. Anaerobic digestion process in 
industrial wastewater treatment, Springer Verlag, Berlin. 
Lettinga, G., Hulshoff Pol, L.W., 1991. UASB process design for various types of 
wastewaters. Water Science and Technology, 24, 87–107. 
Li, D., Yang, M., Hu, J., Ren, L., Zhang, Y., Chang, H., Li, K., 2008a. 
Determination and fate of oxytetracycline and related compounds in 
oxyteracycline production wastewater and the receiving river. 
Environ. Toxicol. Chem., 27, 80–86. 
Li, D., Yang, M., Hu, J., Zhang, Y., Chang, H., Jin, F., 2008b. Determination of 
penicillin G and its degradation products in a penicillin production 
wastewater treatment plant and the receiving river. Water Res., 42, 
307–317. 
Li, K., Yediler, A., Yang, M., Schulte-Hostede, S., Wong, M.H., 2008c. Ozonation 
of oxytetracycline and toxicological assessment of its oxidation by-
products. Chemosphere 72, 473–478. 
Libralato, G., Annamaria, V.G., and Francesco, A., 2010. How toxic is toxic? A 
proposal for wastewater toxicity hazard assessment, Ecotox. And 
Environ. Safety, 73 1602-1611. 
 
 194 
Lindsey, M.E., Meyer, M. and Thurman, E.M. 2001. Analysis of trace levels of 
sulfonamide and tetracycline antimicrobials, in groundwater and 
surface water using solid-phase extraction and liquid 
chromatography/mass spectrometry. Anal. Chem., 73, 4640-4646. 
Loftin, K.A., Henny, C., Adams, C.D., Surampali, R., Mormile, M.R., 2005. 
Inhibition of microbial metabolism in anaerobic lagoons by selected 
sulfonamides, tetracyclines, lincomycin, and tylosin tartrate. Environ. 
Toxic. Chemis., 24(4). 782-788. 
Lopez-Gutierrez, J.C., Henry, S., Hallet, S., Martin-Laurent, F., Catroux, G., 
Philippot, L., 2004. Quantification of a novel group of nitrate-
reducing bacteria in the environment by real-time PCR. J Microbiol 
Methods, 57.399–407. 
Lorenzo, F., Navaratnam, S., Edge, R., Allen, N.S., 2008. Primary photophysical 
properties of moxifloxacin – a fuoroquinolone antibiotic. Photochem. 
Photobiol. 2008 (Jan 15) [Epub ahead of print]. 
Lovell, C.R. and Leaphart, A.B., 2005. Community-level analysis. key genes of 
CO2-reductive acetogenesis. Methods Enzymol 397. 454-469. 
Lunestad, B.T., Goksøyr, J., 1990. Reduction in the antibacterial effect of 
oxytetracycline in sea water by complex formation with magnesium 
and calcium. Dis. Aquat. Organ., 9, 67–72. 
Luton, P.E., Wayne, J.M., Sharp, R.J., and Riley, P.W., 2002. The mcrA gene as 
an alternative to 16S rRNA in the phylogenetic analysis of 
methanogen populations in landﬁll. Microbiology 148. 3521–3530. 
Ma, K., Liu, X., and Dong, X., 2005. Methanobacterium beijingense sp. nov., a 
novel methanogen isolated from anaerobic digesters. Int. J. Syst. Evol. 
Microbiol., 55(Pt 1). 325-329. 
Madigan, M.T., Martinko, J..M., Parker, J., 2009. Brock Biology of 
Microorganisms, (12th edition), Prentice Hall, Inc., New Jersey. 
Maki, T., Hasegawa, H., Kitami, H., Fumoto, K., Munekage, Y., Ueda, K., 2006. 
Bacterial degradation of antibiotic residues in marine fish farm 
sediments of Uranouchi Bay and phylogenetic analysis of antibiotic-
degrading bacteria using 16S rDNA sequences. Fisheries Sci. 72, 
811–820. 
Malina, J.F., Pohland, F.G., (Eds), 1992. Design of anaerobic process for the 
treatment of industrial and municipal wastes, Technomic Publishing 
Co., U.S.A.  
Malinen, E., Kassinen, A., Rinttila, T., Palva, A. 2003.Comparison of real-time 
PCR with SYBR Green I or 5‘-nuclease assays and dot-blot 
hybridization with rDNA-targeted oligonucleotide probes in 
quantification of selected faecal bacteria. Microbiology 149. 269-277. 
Manz, W., Amann, R., Ludwig, W., Wagner, M., Schleifer, K.H., 1992. 
Phylogenetic oligodeoxynucleotide probes for the major subclasses of 
Proteobacteria — problems and solutions. Systematic and Applied 
Microbiology, 15, 593–600. 
 
 
195 
Marengo, J.R., O’ Brian, R.A., Velagaleti, R.R., Stamm, J.M., 1997. Aerobic 
biodegradation of (14C)-sarafloxacin hydrochloride in soil. Environ. 
Toxicol. Chem., 16, 462–471. 
Masse, D.I., Masse, D.L., Droste, R.L., 2000. Effect of antibiotics on psychrophilic 
anaerobic digestion of swine manure slurry in sequencing batch 
reactors. Bioresour. Technol., 75, 205–211. 
Matamoros, V., Caselles-Osorio, A., Garcia, J., and Bayona, J.M. 2008. Sci. Tot. 
Env., 394. 171-176. 
McArdell, C.S., Molnar, E., Suter, M.J.F. and Giger, W. 2003. Occurrence and 
fate of macrolide antibiotics in wastewater treatment plants and in the 
Glatt Valley Watershed, Switzerland. Environ. Sci. Technol., 37, 
5479-5486. 
Mendez-Arriaga, F., Esplugas, S., Gimenez, J., 2008. Photocatalytic degradation 
of non-steroidal anti-inflammatory drugs with TiO2 and simulated 
solar irradiation. Water Res., 42, 585–594. 
Miao, X.S., Bishay, F., Chen, M., Metcalfe, C.D., 2004. Occurrence of 
Antimicrobials in the final effluents of waste water treatment plants in 
Canada. Environ Sci Technol 38.3533–3541. 
Minamisawa, K., Nishioka, K., Miyaki, T., Ye, B., Miyamoto, T., You, M., Saito, 
A., Saito, M., Barraquio, W.L., Teaumroong, N., Sein, T., Sato, T., 
and Barraquio W.L., 2004. Anaerobic nitrogen-fixing consortia 
consisting of clostridia isolated from gramineous plants. Appl. 
Environ. Microbiol., 70(5). 3096-102. 
Miskin, I.P., Farrimond, P., Head, I.M., 1999.Identification of novel bacterial line-
PCR and sequence analysis of amplified 16S rRNA genes ages as 
active members of microbial populations in a freshwater sediment 
using a rapid RNA extraction procedure and RT-PCR. Microbiology-
UK 145. 1977–1987. 
Muyzer, G., De Waal, E.C., and Utterlinden, A.G., 1993. Profiling of complex 
microbial populations by denaturing Gradient Gel Electrophoresis 
analysis of polymerase chain reaction-amplified genes coding for 16S 
rRNA. Appl Environ Microbiol., 59. 695–700.  
Muyzer, G., Hottentrager, S., Teske, A., Wawer, C., 1996. Denaturing gradient 
gel electrophoresis of PCR amplified 16S rDNA – A new molecular 
approach to analyse the genetic diversity of mixed microbial 
communities. In. Akkermans ADL, van Elsas JD & de Bruijn FJ (Eds) 
Molecular Microbial Ecology Manual, 3.4.4, 1–23. Kluwer Academic 
Publishers, Dordrecht, The Netherlands. 
Muyzer, G., Smalla, K., 1998. Application of denaturing gradient gel 
electrophoresis (DGGE) and temperature gradient gel electrophoresis 
(TGGE) in microbial ecology. Antonie Van Leeuwenhoek, 73, 127–
141. 
Nayak, S.S. and Kale, S.P., 2008. PCR and RFLP analysis of anaerobes of 
Nisargruna biogas plant. EBI Gene Data Bank. 
 
 196 
Nogales, B., Timmis, K.N., Nedwell, D.B., Osborn, A.M., 2002. Detection and 
Diversity of Expressed Denitrification Genes in Estuarine Sediments 
after Reverse Transcription-PCR Amplification from mRNA. Appl. 
Environ. Microb., 68(10), 5017-5025. 
Nubel U, Bateson MM, Madigan MT, Kuhl M & Ward DM., 2001. Diversity and 
distribution in hypersaline microbial mats of bacteria related to 
Chloroﬂexus spp. Appl Environ Microbiol., 67. 4365–4371. 
Nubel U, Bateson MM, Vandieken V, Wieland A, Kuhl M & Ward DM., 2002. 
Microscopic examination of distribution and phenotypic properties of 
phylogenetically diverse Chloroﬂexaceae-related bacteria in hot 
spring microbial mats. Appl. Environ Microbiol., 68. 4593–4603. 
Nunoura, T., Oida, H., Miyazaki, J., Miyashita, A., Imachi, H., Takai, K., 2008. 
Quantification of mcrA by fluorescent PCR in methanogenic and 
Methanotrophic microbial communities. FEMS Microbiol Ecol., 64, 
240–247. 
OECD 311, 2006. Anaerobic biodegradability of organic compounds in digested 
sludge – method by measurement of gas production. 
Oka, H., Ikai, Y., Kawamura, N., Yamada, M., Harada, K., Ito, S., Suzuki, M., 
1989. Photodecomposition products of tetracycline in aqueous 
solution. J. Agric. Food Chem., 37, 226–231. 
Oleinick, N. L., 1975. In Mechanism of action of antimicrobial and antitumor 
agents; Corcoran, J. W., Hahn, F. E., Eds.; Springer- Verlag. Berlin. 
Olsen, G. J., Lane D.J., Giovannoni S.J., Stahl and N.R. Pace D.A., 1986. 
Microbial ecology and evolution. a ribosomal RNA approach. Ann. 
Rev. Microbiol., 40.337-365. 
Øvreas, L., Forney, L., Daae, F. L., Torsvik, V., 1997. Distribution of 
bacterioplankton in meromictic Lake Saelevanet, as determined by 
denaturant gradient gel electrophoresis of PCR-amplified gene 
fragments coding for 16S rRNA. Appl. Environ. Microbiol., 63, 3367–
3373. 
Pace, N. R., 1996. New perspective on the natural microbial world. Molecular 
microbial ecology. ASM News, 62.463-470. 
Pace, N. R., 1997. A molecular view of microbial diversity and the biosphere. 
Science, 276.734-740. 
Pace, N. R., Olsen G. J., and Woese C.R., 1986. Ribosomal RNA phylogeny and 
the primary lines of evolutionary descent. Cell, 45.325-326. 
Panichnumsin, P., Chaiprasert, P., Ahring, B.K., Nopharatana, A., 2009. 
Microbial community structure of anaerobic co-digestion of cassava 
pulp and pig manure. EBI Gene Data Bank. 
Paul, T., Miller, P. L., Strathmann, T. J., 2007. Visible-light-mediated TiO2 
photocatalysis of fluoroquinolone antibacterial agents. Environ. Sci. 
Technol., 41, 4720–4727. 
Pavlostathis, S. G., Giraldo-Gomez, E., 1991. Kinetics of anaerobic treatment. A 
review. Critical Reviews in Environmental Control, 21, 411–490. 
 
197 
Payton, M. A., Haddock, B. A., 1986. Principles of biotechnology. Scientific 
fundamentals. Comprehensive Biotechnology, Vol.1. Ed. M. M. 
Young, Pergamon.  
Pearson, W. R., and Lipman, D. J., 1988. Improved tools for biological sequence. 
Proc Natl Acad Sci U S A., 85(8). 2444-2448. 
Pohland, F. G., Suidan, M. T., 1987. Prediction of pH stability in biological 
treatment systems. Chemistry of Wastewater Technology, 37, 441-463. 
Prado, N., Ochoa, J., Amrane, A., 2009a. Biodegradation and biosorption of 
tetracycline and tylosin antibiotics in activated sludge system. Process 
Biochemistry, 44. 1302–1306. 
Prado, N., Ochoa, J., Amrane, A., 2009b. Biodegradation by activated sludge  and 
toxicity of tetracycline into a semi-industrial membrane bioreactor. 
Bioresource Technology, 100. 3769–3774. 
Prasanna, C., Ajmal Khan, S., Lyla, P.S., and Annu, K., 2010. Metagenomics of 
methanogenic archeae. EBI Gene Data Bank. 
Probst, A., Vaishampayan, P., Osman, S., Moissl-Eichinger, C., Venkateswaran, 
K., and Andersen, GL., 2010. Diversity of anaerobic microbes in 
spacecraft assembly clean rooms. Appl. Environ. Microbiol., 76(9). 
2837-45. 
Qiting, J., Xiheng, Z., 1988. Combination process of anaerobic digestion and 
ozonization technology for treating wastewater from antibiotics 
production. Wat. Treat., 3, 285–291. 
Rahman, S.Z., Khan, R.A., Gupta, V., Uddin, M., 2007. 
Pharamacoenvironmentology – a component of pharmacovigilance. 
Environ Health, 6.1–3. 
Raskin, L., Rittmann, B.E., Stahl, D.A., 1996. Competition and coexistence of 
sulfate-reducing and methanogenic populations in anaerobic biofilms. 
Applied and Environmental Microbiology, 62, 3847-3857. 
Raskin, L., Stromley, J. M., Rittmann, B. E., Stahl, D.A., 1994. Group-specific 
16S rRNA hybridization probes to describe natural communities of 
methanogens. Appl. Environ. Microbiol., 60 (4), 1232–1240. 
Rastogi, G. and Shouche, Y.S., 2005. Molecular Phylogenetic Analysis of 
Methanogens from Biogas Plants. EBI Gene Data Bank. 
Ratusznei, S. M., Rodrigues, J. A. D., Zaiat, M., 2003. Operating feasibility of 
anaerobic whey treatment in a stirred sequencing batch reactor 
containing immobilized biomass. Water Science and Technology, 48, 
179–186.  
Ravina, M., Campanella, L., Kiwi, J., 2002. Accelerated mineralization of the drug 
diclofenac via Fenton reactions in a concentric photo-reactor. Water 
Res., 36, 3553–3560. 
Rawls, J.F., Mahowald, M.A., Ley, R.E., Gordon, J.I., Rawls, J.F., 2006. 
Reciprocal gut microbiota transplants from zebrafish and mice to 
germ-free recipients reveal host habitat selection. Cell, 127(2). 423-
33. 
 198 
Reysenbach, A.L., Giver, L.J., Wickham, G.S., Pace, N.R., 1992. Differential 
amplification f rRNA genes by polymerase chain reaction. Appl 
Environ Microbiol., 58. 3417-3418. 
Richardson, M.L., Bowron, J.M., 1985. The fate of pharmaceutical chemicals in 
the environment. J. Pharm. Pharmacol., 37, 1–12. 
Riviere, D., Desvignes, V., Pelletier, E., Chaussonnerie, S., Guermazi, S., 
Weissenbach, J., Li, T., Camacho, P., and Sghir, A., 2009. Towards 
the definition of a core of microorganisms involved in anaerobic 
digestion of sludge. ISME J., 3(6). 700-714. 
Rodriguez-Rodriguez, C.E., Jelic, A., Llorca, M., Farrel, M., Caminal, G., 
Petrovic, M., Barcelo, D., Vicent, T., 2011. Solid-phase treatment 
with the fungus Trametes versicolor substantially reduces 
pharmaceutical concentrations and toxicity from sewage sludge. 
Biores. Tech., DOI. 10.1016/j.biortech.2011.02.029. 
Rönnefahrt, I., 2005. Verbrauchsmengen in der Bewertung des Umweltrisikos von 
Humanarzneimitteln, In. Umweltbundesamt (Hrsg) Arzneimittel in 
der Umwelt – Zu Risiken und Nebenwirkungen fragen Sie das 
Umweltbundesamt. Dessau, UBA texte 29/05.  
Rui, J., Peng, J., Lu, Y., 2009. Succession of bacterial populations during plant 
residue decomposition in rice field soil. Appl. Environ. Microbiol., 
75(14).4879-4886. 
Ruiz, I., Blazquez, R., Soto, M., 2009. Methanogenic toxicity in anaerobic digesters 
treating municipal wastewater. Biores. Tech., 100, 97-103. 
Saitou, N., and Nei, M., 1987. The neighbor-joining method. a new method for 
reconstructing phylogenetic trees. Mol. Biol. Evol., 4.406-425. 
Samuelsen, O.B., 1989. Degradation of oxytetracycline in seawater at two different 
temperatures and light intensities, and the persistence of 
oxytetracycline in the sediment from a fish farm. Aquaculture, 83, 7–
16. 
Samuelsen, O.B., Lunestad, B.T., Fjelde, S., 1994. Stability of antibacterial agents 
in an artificial marine aquaculture sediment studied under laboratory 
conditions. Aquaculture, 126, 183–290. 
Samuelsen, O.B., Solheim, E., Lunestad, B.T., 1991. Fate and microbiological 
effects of furazolidone in a marine aquaculture sediment. Sci. Total 
Environ., 108, 275–283. 
Samuelsen, O.B., Torsvik, V., Ervik, A., 1992. Long-range changes in 
oxytetracycline concentration and bacterial resistance towards 
oxytetracycline in fish farm sediment after medication. Sci. Total 
Environ., 114, 25–36. 
Santegoeds, C.M., Ferdelman, T.G., Muyzer, G., de Beer, D., 1998. Structural 
and functional dynamics of sulfate-reducing populations in bacterial 
biofilms. Applied and Environmental Microbiology, 64, 3731–3739. 
 
 
199 
Santegoeds, C.M., Nold, S.C., Ward, D.M., 1996. Denaturing gradient gel 
electrophoresis used to monitor the enrichment culture of aerobic 
chemoorganotrophic bacteria from a hot spring cyanobacterial mat. 
Applied and Environmental Microbiology, 62, 3922–3928. 
Sanz, J.L., Rodriguez, N., Amils, R., 1996. The action of antibiotics on the 
anaerobic digestion process. Appl. Microbiol. Biotechnol., 46, 587–
592. 
Sanz, J., Kochling, T., 2007. Molecular biology techniques used in wastewater 
treatment. An overview. Process Biochem., 42, 119-133. 
Sawayama, S., Tsukahara, K., Yagishita, T., 2006. Phylogenetic description of 
immobilized methanogenic community using real-time PCR in a 
fixed-bed anaerobic digester. Bioresource Technology, 97, 69–76. 
Sattelberger, S., 1999. Arzneimittelruckstande in der Umwelt, Bestandsaufnahme 
und Problemstellung. Report des Umweltbundesamtes Österreich, 
Wien. 
Schmidt, B., Ebert, J., Lamshöft, M., Thiede, B., Schumacher-Buffel, R., Ji, R., 
Corvini, P.F., Schäffer, A., 2008. Fate in soil of (14)C-sulfadiazine 
residues contained in the manure of young pigs treated with a 
veterinary antibiotic. J. Environ. Sci. Heal. B., 43, 8–20. 
Schwarz, J.I.K., Lueders, T., Eckert, W., Conrad, R., 2007. Identification of 
acetate-utilizing Bacteria and Archaea in methanogenic profundal 
sediments of Lake Kinneret (Israel) by stable isotope probing of 
rRNA. Environ. Microbiol., 9(1). 223-237. 
Schrenk, M.O., Kelley, D.S., Delaney, J.R., Baross, J.A., 2003. Incidence and 
diversity of microorganisms within the walls of an active deep-sea 
sulfide chimney. Applied and Environmental Microbiology, 69 (6). 
3580-3592. 
Sedlak, D.L., Pinkston, K. and Huang, C.H. 2005. Occurrence survey and of 
pharmaceutically active compounds. Denver, CO. Awwa Research 
Foundation.  
Seghezzo, L., Zeeman, G., van Lier, J.B., Hamelers, H.V.M., Lettinga, G., 1998. 
A review. the anaerobic treatment of sewage in UASB and EGSB 
reactors. Bioresource Technology, 65, 175–190. 
Segura, P.A., Francois, M., Gagnon, C., Sauve, S., 2009. Review of the 
Occurrence of Anti-infectives in Contaminated Wastewaters and 
Natural and Drinking Waters. Environ. Heal. Perspec., 117, 675-684. 
Schroder, H.F., 2002. Mass spectrometric monitoring of the degradation and 
elimination efficiency for hardly eliminable and hardly biodegradable 
polar compounds by membrane bioreactors. Water Sci. Technol., 46, 
57–64. 
Shi, Y., Zwolinski, M.D., Schreiber, M.E., Bahr, J.M., Sewell, G.W., Hickey, 
W.J., 1999. Molecular analysis of microbial community structures in 
pristine and contaminated aquifers. field and laboratory microcosm 
experiments. Appl. Environ. Microbiol., 65, 2143–2150. 
 200 
Shi, J.C., Liao, X.D., Wu, Y.B., Liang, J.B., 2011. Effect of antibiotics on methane 
arising from anaerobic digestion of pig manure. Animal Feed Science 
and Technology, doi.10.1016/j.anifeedsci.2011.04.033.   
Shimada, T, Zilles, J.L., Morgenroth, E., and Raskin, L., 2008. Inhibitory Effects 
of the Macrolide Antimicrobial Tylosin on Anaerobic Treatment. 
Biotechnology and Bioengineering, 101 (1). 73-82. 
Shinzato, N., Matsumoto, T., Yakaoka, I., Oshima, T., and Yamagoshi, A., 1999. 
Phylogenetic diversity of symbiotic methanogens living in the hindgut 
of the lower termite Reticulitermes speratus analysed by PCR and in 
situ hybridisation. Appl Environ Microbiol., 65. 837–840. 
Siggins, A., Enright, A.M., O’Flaherty, V., 2011. Methanogenic community 
development in anaerobic granular bioreactors treating 
trichloroethylene (TCE)-contaminated wastewater at 37 ºC and 15 ºC. 
Water Research, 45, 2452- 2462. 
Smit, E., Leeflang, P.,Wemars, K., 1997. Detection of shifts in microbial 
community structure and diversity in soil caused by cooper 
contamination using amplify ribosomal DNa restriction analysis. 
FEMS Microbiol Ecol., 23.249-261. 
Snaidr, J., Amann, R., Huber, I., Ludwig, W., Schleifer, K.-H., 1997. 
Phylogenetic analysis and in situ identification of bacteria in activated 
sludge. Appl. Environ. Microbiol., 63, 2884–2896. 
Sousa, D.Z., Smidt, H., Alves, M.M., Stams, A.J., 2007. Syntrophomonas zehnderi 
sp. nov., an anaerobe that degrades long-chain fatty acids in co-culture 
with Methanobacterium formicicum. Int. J. Syst. Evol. Microbiol., 
57(Pt 3). 609-15. 
Speece, R.E., 1996. Anaerobic Biotechnology for Industrial Wastewaters. Archae 
Press, Tenesse, USA. 
Speir, T.W., van Schaik, A.P., Hunter, L.C., Ryburn, J.L., and Percival, H.J., 
2007. Attempts to derive EC50 values for heavy metals from land-
applied Cu-, Ni-, and Zn-spiked sewage sludge, Soil Biol. And 
Biochem., 39, 539-549. 
Sponza, D.T. and Demirden, P., 2007. Treatability of sulfamerazine in sequential 
upflow anaerobic sludge blanket reactor (UASB)/completely stirred 
tank reactor (CSTR) processes. Separation and Purification 
Technology, 56. 108–117. 
Stahl, D.A., Flesher, B., Mansfield, H.R., Montgomery, L., 1988. Use of 
phylogenetically based hybridization probes for studies of ruminal 
microbial ecology. Applied and Environmental Microbiology, 54, 
1079–1084. 
Stams, A. J. M.; Dong, X. Z., 1995. Role of formate and hydrogen in the 
degradation of propionate and butyrate by defined suspended 
cocultures of acetogenic and methanogenic bacteria. Antonie Van 
Leeuwenhoek Int. J Gen. Mol. Microbiol., 68 (4), 281-284. 
 
 
201 
Stams, A.J.M., Alfons, J. M., de Bok, F.A.M., Plugge, C.M., van Eekert, M.H.A., 
Dolfing, J., Schraa, G., 2006. Exocellular electron transfer in 
anaerobic microbial communities. Environmental Microbiology, 8, 3, 
371–382. 
Stockholm County Council. 2005. Environmentally classified pharmaceuticals, 
Miljöavdelningen (Department of the environment, www. 
Janusinfo.se/miljoklassificering), Stockholm, Sweden. 
Stone, J.J., Clay, S.A. Zhu, Z., Wong, K.L., Porath, L.R., Spellman, G.M., 2009. 
Effect of antimicrobial compounds tylosin and chlortetracycline 
during batch anaerobic swine manure digestion. Water Research, 43. 
4740–4750. 
Stone, J.J., Clay, S.A., Spellman, G.M., 2010. Tylosin and chlortetracycline effects 
during swine manure digestion. Influence of sodium azide. 
Bioresource Technology, 101. 9515–9520. 
Stronach, S.M., Rudd, T., Lester, J.N., 1986. Anaerobic Digestion Processes in 
Industrial Wastewater Treatment. Springer Verlag, Berlin. 
Stuer-Lauridsen, F., Birkved, M., Hansen, L.P., Lutzhoft, H.C.H. and Halling-
Sorenson, B., 2000. Environmental risk assessment of human 
pharmaceuticals in Denmark after normal therapeutic use. 
Chemosphere, 40, 783-793. 
Sung, S., Dague, R.R., 1995. Laboratory studies on enhancement of granulation in 
the anaerobic sequencing batch reactors. Water Environment 
Research, 67, 294–301. 
Suzuki, M.T., Giovannoni, S.J., 1996. Bias caused by template annealing in the 
amplification of mixtures of 16S rRNA genes by PCR. Applied and 
Environment Microbiology, 62, 625-630. 
Sweetman, S.C. (Ed.), 2009. Martindale. The complete drug reference, 36
th
 edition. 
Pharmaceutical Press, London UK. 
Takai K., Horikoshi K., 2000. Rapid detection and quantification of members of the 
archaeal community by quantitative PCR using fluorogenic probes. 
Applied Environmental Microbiology, 66, 5066–5072. 
Tchobanoglous, G., Burton, F.L., Stensel, H.D., 2003. Wastewater engineering, 
treatment and reuse, fourth ed., McGraw-Hill, New York. 
Ternes, T.A., Stuber, J., Herrmann, N., McDowell, D., Ried, A., Kampmann, 
M., 2003. Ozonation: a tool for removal of pharmaceuticals, contrast 
media and musk fragrances from wastewater? Water Research, 37(8), 
1967-1982. 
Teiser, B., 2003. Ozonation. a tool for removal of pharmaceuticals, contrast media 
and musk fragrances from wastewater? Water Res., 37, 1976–1982. 
Ternes, T.A., Joss, A. (Eds.), 2006. Human Pharmaceuticals, Hormones and 
Fragrances. The Challenge of Micro-pollutants in Urban Water 
Management. IWA Publishing, London. 
Thiele-Bruhn, S., 2003. Pharmaceutical antibiotic compounds in soils – a review. J. 
Plant. Nutr. Soil Sci., 166, 145–167. 
 202 
 
Thomas, K.V., 2008. The relevance of different point sources. Lecture given at the 
‗‗First International Conference on Sustainable Pharmacy‖, 24–25. 
April 2008, Osnabruck, Germany 
<http.//www.dbu.de/550artikel27307_135.html>. 
Timur., H., Özturk., I., 1999. Anaerobic treatment of leachate using sequencing 
batch reactor and hybrid bed filter. Water Research, 33, 3225–3230. 
Tolls, J., 2001. Sorption of veterinary pharmaceuticals in soils. a review. Environ. 
Sci. Technol., 35, 3397–3406. 
Trautwein, C., Metzger, J., Kummerer, K., 2008. Aerobic biodegradability of the 
calcium channel antagonist verapamil and identification of the dead-
end metabolite 2-(3,4-dimethoxyphenyl)-2isopropyl-5-(methylamino) 
pentane nitrile. Chemosphere, 72, 442–450. 
Trivedi, P., Vasudevan, D., 2007. Spectroscopic investigation of ciprofloxacin 
speciation at the goethite-water interface. Environ. Sci. Technol., 4, 
3153–3158. 
Turiel, E., Bordin, G., Rodríguez, A.R., 2005. Study of the evolution and 
degradation products of ciprofloxacin and oxolinic acid in river water 
samples by HPLC–UV/ MS/MS–MS. J. Environ. Monitor., 7, 189–
195. 
Ueki, A., Ueki, K., Kaku, N., Abe, K., 2007. Community structure of Bacteria in a 
methanogenic fermenter of cattle waste and some characteristics of 
fermentative bacterial isolates. EBI Gene Data Bank. 
Ueki, A., Kaku, N., Ueki, K., and Sugawara, Y., 2009. Microbial community. EBI 
Gene Data Bank. 
Union of Concerned Scientists, 2001. 70 Percent of all Antibiotics Given to 
Healthy Livestock. Press release, 8 January, Cambridge, MA 
Vachée, A., Vincent, P., Struijk, C.B., Mossel, D.A.A. and Leclerc, H., 1997. A 
study of the fate of the autochthonous bacterial flora of still mineral 
waters by analysis of restriction fragment length polymorphism of 
genes coding for rRNA.  Syst. Appl. Microbiol., 20, 492–503. 
van der Meer JR., de Vos WM, Harayama, S., and Zehnder AJB., 1992. 
Molecular Mechanisms of Genetic Adaptation to Xenobiotic 
Compounds. Microbiological Reviews, 56 (4), 677-694. 
van de Peer, Y., van der Auwera G., de Wachter R., 1996. The evolution of 
stramenopiles and alveolates as derived by "substitution rate 
calibration" of small ribosomal subunit RNA. Journal of molecular 
evolution, 42, 201-210. 
Verbrugh, H.A., de Neeling, A.J., Eds, 2003. Consumption of antimicrobial agents 
and antimicrobial resistance among medically important bacteria in 
the Netherlands. SWAB NETHMAP. 
 
 
 
203 
Viola, G., Facciolo, L., Canton, M., Vedaldi, D., Dall’Acqua, F., Aloisi, G.G., 
Amelia, M., Barbafina, A., Elisei, F., Latterini, L., 2004. 
Photophysical and phototoxic properties of the antibacterial 
fluoroquinolones levofloxacin and moxifloxacin. Chem. Biodivers., 1, 
782–801. 
Visvanathan, C., Ben Aim, R., and Parameshwaran, K. 2000. Membrane 
separation bioreactors for wastewater treatment. Crit. Rev. Environ. 
Sci. Technol., 30(1).1–48. 
Wagner, M., Amann, R. I., Lemmer, H., Schleifer, K.-H. 1993. Probing activated 
sludge with oligonucleotides specific for proteobacteria. inadequacy 
of culture-dependent methods for describing microbial community 
structure. Appl. Environ. Microbiol., 59, 1520–1525. 
Wagner, M., Rath, G., Amann, R., Koops, H.P., Schleifer, K. H., 1995. In-situ 
identification of ammonia-oxidizing bacteria. Syst Appl Microbiol., 
18. 251–264. 
Watanabe, K., Kodama, Y., Hamamura, N., and Kaku, N., 2002. Diversity, 
abundance, and activity of archaeal populations in oil-contaminated 
groundwater accumulated at the bottom of an underground crude oil 
storage cavity. Appl. Environ. Microbiol., 68(8). 3899-3907. 
Werner, J. J., Arnold, W. A., McNeill, K., 2006. Water hardness as a 
photochemical parameter. tetracycline photolysis as a function of 
calcium concentration, magnesium concentration, and pH. Environ. 
Sci. Technol., 40, 7236–7241. 
Werner, J. J., Chintapalli, M., Lundeen, R. A., Wammer, K. H., Arnold, W. A., 
McNeill, K., 2007. Environmental photochemistry of tylosin. 
efficient, reversible photoisomerization to a less-active isomer, 
followed by photolysis. J. Agric. Food Chem., 55, 7062–7068. 
Whiticar, M. J., Faber, E., Schoell M., 1986. Biogenic methane formation in 
marine and freshwater environments. CO2 reduction vs. acetata 
formation-isotope evidence. Geochimica et Cosmochimica Acta, 
50(5). 693-709. 
Wiethan, J., Al-Ahmad, A., Henninger, A., Kummerer, K., 2000. Simulation des 
Selektionsdrucks der Antibiotika Ciprofloxacin und Ceftazidim in 
Oberflächengewässern mittels klassischer Methoden (Simulation of 
the selection pressure of the antibiotics ciprofloxacin and ceftazidim 
in surface water with classical methods). Vom Wasser, 95, 107–118. 
Wise, R., 2002. Antimicrobial resistance. priorities for action. J. Antimicrob. 
Chemoth., 49, 585–586. 
Woese, C.R., 1987. Bacterial evolution. Microbiology Reviews, 51, 221–271. 
Wu, J. H., Liu, W. T., Tseng, I. C., Cheng, S. S., Wu, J., Liu, W., Tseng, I., and 
Cheng, S., 2001. Characterization of a 4-methylbenzoate-degrading 
methanogenic consortium as determined by small-subunit rDNA 
sequence analysis. J. Biosci. Bioeng., 91(5). 449-55. 
 204 
Wu, X., Wei, Y., Zheng, J., Zhao, X., Zhong, W., 2011. The behavior of 
tetracyclines and their degradation products during swine manure 
composting. Bioresource Technology., 102. 5924–5931. 
Xing, J., Criddle, C., Hickey, R., 1997. Effects of a long-term periodic substrate 
perturbation on an anaerobic community. Water Research, 31, 2195-
2204. 
Xing, W., Zhao, Y., Zuo, J.E., 2010. Microbial activity and community structure in 
a lake sediment used for psychrophilic anaerobic wastewater 
treatment. J. Appl. Microbiol., 109(5). 1829-1837.  
Xu, W., Zhang, G., Li, X., Zou, S., Li, P., Hu, Z., and Li, J., 2007. Occurrence and 
elimination of antibiotics at four sewage treatmentplants in the Pearl 
River Delta (PRD), South China, Water Res., 41, 4526–4534. 
Xu, B., Mao, D., Luo, Y, and Xu, L., 2011. Sulfamethoxazole Biodegradation and 
Biotransformation in the Water-Sediment System of a Natural River. 
Bioresource Technology, 10.1016/j.biortech.2011.04.086. 
Yang, D., Kaine, B.P., Woese, C.R., 1985. The phylogeny of archaebacteria Syst. 
Appl. Microbiol. 6.251-256. 
Zeeman, G., Sanders, W.T.M., Wang, K.Y., and Lettinga, G., 1996. Anaerobic 
treatment of complex wastewater and waste activated sludge- 
application of an upflow anaerobic removal (UASR) reactor for the 
removal and pre-hydrolysis of suspended COD. IAWQ-NVA 
Conference for Advanced Wastewater Treatment, Amsterdam, 23-35. 
Zhang, Y., Zamudio Canas, E.M., Zhu, Z., Chen, S., Linville, J.L., He, Q., 2010. 
Anaerobic Co-digestion of Dairy Cow Manure with Chicken Litter. 
EBI Gene Data Bank. 
Zhao, L., Dong, Y.H., Wang, H., 2010. Residues of veterinary antibiotics in 
manures from feedlot livestock in eight provinces of China. Sci. Total 
Environ., 408 (5), 1069–1075. 
Zinder S.H., 1993. Physiological ecology of methanogens. In Methanogenesis - 
Ecology, Physiology, Biochemistry & Genetics (ed. J. G. Ferry), 
Chapman & Hall, Inc., 128-206. 
Zoutberg, G.R., Frankin, R., 1996. Anaerobic treatment of chemical and brewery 
wastewater with a new type of anaerobic reactor. the Biobed EGSB 
reactor. Water Science and Technology, 34, 5-6, 375–381. 
Zuckerkandl E. and Pauling L., 1965. Molecules as documents of evolutionary 
history. J. Theor. Biol. 8. 357-366. 
Zuhlke, S., Dunnbier, U., Heberer, T., 2004. Detection and identification of 
phenazone-type drugs and their microbial metabolites in ground- and 
drinking water applying solid-phase extraction and gas 
chromatography with mass spectrometric detection. J. Chromatogr. A, 
1050, 201–209. 
Url-1<http://www.chemicalbook.com/CAS/GIF/723-46-6.gif>, accessed at 
12.06.2011. 
 
 
205 
Url-2<http://www.chemicalbook.com/CAS/GIF/114-07-8.gif>, accessed at 
12.06.2011. 
Url-3<http://www.chemicalbook.com/CAS/GIF/60-54-8.gif>, accessed at 
12.06.2011. 
 
 
 
 
 
 
 
207 
CURRICULUM VITAE  
Candidate’s full name.  Zeynep Çetecioğlu 
Place and date of birth.  Istanbul, 14/02/1981 
Permanent Address.  İstanbul Teknik Üniversitesi İnşaat Fakültesi Çevre 
Mühendisliği Bölümü Ayazağa Kampüsü Maslak 
34469 Istanbul 
Universities and Colleges attended.   
  
2006- Present. PhD, ITU Institute of Science and Technology, Environmental 
Biotechnology Programme  
2004 – 2006. M.Sc., ITU Institute of Science and Technology, Environmental 
Biotechnology Programme 
2002 – 2006.  B.Sc., ITU Faculty of Science and Letter, Molecular Biology and 
Genetics Department  
2000 – 2004.  B.Sc., ITU Faculty of Civil Engineering, Environmental Engineering 
Department  
Publications. 
Cetecioglu, Z., Ince, B., Azman, S., Insel, G., Orhon, D., Ince, O., 2011. Acute 
inhibitory impact of antimicrobials on acetoclastic methanogenic activity, Journal of 
Hazardous Materials, submitted. 
 
Basak, B., Ince, O., Ince, B., Cetecioglu, Z., Celikkol, S., Kolukirik, M., 2011. 
Effect of Nitrogen Deficiency during SBR Operation on PHA Storage and Microbial 
Diversity, Environmental Technology, Accepted. 
 
Ince, B., Koksal, G., Cetecioglu, Z., Oz, N.A., Coban, H., Ince, O., 2011. Inhibition 
effect of isopropanol on acetyl-CoA synthetase expression level of acetoclastic 
methanogen, Methanosaeta concilii, Journal of Biotechnology, 156 (2): 95-99. 
 
Kolukirik, M., Ince, O., Cetecioglu, Z., Celikkol, S., Ince, B.K., 2011. Local and 
Seasonal Changes in Microbial Diversity of the Marmara Sea Sediments, Marine 
Pollution Bulletin, 62 (11): 2384-2394. 
 
Ince, O., Kolukirik, M., Cetecioglu, Z., Eyice, O., Inceoglu, O., Ince, B., 2009. 
Toluene Inhibition of an Anaerobic Reactor Sludge in Terms of Activity and 
Composition of Acetoclastic Methanogens. Journal of Environmental Science and 
Health- Part A. Toxic/Hazardous Substances & Environmental Engineering, 44 (14), 
1551-1556. 
 208 
 
Cetecioglu, Z., Ince, B.K., Kolukırık, M., Ince, O., 2009. Biogeographical 
Distribution and Diversty of Bacterial and Archaeal Communities within Highly 
Polluted Anoxic Marine Sediments from the Marmara Sea, Marine Pollution 
Bulletin, 58 (3), 384-395. 
 
Ince, O., Kolukirik, M., Cetecioglu, Z., Eyice, O., Tamerler, C., Ince, B., 2007. 
Methanogenic and sulfate reducing bacterial population levels in a full-scale 
anaerobic reactor treating pulp and paper industry wastewater using fluorescence in 
situ hybridization. Water Science and Technology, 55 (10). 183–191. 
